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CHAPTER I 
 
INTRODUCTION TO ISOKETAL-MEDIATED OXIDATIVE DAMAGE AND ITS 
EFFECTS ON AGING 
 
Introduction 
 Free radical attack of tissue biomolecules, such as lipids, are major indicators of oxidative 
stress. (Gardner 1989, Niki 2009).  Upon oxidant injury, free radicals readily attack lipid 
biomolecules which forms of a wide variety of peroxidation products. Accumulation of lipid 
peroxidation products has been thought to contribute to the pathogenesis in a number of human 
diseases, including, but not limited to atherosclerosis, cancer, and neurodegenerative diseases 
(Halliwell and Gutteridge 1990, Gutteridge 1995, Butterfield 1997).  The formation of secondary 
products of lipid peroxidation, such as the reactive aldehydes, play a pivotal role in the propagation 
of oxidative damage (Poon, Calabrese et al. 2004).  Lipid peroxidation byproducts, including 
malondialdehyde (MDA), a potential crosslinking agent, and the reactive hydroxyalkenals, are 
known to serve a dual role in propagating and partially mediating the deleterious effects of lipid 
peroxidation (Comporti 1998, Poon, Calabrese et al. 
2004).   
A family of 64 highly reactive levuglandin-
like -ketoaldehyde (-KA, or isoketals, IsoK) regio- 
and stereo-isomers are formed as products of the 
isoprostane pathway via rearrangement of 
prostaglandin H2-like endoperoxide intermediates 
(H2-isoprostanes) (Morrow, Hill et al. 1990, Brame, 
 
Figure 1.1. Isoketal synthesis from the 
non-enzymatic oxygenation of 
arachidonic acid 
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Salomon et al. 1999) (Fig. 1.1). H2-IsoPs undergo non-enzymatic rearrangement to form F2-IsoPs, 
D2-IsoPs, E2-IsoPs, and highly reactive IsoKs (Davies, Amarnath et al. 2004).  
Although F2-IsoPs and IsoKs are formed through the same pathway, both species play 
vastly differing functions in the body. According to the Biomarkers of Oxidative Stress Study 
(BOSS), quantification of F2-IsoPs is one of the most reliable approaches to assess oxidative stress 
in vivo, which has allowed for establishment of the important role of oxidant injury in numerous 
human diseases (Morrow, Hill et al. 1990, Kadiiska, Basu et al. 2013). In contrast, IsoKs 
irreversibly and rapidly react with the -amino lysyl residues of proteins, forming stable adducts 
and intramolecular cross-links. Therefore, IsoK generation and subsequent adduction can produce 
deleterious effects, consequently resulting in negative attenuation of biological function via protein 
modification. As stated previously, F2-IsoPs and IsoKs are generated in the same pathway, formed 
in tissues from arachidonic acid esterified to phospholipids, upon an acute oxidative injury 
(Morrow, Harris et al. 1990, Brame, Boutaud et al. 2004). Both F2-IsoP and IsoK levels rise 
swiftly, in a matter of hours after oxidative injury, yet clearance occurs on different orders of 
magnitude for the two species. F2-IsoPs have a half-life of less than 20 minutes, and it is due to 
this rapid clearance that F2-IsoPs can readily be measured in plasma or urine (Moore 2004). 
However, in direct contrast to the rapid clearance of F2-IsoPs, IsoKs are not immediately cleared 
from the body due to its proclivity to forming protein adducts.  
There is considerable interest in the biological relevance of IsoKs, partially because of their 
potential in modifying proteins to cause cellular dysfunction, along with initial findings suggesting 
a likelihood of IsoK involvement in the mechanisms of disease. This interest is in part due to basic 
features of their biochemistry: IsoKs rapidly adduct to solvent-accessible lysine residues of 
proteins (Brame, Salomon et al. 1999), have a propensity to cross-link proteins (Iyer, Ghosh et al. 
3 
 
1989, Boutaud, Li et al. 2001, Boutaud, Ou et al. 2002, Davies, Amarnath et al. 2002), and lastly, 
known to adduct to aminophospholipids (Sullivan, Matafonova et al. 2010). 
Discovery of -Ketoaldehydes 
In 1990, Morrow, Roberts, and colleagues reported the formation of prostaglandin (PG)-
like compounds in vivo, termed isoprostanes, by free radical-induced peroxidation of biologically 
relevant poly unsaturated fatty acids (PUFAs) such as arachidonic acid (AA, C20:4, -6) and 
eicosapentaenoic acid (EPA, C20:5, n-3)  (Morrow, Harris et al. 1990). Highly labile, PGH2-like 
intermediates in the IsoP pathway are unstable and undergo non-enzymatic rearrangement   in vivo 
to form E2-IsoPs, D2-IsoPs, and isothromboxanes along with F2-IsoPs (Morrow, Minton et al. 
1994, Morrow, Awad et al. 1996).  
 Studies indicate IsoKs could be the most prevalent H2-IsoP product rearrangement product 
in vivo, which was discovered through research conducted to assess the percent yield of 
levulinaldehyde product formation upon lipid peroxidation. If IsoKs were the major agents of 
oxidant-mediated cellular dysfunction, it would be reasonable to predict a high abundance of -
ketoaldehydes formation in the event of arachidonic acid peroxidation. To investigate the yield of 
IsoK formation from the rearrangement of H2-IsoPs, the precursor PGH2 was oxidized in a neutral 
phosphate buffer solution. PGH2 was used instead of arachidonic acid because of the relative 
convenience in obtaining PGH2 enzymatically rather than the labor-intensive efforts in isolating 
the H2-IsoPs from the mixture formed during oxidation of arachidonic acid. Thus, incubation of 
PGH2 in phosphate buffered solution results in 22% yield of -ketoaldehyde (Salomon, Miller et 
al. 1984).  Although this unexpected low yield indicate little probability of IsoK-mediated oxidant 
damage, Salomon and colleagues postulated this result was due to utilizing a solvent dissimilar to 
its endogenous environment. The rationale was due to the fact H2-IsoPs form in a lipophilic 
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environment, considering the arachidonic acid (or other PUFA moiety) is still esterified to the 
phospholipids (Morrow, Awad et al. 1992). Therefore, repeating the experiment in a more 
hydrophobic buffer would result in a different percent yield of IsoK which more closely mimics 
the endogenous environment during its rearrangement. When the reaction was repeated in the more 
hydrophobic organic solvent, dimethyl sulfoxide (DMSO), 70% of yield was -ketoaldehyde 
(Salomon, Miller et al. 1984, Salomon 1985), which is remarkable because this suggests that IsoKs 
could be the major product of H2-IsoP rearrangement in vivo.  
The question of whether -ketoaldehydes are biologically relevant lipid peroxidation 
products still remains. Considering that the IsoP endoperoxides undergo rearrangement to form 
various eicosanoids, Brame and colleagues sought to evaluate the relevance of -ketoaldehydes by 
first quantifying the formation of these products upon oxidant insult. Although their biochemical 
reactivity to proteins suggest a compelling contribution to disease development, Brame et al. 
probed whether level of IsoK generation after acute oxidative injury was sufficient in mediating 
deleterious effects from protein adduction. In order to determine the relative abundance of IsoK 
formation relative to other H2-IsoP rearrangement products, arachidonic acid was oxidized using 
iron/ascorbate/ADP in a neutral phosphate buffer. The percent composition of the H2-IsoP 
rearrangement products was then analyzed by gas chromatography-mass spectrometry (GC/MS) 
after derivatization (Fig. 1.2). For every 1 mg of arachidonic acid oxidized, 1.8 g of E2/D2-IsoP 
is formed, along with 1.2 g IsoK and 0.8 g F2-IsoPs (Brame, Salomon et al. 1999). From this, 
Brame and colleagues established that IsoK formation occurs at comparable rates to F2-IsoP 
formation. Considering the relative amount of IsoK and F2-IsoP formation, one can predict 
conditions that increase F2-IsoP levels will likely raise IsoK levels in tandem.   
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-Ketoaldehydes Cross-link Proteins 
IsoKs react covalently to lysyl residues of proteins to form a stable adduct and 
intramolecular cross-links (Iyer, Ghosh et al. 1989, Boutaud, Brame et al. 1999, Brame, Salomon 
et al. 1999). These molecules react at a rate that far exceeds other well studied products of lipid 
peroxidation, including 4-hydroxynonenal (4-HNE) (Brame, Salomon et al. 1999). One of the 
earliest conundrums facing investigators was the lack of detectable IsoK in tissues such as plasma 
and urine, despite the wealth of F2-IsoPs as determined by GC/MS. In addition, although large 
quantities of F2-IsoPs were found in iron/ADP/ascorbate treated liver microsomes, investigators 
failed to detect IsoKs in the samples. Keeping in mind the relative ratio of IsoKs and F2-IsoPs 
formed upon arachidonic acid peroxidation, detection of F2-IsoPs in biological samples should in 
theory also indicate the occurrence of IsoK formation. In order to understand this phenomenon, 
Brame and colleagues carried out studies to determine if rate of reactivity of IsoKs with proteins 
could potentially explain the lack of IsoK detection in biological samples.  
Brame and colleagues incubated synthetic IsoK with a protein source, bovine serum 
albumin, and observed a swift depletion in free IsoK, where within 20 s less than 50% of the free 
n
g
/m
g
 a
ra
c
h
id
o
n
ic
 a
c
id
0
450
900
1350
1800
2250
E2/D2-IsoPs    IsoKs       F2-IsoPs
Figure 1.2. IsoK formed in tandem with other H2-IsoP rearrangement products upon 
oxidation of arachidonic acid   
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compound remained (Brame, Salomon et al. 1999). When another fast reacting lipid alkenal, 4-
hydroxynonenal (4-HNE), was incubated with albumin, the investigators observed a period of 80 
min for the level of free 4-HNE to reduce to 50%, which corroborates with previously published 
reaction rates. Bearing in mind the fast rate of IsoK depletion, these results suggest that IsoK is 
largely found as an adduct on any macromolecule containing a solvent-accessible amine group. 
The reaction of isoketals with lysine forms pyrrole adducts which then rearrange into lactam, 
hydroxylactam, or cross-linked adducts under oxidizing conditions. In addition, when oxidation of 
protein pyrrole adducts occur in the proximity of other nucleophiles, such as cysteine, cross-
linkage occurs between the amino acid residues. (Amarnath, Valentine et al. 1994). 
 Seeing that highly reactive -ketoaldehydes are known to react with amine groups to form 
protein crosslinks, Davies and colleagues set out studies assaying the conditions in which 
intramolecular crosslinkage occurs. Considerate attention was given in observing which conditions 
gave rise to IsoK-protein crosslinkage, such as IsoK to protein ratio, protein concentration, and the 
concentration of other nucleophiles in close proximity.  When IsoK is added to ovalbumin (OVA) 
in phosphate buffer in a 1:1 ratio, a slight fraction of monomer is converted to high molecular 
weight oligomers via intramolecular cross-links (Davies, Amarnath et al. 2002). Isoketals crosslink 
proteins more potently and rapidly than other known reactive lipid aldehydes (Davies, Amarnath 
et al. 2002), to where HNE and MDA concentrations required at least 100-fold higher levels to 
achieve the same extent of crosslinking (Iyer, Ghosh et al. 1989).  
 Formation of isoketal crosslinks can alter the conformation and function of proteins, 
therefore the extent crosslinking contributes to isoketal action needs to be further explored. Due to 
the rapidness of IsoK reactivity towards lysine, free IsoKs are not detectable in vivo where protein 
is present (Iyer, Ghosh et al. 1989, Brame, Salomon et al. 1999). Although free IsoKs cannot be 
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detected in biological samples, the formation of isoketals in vivo can be quantified by measuring 
highly stable isoketal-lysyl-lactam adducts using mass spectrometry (Davies, Amarnath et al. 
2007). Due to their long half-life, isoketal-lysyl-lactam adduct levels in tissues serve as a measure 
of oxidative stress over time (Poliakov, Brennan et al. 2003).  
Biological relevance of -Ketoaldehydes 
 Significantly increased levels of IsoK-lysyl-lactam adducts can be found in several 
pathological conditions including cardiovascular disease (atherosclerosis, end-stage renal disease, 
etc.), neurodegenerative diseases such as Alzheimer’s disease, and is an important factor in the 
etiology of hypertension (Salomon, Batyreva et al. 2000, Zagol-Ikapitte, Masterson et al. 2005). 
Elevated levels of isoketal adducted proteins are predicted in a wide variety of conditions 
associated with oxidative injury and inflammation (Reilly, Delanty et al. 1996, Montine, 
Markesbery et al. 1998, Dworski, Murray et al. 1999, Laight, Desai et al. 1999, Voutilainen, 
Morrow et al. 1999, Davies, Amarnath et al. 2002). In fact, experimental models of oxidative injury 
and inflammation show increased isoketal adduct formation, which can be seen in carbon 
tetrachloride treated rats (Brame, Boutaud et al. 2004), hyperoxia-treated mice (Davies, Talati et 
al. 2004), septic mice (Poliakov, Brennan et al. 2003), and ex vivo activation of platelets (Boutaud, 
Li et al. 2003). Despite IsoKs having a demonstrated cytotoxic effect, a causal role in induction of 
protein aggregation, and a detrimental impact on enzymatic function, (Schmidley, Dadson et al. 
1992, Boutaud, Ou et al. 2002, Davies, Amarnath et al. 2002), concerted efforts in discovering and 
developing pharmacological probes are essential for in vivo studies to reveal the contribution of 
IsoK adduction to proteins in disease. Additionally, such probes could prove therapeutically useful 
as preventative measures against IsoK-mediated pathology. 
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Pyridoxamine, the First Small-Molecule Scavenger of Isoketals 
 A lead compound, pyridoxamine (PM) was first discovered as a carbonyl scavenger in 
1996 by Billy G. Hudson and colleagues (Booth, Khalifah et al. 1996).  Pyridoxamine is a vitamer 
in the vitamin B6 family. Pyridoxamine was subsequently identified as an isoketal scavenger 
through initial screens looking at primary amines that protected radiolabeled lysine from 
modification by synthetic isoketal. Subsequently,  Amarnath and colleagues measured second-
order reaction rates for a series of primary amines relative to N-α-acetyl-lysine (Amarnath, 
Amarnath et al. 2004). Reaction of -ketoaldehyde with pyridoxamine was 2,000 times greater 
than that of N-α-acetyl-lysine (Amarnath, Amarnath et al. 2004). Delivery of high concentrations 
of pyridoxamine is tolerated well in vivo (Degenhardt, Alderson et al. 2002), and can neutralize 
multiple -ketoaldehydes generated during lipid and sugar metabolism  (Onorato, Jenkins et al. 
2000, Voziyan, Metz et al. 2002). Despite the plausibility of PM as surrogate probe of isoketal 
function in vivo, lipid peroxidation forms IsoKs esterified in situ to phospholipids (Brame, Boutaud 
et al. 2004), therefore lipophilic scavengers are expected to be more efficacious than the 
hydrophilic pyridoxamine. Utilizing structure-activity relationships (SAR), the critical moiety 
needed to still allow for scavenging of IsoKs was determined to be a phenolic amine composed of 
the hydroxyl group adjacent to the methyl amine. Consequently, alternative lipophilic phenolic 
amines such as salicylamine (SA) and pentylpyridoxamine (PPM) show comparable potencies and 
selectivity as PM for scavenging isoketals (Davies, Brantley et al. 2006). 
Selective Scavengers of Isoketals 
 All three scavengers show selectivity towards -ketoaldehydes over other dicarbonyls and 
do not significantly scavenge -unsaturated carbonyls such as HNE (Amarnath, Amarnath et al. 
2004, Davies, Brantley et al. 2006). From these results, Amarnath et al. concluded that PM and 
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related phenolic amines preferentially scavenge IsoKs compared to other lipid aldehydes. 
Selectivity of these phenolic amines for IsoKs is thought to be attributed to the ability of the 
hydroxyl group adjacent to the methylamine to catalyze pyrrole formation (Amarnath, Amarnath 
et al. 2004). Reduction of IsoK levels by PM, SA, and PPM is due to direct IsoK scavenging, and 
not through inhibition of lipid peroxidation; in vitro studies of arachidonic acid oxidation in the 
presence of the three scavengers did not show significantly reduced  levels of F2-IsoPs, indicating 
normal occurrence of lipid peroxidation (Davies, Brantley et al. 2006). All three scavengers 
significantly decreased IsoK-Lys-lactam adduction in aqueous solutions, however in platelets, PM 
reduces levels of IsoK protein adducts to a lesser extent than that of SA and PPM (Davies, Brantley 
et al. 2006). In intact cells challenged with hydrogen peroxide, pre-incubation of PM did not 
protect cell viability, in contrast, SA and PPM shielded cells against death (Davies, Brantley et al. 
2006). Likewise, SA and PPM exhibited protective effects against oxidant induced inhibition of 
sodium currents, whereas PM lacks protective effects (Nakajima, Davies et al. 2010). SA is orally 
bioavailable (Zagol-Ikapitte, Matafonova et al. 2010), and delivery of SA in the drinking water of 
an Alzheimer’s mouse model prevented the age-associated decline in working memory (Davies, 
Bodine et al. 2011). Accordingly, IsoK scavengers could be valuable tools for probing the 
contribution of IsoKs in the etiology of human diseases. Therefore, the primary goal of this project 
is to reveal the molecular processes involved in IsoK-mediated oxidative injury, thereby opening 
new avenues of therapeutic interventions to limit oxidative damage.  
Putative Role of IsoKs in Aging 
 The aging field has actively embraced the role of oxidative stress in the development of 
aging and age-related disease. Although great advances and breakthroughs have informed the field, 
the exact molecular events involved in aging are unclear (Voss and Siems 2006). In order to study 
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the effect of oxidative stress on aging at the cellular level, several biomarkers of oxidative damage 
have been identified, including but not limited to lipid peroxidation and protein oxidation products, 
antioxidative acting enzymes, and glutathione among many other substances.  Although there is a 
scarcity of data relating to the bioactivity of IsoK adducts in aging, recent studies suggest a 
potential role for IsoK adduction in mediating some of the aging effects of lipid peroxidation. For 
instance, in studies with young and aged rats, quantification of free circulating F2-IsoPs in aged 
rats (22 – 24 month) showed a mean of 20.3-fold (range 4.3 – 42.9-fold) increase compared to 
levels measured in young animals (Roberts and Morrow 2000). The fact that levels of F2-IsoPs in 
plasma were increased with age adds legitimacy to the prevailing thought that aged animals are 
under a remarkable amount of general oxidant stress. This data also suggests a similar increase in 
IsoK production with age, considering previous studies indicate F2-IsoP formation occurs in 
relative amounts to IsoK formation (Figure 1.2).Hence, there is an open question over the potential 
part that IsoKs may intervene in the aging process and if so, how scavengers of IsoKs may be 
potentially influence normal aging. 
The State of Health and Aging in the World 
 People worldwide are living longer. For the first time in history, the proportion of people 
aged over 60 years is expanding faster than any other age group, as result of longer life 
expectancies and declining fertility rates (Public health report: The Department of Economic and 
Social Affairs of the United Nations Secretariat;  
http://www.un.org/en/development/desa/policy/wess/wess_archive/2007wess.pdf). In low- and 
middle-income countries, this demographic shift is largely due to massive reductions in mortality 
at younger ages from infectious diseases. In high-income countries, increases in life expectancy 
are due to positive outcomes of medical progress. Due to these technological advances, the World 
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Health Organization (WHO) predicts that between 2015 and 2050, the percentage of the world’s 
population over 60 years will nearly double from 12% to 22%, and by 2020, the number of 
individuals aged 60 years and older will outnumber children younger than 5 years. (World Report 
on Health and Ageing: World Health Organization;  
http://apps.who.int/iris/bitstream/10665/186463/1/9789240694811_eng.pdf?ua=1).  
The current pace of an aging population is exponentially faster than in the past, and with this all 
countries face major challenges to ensure their public health, social services, and health care 
systems are ready to service this growing demographic. Encouragingly, public health initiatives in 
America are being launched to promote healthy aging, improve quality of life in older adults, and 
identify pharmacological therapeutics to promote healthy aging (termed health span) with the goal 
of postponing the onset of geriatric syndromes and chronic health conditions (Centers for Disease 
Control and Prevention (CDC); https://www.cdc.gov/aging/pdf/state-aging-health-in-america-
2013.pdf). 
The Concept of Aging 
 According to a recent review in the previous year by Riera and Dilin, “aging is considered 
to be the biggest risk factor for developing several of the world’s most prevalent chronic diseases” 
(Riera and Dillin 2015). These aging and age-related diseases include metabolic syndromes, 
cardiovascular and neurodegenerative diseases, and most prevalent forms of cancer (Kennedy, 
Berger et al. 2014). Typically, there is a high incidence of chronic diseases and co-morbidities in 
the elderly. In the United States, more than a quarter of its citizens and two out of every three older 
individuals have multiple chronic conditions, and disease management for this population accounts 
for over 60% of the country’s health care budget. Generally, aging is viewed as an overall decline 
12 
 
in cell and tissue function, which increases susceptibility to disease, and ultimately leading to 
tissue failure and death.  
Denham Harman characterizes aging as the aggregation of changes to the body over time 
(Harman 1956). American gerontologist, Bernard Strehler defines aging as universal, progressive, 
and deleterious (Baker 1965). According to Strehler, aging is considered to be universal, because 
it is a “phenomenon that occurs in different degrees in all individuals of a species”. Aging must be 
progressive, through which it leads to changes that additively occur throughout the lifespan. Aging 
is lastly defined to be deleterious, due to the changes associated with aging tend to be harmful to 
the individual (Rose, Flatt et al. 2012).  
Therefore, it is crucial to define the underlying molecular events through which aging 
occurs, understand how these changes lead to the diseases of old age, and how researchers can 
utilize this knowledge to devise methods for diagnosis, treatment, and prevention of aging and 
age-related diseases. As aging occurs for inexplicable reasons and unfolds in complex ways, theory 
plays a remarkably fundamental role in its research. Considering human aging remains a largely 
unexplored area of research, strides should be taken to identify small molecules that extend 
lifespan in tandem with healthy aging (healthspan), as well as understanding the mode of action 
of these drugs. 
General Theories of Aging 
Aging is defined by deteriorating changes that progressively diminish function, resulting 
in a gradual decline in the capacity to respond to environmental challenges and an increasing 
vulnerability to disease and death. It is also associated with a progressive loss of tissue and function 
over time (Flatt 2012). Nearly all physiological functions lose efficiency with aging, in which aged 
individuals lose the capacity to maintain homeostasis when faced by changes in external 
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environment. However, the exact molecular events occurring in this process and are responsible 
for aging are yet to be defined. There are many theories of aging; Medvedev counted over 300 
theories of aging in 1990 (Medvedev 1990). New classes arise constantly as research in molecular 
and cellular biology uncover previously unimagined phenomena.  
Evolutionary Programmed and Non-Programmed Aging/Longevity 
Programmed aging implies that aging follows a biological timetable, in which a set of genes 
control a signaling cascade to initiate cellular senescence, leading to death (Giaimo and d'Adda di 
Fagagna 2012). In this theory, the regulation of aging occurs through changes in gene expression 
to alter molecular pathways involved in cellular maintenance and defense systems. The theory of 
programmed aging proposes that organismal fitness declines in favor of natural selection for 
genetic programs with beneficial effects on reproductive health early in life.  
There are two main classes of evolutionary programmed aging theories: 1.) Modern 
programmed theories, state that species have an evolutionary need to live for a particular time, and 
once the time has passed organisms need to limit their lifespans and therefore developed aging 
programs as mechanisms to limit organism lifespan in order to obtain a species-specific optimum 
lifespan (Libertini 1988, Skulachev 1997, Goldsmith 2010), and 2.) Modern non-programmed 
theories, such as antagonistic pleiotropy theory (Williams 2001)  and disposable soma theory 
(Kirkwood and Holliday 1979), which contend that a species has an evolutionary need to live for 
a particular minimum lifespan and therefore only evolved the capability for overcoming natural 
progression toward decline to the extent necessary to achieve said lifespan. 
Modern programmed aging theory suggests an innate program in the genome, which is 
initiated at a given life stage in the organism’s life cycle. The activation of this biological timetable 
leads to a death cascade in various bodily systems (Libertini 2015). Within the programmed theory 
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of aging lies three major avenues of investigation which encompass the activation of this biological 
timetable; 1.) Programmed longevity, 2.) Endocrine theory, and 3.) Immunological theory.  
Programmed Aging. Programmed longevity posits an evolutionary bias for genes 
controlling the activation and rate of senescence, which leads to disease states, and eventually 
death. A central tenant of this theory involves the concept of a programmed gene control of 
development that exists to control a genetic cascade responsible for senescence. Most hypotheses 
to explain the occurrence of programmed aging pertain to the notion that aging benefits species by 
preventing overcrowding and/or facilitating further evolution by turnover of generations. These 
ideas can be traced back in earlier days, with Weismann (Weismann, Poulton et al. 1891) stating 
“Worn out individuals are not only valueless to the species, but they are even harmful, for they 
take place of those which are sound.” With the thought of a programmed gene control cascade 
driving the occurrence of aging, the general consensus is to discover and develop an agent that can 
interfere with the activity of any gene belonging to the death cascade, particularly via mutation in 
order to modulate the lifespan of the organism. The goal of such a therapy is to extend longevity 
with a minimal effect on development and reproduction of the organism. 
Endocrine Theory of Aging. The endocrine theory of aging is at the moment, one of the 
most studied genetic regulatory networks that impacts aging through a biological clock which acts 
through hormones. The evolutionarily conserved insulin/insulin growth factor 1(IGF-1)-like 
endocrine system is a major component in the hormonal regulation of aging. Genetic mouse 
models of decreased insulin/IGF-1 signaling (IIS) extends lifespan and healthspan in mice (Bluher, 
Kahn et al. 2003, Holzenberger, Dupont et al. 2003, Taguchi, Wartschow et al. 2007, Selman, 
Lingard et al. 2008, Ortega-Molina, Efeyan et al. 2012, Foukas, Bilanges et al. 2013, Nojima, 
Yamashita et al. 2013, Xu, Gontier et al. 2014). In addition, inhibition of the IIS in Caenorhabditis 
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elegans results in a constitutive dauer formation during development. Dauer formation in this 
critical developmental period results in increased lifespan in adult animals (Kenyon, Chang et al. 
1993). In addition, IIS mutants show abnormal egg-laying, increased lipid storage, and robustness 
during cellular stress (Kimura, Tissenbaum et al. 1997, Paradis and Ruvkun 1998, Kenyon 2005). 
With all the research on the role and mechanisms of insulin/insulin-like growth factor signaling on 
aging, the prevalent therapeutic strategy is to use natural activators and inhibitors of the 
insulin/insulin-like growth factor signaling pathway to design drug therapies. Currently, three 
proteins have demonstrated lifespan extension possibly via IGF-1 (Kurosu, Yamamoto et al. 2005, 
Zhang, Xie et al. 2012). 
Immunological Theory of Aging. The immunological theory of aging, or 
immunosenescence, advances the idea that there are genetic programs in place to degrade the 
immune system over time. The gradual decline of the immune system leads to loss of antibody 
efficacy, and with the body’s defense mechanisms against new diseases compromised, the body 
becomes more susceptible to cellular stress and eventual death (Cornelius 1972). The 
immunological theory of aging was proposed by leading pathologist, Roy Walford in 1964 
(Walford 1964), based on the observation that optimal functioning of the immune system occurs 
at reproductive maturation and gradually lessens with age. This age-associated immune deficiency 
is ubiquitous and found in both long- and short-lived species (Ginaldi, Loreto et al. 2001), and 
found to be under genetic control rather than as a deteriorative occurrence (Franceschi, Valensin 
et al. 1999). Wolford states there is a growing amount of evidence that many age-related diseases 
result from malfunctioning immune system in conjunction with heightened inflammation (Caruso, 
Candore et al. 2005). Although direct relationships depicting causation between dysregulated 
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immune response and age-related diseases have not been fully elucidated, a role for indirect 
involvement of the immune system exists.  
Non-Programmed Evolutionary Aging. In contrast, modern non-programmed evolutionary 
aging considers genes have only evolved the capability of overcoming progressive deterioration 
processes for an organism to live only for a particular minimum lifespan. One central premise to 
this theory is the existence of genes with dual functions which may be both beneficial and 
detrimental to the organism depending on the life cycle stage. One example of this evolutionary 
theory of aging is the disposable soma hypothesis, where one of the basic tenets contends that there 
are physiological and/or biochemical restrictions that limit and hamper the preservation of an 
optimal maintenance system at advanced ages. Due to limited resources, the body must choose 
between reproductive capacity and a more efficacious maintenance/homeostatic system. Thus, this 
limiting factor makes the maintenance of an optimum efficiency vulnerable at advanced ages.  
The antagonistic pleiotropy theory was proposed by Williams in 1957, whereby Williams 
suggest a specific type of genetic inter-trait linkage, pleiotropy, as an evolutionary explanation for 
senescence (Williams 2001). Pleiotropy, or inter-trait linkage exists in a way to make it difficult 
for the evolution process to remove an individually adverse trait, such as aging, without 
simultaneously removing one or more beneficial traits. To explain further, inter-trait linkage is the 
phenomenon where one gene produces more than one phenotypic trait in an organism which may 
produce dichotomizing results. The gene could potentially produce a trait beneficial to the 
organism’s fitness and also result in one or more trait adverse to fitness. In summation, the 
antagonistic pleiotropy hypothesis proposes aging is caused by genes that are simultaneously 
advantageous in the young or adult stage and unfavorable in the older ages, and are consequently, 
only partially countered by natural selection. 
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In evolutionary biology, the fitness trade-offs from antagonistic pleiotropy is one of the 
reasons to explain why organisms are never able to reach perfection through natural selection.  
Within this theory, mutational changes to a gene that can result in a beneficial effect (e.g. increased 
lifespan) would likely also cause adverse changes to other phenotypic traits in a linkage that would 
prevent the evolution process from accomplishing the beneficial effect (greater longevity) without 
incurring the adverse penalties. According to Williams’ evolutionary antagonistic pleiotropy aging 
theory, there is an evolutionary need to live and produce for a certain species-specific minimum 
time and after that age, there is no net evolutionary advantage or disadvantage from reproducing 
longer. Proponents of this theory believe the inter-trait linkage prevents the discovery of finding 
an anti-aging agent due to the large number of independent factors that contribute to aging.  
Error Theories of Aging 
The error theories of aging highlights environmental damage to living organisms over time, 
which causes an accumulation of errors in cellular structures to reach a catastrophic level that is 
incompatible with cellular survival. Environmental factors, such as extreme temperatures, 
malnutrition, oxidations, and hypoxia affects maintenance required for stress response, signal 
transduction, and metabolism. The damage accrued gradually causes attrition in the efficacy of 
organismal function, leading to death.  
DNA damage theory. This theory posits cellular deterioration and dysregulation occurs 
from an accumulation of DNA damage associated with age. Healthy individuals are able to respond 
and repair DNA damage that occurs constantly in living organisms, however some DNA defects 
accumulate as damage outpaces the rate of repair.  Of note, errors in mitochondrial DNA may 
result in mitochondrial dysfunction. Maintenance of metabolic homeostasis along with appropriate 
stress responses absolutely requires proper mitochondrial function. Mitochondrial dysfunction is 
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known to play a critical role in aging and as well as other numerous human diseases, for example 
cancer and neurodegenerative disorders (Wallace 2005). The causes of the onset and progression 
of these pathologies are a result of metabolic disruption and oxidative injury.   
Metabolic ‘Rate of Living’ Theory. In the early 1900s, work of Max Rubner suggest a role 
for oxygen in determining lifespan. Rubner noted that large animals tend to outlive smaller 
animals, and speculated this phenomena was due to an inverse relationship in metabolic rate to 
organismal size (Rubner 1908); shorter lifespans were seen in organisms with a greater rate of 
oxygen basal metabolism (Brys, Vanfleteren et al. 2007). The inverse relationship between basal 
metabolism and longevity provided the groundwork for Raymond Pearl’s rate-of-living theory of 
aging (Pearl 1928). As originally proposed by Pearl, this theory stated that the lifespan of an 
organism is reliant on upon the depletion of a fixed amount of a “vital substance,” or energy 
expenditure occurs at a rate proportional to the metabolic rate of the organism. There are two 
distinct factors thought to govern length of life, according to the rate of living theory of aging: 1.) 
a genetically determined metabolic potential, and 2.) rate of metabolism (Sohal 1986).  
This theory predicts that long-lived species or individuals should have a reduced rate of 
basal oxygen metabolism as compared to shorter-lived organisms. Or in other words, as 
summarized in a common popular phrase, the rate of living theory of aging is likened to “live fast 
and die young” of which is still prevalent in common perception, although this theory cannot 
explain many exceptions to its rule (e.g. extreme longevity of some eusocial animals such as naked 
mole rats and ant queens). Furthermore, the rate-of-living theory of aging does not 
comprehensively explain the maximum lifespan of organisms (Hulbert, Pamplona et al. 2007). 
Modern studies propose an adapted version of Pearl’s rate of living theory underscoring the role 
of growth (TOR) and stress resistance (FOXO) pathways (Rollo 2010). 
19 
 
Free Radicals Theory of Aging. Based from observations made in the early 1950s, 
prominent biogerontologist, Denham Harman proposed that the most prevalent molecular 
explanation for aging – whereby aging is due to a decline in cellular and tissue function – was a 
result from oxygen radicals produced by respiratory enzymes causing additive damaging effects 
to macromolecules (Harman 1956). Breaking down this theory in a linear fashion, it proposes that 
free radicals released during respiration cause damage to macromolecules comprising the cell, 
which results in an accumulation of damage to ultimately cause the cells, and eventually organs, 
to cease functional activity. This chain of events leads to the aging phenotype (Sohal and 
Weindruch 1996, Clancy and Birdsall 2013). Although free radicals are generated constantly 
throughout the life of the cell, oxidative damage to macromolecules occurs when antioxidant 
systems are overwhelmed with an influx of free radicals generated at a rate faster than antioxidant 
systems can detoxify.  
In a broad assortment of tissues and animal models of aging (yeast, nematodes, fruit flies, 
mice, et cetera), increases in oxidative damage to macromolecules (nucleic acids, lipids, and 
proteins) have been reported (Agarwal and Sohal 1994, Bokov, Chaudhuri et al. 2004, Stadtman 
2006). Furthermore, in animal models with increased lifespan, either a reduction in oxidative 
damage and/or protection against oxidant injury was observed; in Caenorhabditis elegans, strains 
containing mutations in the insulin/IGF-1 signaling pathways, such as age-1, daf-2, and daf-16 
mutants, resulted in reduction in oxidant injury and increased resistance to oxidative damage 
(Lithgow, White et al. 1995, Johnson, Lithgow et al. 1996, Honda and Honda 1999, Ishii, Goto et 
al. 2002). The inverse is also observed, where increased production of ROS shortens lifespan. 
Lastly, early studies on caloric restriction showed reductions in oxidative injury to lipids, nucleic 
acids, and proteins in caloric restricted rodents compared to free-feeding rodents (Sohal and 
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Forster 2014), along with greater resistance to oxidative stress (Sohal and Weindruch 1996, Yu 
1996, Barja 2002).  Among the many theories of aging, the free radical theory of aging carries the 
most extensive body of literature (Blagosklonny 2008, Doonan, McElwee et al. 2008, Mockett, 
Sohal et al. 2010, Cabreiro, Ackerman et al. 2011) 
Mitochondrial Theory of Aging. After years of research investigating the Free Radical 
Theory of Aging, Harman revised this theory to incorporate the role of mitochondria in aging. This 
“mitochondrial theory of aging”, (Lee and Wei 2012, Bereiter-Hahn 2014) encompasses the effects 
of cumulative oxidative damage to mitochondria induced by ROS toxicity in the organism’s 
lifetime. Regarding the role of mitochondria in aging, the electron transport chain (ETC) leaks 
electrons during normal metabolic respiration which then generates ROS. Oxidative damage 
occurs in times when environmental stressors increase the rate of ROS production to overwhelm 
antioxidative response elements and/or compromised antioxidative response elements lead to 
imbalances in ROS equilibrium.   
 Mitochondrial damage in aged cells is well characterized. Notable damage observed 
includes a steady drop in respiratory chain capacity, elevated oxidative damage, lower levels of 
mitochondrial content, and irregular mitochondrial morphology (Kirkwood 2005, Gaziev, 
Abdullaev et al. 2014, LaRocca, Hearon et al. 2014). Mitochondrial dysfunction can lead to severe 
damage in an organism. A vast majority of research on why mitochondrial dysfunction gradually 
develop with time has focused on mtDNA integrity. Mutations and deletions in mtDNA increase 
with age, and areas of aged tissue that show mitochondrial ETC dysfunction contain abundant 
mtDNA damage (Xie, Lu et al. 2014). These findings and many earlier studies indicate that 
continuous accumulation of mtDNA damage may be responsible in aging. 
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Proteostasis and Aging. A living organism exhibiting protein homeostasis (proteostasis) 
possesses a proteome in functional balance, where cells, tissues, and organs are properly 
functioning due to the taut regulation of protein maintenance. Stress-response transcription factors, 
molecular chaperones, and protein degradation responses constitute the proteostasis network (PN), 
whose main function is to sense and react to “proteotoxic stress” and occurrences of protein 
misfolding to ensure cell viability (Balch, Morimoto et al. 2008). Maintenance of proteome 
balance is valuable for preservation of normal protein quality control and cellular function. It 
requires a multiplex web of cellular components, primarily mechanisms of the production and 
maintenance of proteins synthesis (Balch, Morimoto et al. 2008, Hartl, Bracher et al. 2011).The 
proteostasis network consists of ~1,400 proteins in human cells (Kim, Hipp et al. 2013), which 
includes molecular chaperones (Brehme, Voisine et al. 2014) in addition to proteins comprising 
the oxidative stress defense, along with of the  proteolytic degradation network. These quality 
control mechanisms is central to the health of the proteome.  
Chronic stressors challenge the proteostasis balance, causing an accumulation of 
intracellular damage, and allowing for proteotoxicity to develop (Vilchez, Saez et al. 2014). The 
ability of cells and organs to preserve proteostasis is gradually compromised with age (Labbadia 
and Morimoto 2015), and the cell’s ability to manage misfolded proteins declines (Ben-Zvi, Miller 
et al. 2009, Douglas and Dillin 2010) with an increase in protein oxidation as defenses against 
ROS declines (Finkel and Holbrook 2000), mislocalization, and protein aggregation observed in 
aged organisms (Morimoto 2008, David, Ollikainen et al. 2010, Reis-Rodrigues, Czerwieniec et 
al. 2012, Rana, Rera et al. 2013). In order to untangle the complex network of responses, careful 
examination of the evolution in proteome architecture and regulation occurring during aging is 
needed. In 2015, studies using quantitative mass spectrometric methods, Walther and his cohorts 
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discovered that aging in C. elegans, is accompanied by degrading protein homeostasis, resulting 
in widespread alterations in the proteome (Walther, Kasturi et al. 2015). In addition, protein 
degradation pathways have also been shown to cause proteotoxicity and reduction of lifespan in 
Drosophila, C. elegans, and mice (Finley 2009, Li, Zhao et al. 2013, Tsakiri, Sykiotis et al. 2013). 
All things considered, the idea that reduced function in the protein degradation pathway could 
contribute to proteostasis collapse and aging remains a viable theory. 
Risk analysis of Parkinson’s, Alzheimer’s, and Huntington’s and other neurodegenerative 
diseases find aging as a primary indicator of disease emergence associated with aggregate 
deposition (Balch, Morimoto et al. 2008, Knowles, Vendruscolo et al. 2014, Labbadia and 
Morimoto 2015). Increased levels of aberrant proteins place great stress on the apparatuses of 
proteostasis and as a result may hasten aging (Gidalevitz, Ben-Zvi et al. 2006, Balch, Morimoto et 
al. 2008, Olzscha, Schermann et al. 2011, Hipp, Park et al. 2014).  
Summary 
Aging is a complex and multiplex process that has induced countless new and modified 
theories to explain the aging process. Despite a robust literature on several theories of aging, no 
consensus on a comprehensive and unifying theory of aging exists; in fact, numerous proposed 
theories overlap in non-trivial ways. Several of the aforementioned theories have been found to 
interact and influence each other in a multifactorial manner. A comprehensive approach to aging 
research is critical to further advances. 
Caenorhabditis elegans as a Model of Aging 
The nematode Caenorhabditis elegans (C. elegans) is a genetically tractable and powerful 
model organism useful for exploring aging research (Herndon, Schmeissner et al. 2002, Golden, 
Hubbard et al. 2006)`. C. elegans has been a model system at the leading edge of aging research 
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ever since the first long-lived mutant was discovered (Klass 1983, Kenyon, Chang et al. 1993, 
Lithgow, White et al. 1995). C. elegans is a small, free-living, soil-dwelling nematode of about 1 
mm in length that feeds primarily on bacteria. This nematode has a number of features that makes 
it a powerful tool in aging research. First, its small size allows for easy and inexpensive storage 
and culturing in the laboratory on a diet of Escherichia coli. Second, C. elegans is hermaphroditic, 
allowing genetically identical populations to be maintained in a laboratory setting. Third, it 
reproduces rapidly and prolifically, with a short generation time, and approximately 300 progenies 
per self-fertilizing hermaphrodite. Most importantly, C. elegans have a short life-cycle (~3 weeks), 
which is significant for whole life-span assays (Johnson and Wood 1982), are sophisticated 
multicellular animals, with 959 somatic cells that form multiple organ systems including nervous 
tissue, musculature, and epidermis, and contain 302 neurons, capable of demonstrating complex 
behaviors. Due to their transparency, the exact anatomical position and fate of all of their somatic 
cells is known, which allows for the relatively easy identification of cellular abnormalities. The 
somatic cells of the adult animals are post-mitotic, and thus makes C. elegans an ideal animal 
model for aging research in non-dividing cells.  Nematodes have been genetically tractable since 
completion of sequencing on the entire nematode genome; these worms can be 1.) manipulated by 
genetic tweaks to provide strains with either loss-of-function mutations or complete gene knockout 
(Brenner 1974) or 2.) inactivated through RNA interference (RNAi) by feeding bacteria that 
express double-stranded RNA for the gene of interest to the animals (Fire, Xu et al. 1998). Studies 
conducted by the C. elegans Sequencing Consortium found the C. elegans genome contains 
homologs of approximately two-thirds of all human disease genes (Consortium 1998), and C. 
elegans aging shares many characteristics with human aging. Taken together, all of the features 
mentioned make the C. elegans worm a clearly beneficial animal model in the study of aging. 
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Early major breakthroughs in aging research were derived from C. elegans studies. In 1983, 
Klass identified mutants that altered lifespan (Klass 1983). All mutants identified by Klass were 
subsequently found to be in one locus, termed age-1 (Friedman and Johnson 1988, Johnson 1990, 
Morris, Tissenbaum et al. 1996). From this finding, aging researchers discovered aging is 
modulated by genes which can attenuate gene function to either extend or shorten life. A second 
breakthrough was the identification of another mutant that alters lifespan (Age mutant), daf-2, 
which similarly to age-1, lengthened the life of adult worms (Kenyon, Chang et al. 1993).  
Subsequent molecular cloning and identification of identification of daf-2 showed it to be an 
insulin/IGF-1 receptor (Kimura, Tissenbaum et al. 1997).  
The genetic tractability of this nematode and its ease in molecular cloning is one of the 
main rationale for the popularity of C. elegans; particularly, the discovery of the mutations in the 
insulin/IGF-1 signaling pathway propelled the popularity of using worms in aging studies. Other 
experimental techniques are being applied to C. elegans aging research. Taken together, the C. 
elegans system has provided several major advances in the identification of molecular mechanisms 
of aging. 
Significance and Central Premise 
 Clearly, taken all together from earlier studies, countering IsoK reactivity to proteins has 
extensive beneficial biological effects. Yet, little is known about and/or which molecular processes 
that are being altered by the IsoK scavengers.  Specifically, the potential role that oxidative injury 
from IsoKs may play in the aging process, and how IsoK scavengers may attenuate normal aging 
is an open question. In order to answer this question, we looked to one of the most well 
characterized pathways involved in the intersection of metabolic control, redox regulation, and 
aging: the sirtuin pathway. Sirtuins are a highly conserved family of nicotinamide adenine 
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dinucleotide (NAD+)-dependent protein deacetylases that was historically discovered through its 
association with aging in yeast and other lower eukaryotic organisms (Blander and Guarente 2004, 
Sauve, Wolberger et al. 2006). Sirtuins play a crucial part in countering nutritional and 
environmental stressors such as fasting, DNA damage, and oxidative stress (Ciccia and Elledge 
2010, Majmundar, Wong et al. 2010, Sengupta, Peterson et al. 2010, Wellen and Thompson 2010). 
Furthermore, it has been shown that sirtuins deacetylate lysine residues (Tao, Coleman et al. 2010), 
which suggests a molecular target for isoketal-protein adducts. Specifically, we hypothesize that 
sirtuin activity may be negatively attenuated by isoketal adduction, whereby administration 
of selective scavengers of IsoK could prevent inactivation of sirtuins to attenuate the lifespan 
of an organism. 
A Therapeutic Role for Sirtuins in Diseases of Aging 
 As stated above, sirtuins are key regulators of organismal longevity. Genes encoding 
proteins of whose increased activity positively affects longevity are considered to be anti-aging 
genes. Out of the multitude of genes identified that influence aging in model organisms, genes 
encoding sirtuins are considered to be one of the only anti-aging genes due to the fact their gene 
dosage level is correlated with increases in lifespan. Manipulating gene dosage of Sirtuin 1 
(SIRT1) orthologs show a retardation of the aging phenotype in Saccharyomyces cerevisiae, 
Caenorhabditis elegans, and Drosophila melanogaster (Kaeberlein, McVey et al. 1999, 
Tissenbaum and Guarente 2001, Wood, Rogina et al. 2004). To date, most interventions targeting 
processes that contribute directly to aging have generally failed (Le Couteur, McLachlan et al. 
2012), yet attenuation of SIRT1 orthologs demonstrate a consistent deceleration of aging and 
lifespan extension across taxa. Sirtuin activity in aging is of particular interest, due to their 
characteristic of being a druggable class of enzymes. Opening up the possibility of using small 
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molecules to target sirtuin modulation could positively affect a range of aging and age-related 
diseases.  
Sirtuin Biology: Structure, Function, and Diversity of Sirtuins 
 Sirtuins are deacetylases or ADP-ribosyltransferases that requires NAD+ for their 
enzymatic activity. As a broad overview, sirtuin activation initiates a transcriptional cascade that 
promotes a more optimal mitochondrial oxidative metabolic function which results in increased 
resilience to oxidative stress (Haigis and Sinclair 2010). Sirtuins armor against oxidative stress by 
1.) increasing antioxidant pathways via deacetylation to boost catalytic activity of superoxide 
dismutase 2 (SOD2) and isocitrate dehydrogenase 2 (IDH2), both located in mitochondria, and 2.) 
promoting DNA damage repair through deacetylation or ADP-ribosylation of DNA repair proteins 
(Tennen and Chua 2011). This conserved family of enzymes contain seven family members found 
in mammals, SIRT1-7, which are categorized by their highly conserved NAD+-binding and 
catalytic domain, termed the sirtuin core domain (Frye 2000).  
Crystal structures of sirtuins from a variety of organisms have shown these proteins consist 
of a catalytic core of approximately 250 amino acids, which is made up of a NAD+-binding domain 
and a Zn2+-binding domain containing four highly conserved cysteine residues (Finnin, Donigian 
et al. 2001, Min, Landry et al. 2001, Avalos, Celic et al. 2002, Chang, Kim et al. 2002, Zhao, 
Harshaw et al. 2004). The catalytic site sits in a hydrophobic interface of the two domains. The 
hydrophobic channels places the acetyl-lysine side chain optimal to catalyze the reaction with 
NAD+. Although sirtuins are relatively conserved across the seven family members, significant 
departures can be observed in their N and C termini. With differences in enzymatic activities, 
unique binding partners and substrates, and distinct subcellular localization and expression 
patterns, the seven sirtuin family members are likely to impact differing biology.  
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 Mammalian sirtuins are found in numerous compartments located within the cell and 
various organ systems (Haigis and Sinclair 2010), of which a summary of distributions can be seen 
in Table 1.1. SIRT1, SIRT6, and SIRT7 are found predominantly in the nucleus (even though 
SIRT1 is known to have significant cytoplasmic functions as well) (Michan and Sinclair 2007), 
whereas SIRT3-5 reside in mitochondria, and lastly SIRT2 is primarily cytoplasmic (with some 
known associations between SIR2 and nuclear proteins). Broadly speaking, sirtuins can be found 
in several compartments of the cell, with a fluid localization that can be determined by cell type 
and its physiology. 
Table 1.1: Summary of mammalian sirtuins 
Sirtuin Organ/Tissue Location Interactions Biology 
SIRT1 L, B, P, H, M, 
A 
Nucleus FOXO, PGC-1 
NF-B, Ku70, etc. 
Metabolism, stress 
SIRT2 H, B, SM Cytosol Tubulin, H4, FOXO Cell cycle 
SIRT3 K, B, H, L, 
BA, MM 
Mitochondria AceCS2, GDH 
complex I 
Thermogenesis,  
ATP production 
SIRT4 H, LVSM, 
SRM, Pβ 
Mitochondria GDH, IDE, ANT Insulin secretion 
SIRT5 B, H, M, L, K Mitochondria CPS1 Urea cycle 
SIRT6 M, B, L Nucleus Histone H3, NF-B Base excision 
repair, metabolism 
SIRT7 L, S Nucleolus Pol I rDNA 
transcription 
Abbreviations: L, Liver; B, Brain; P, Pancreas; Pβ, Pancreatic β–cells; H, Heart; M, Muscle; SM, 
Skeletal Muscle; VSM, Vascular Smooth Muscle; SRM, Vascular Striated Muscle; A, Adipose; 
BA, Brown Adipose; K, Kidney; MM, Mitochrondrial Matrix; S, Spleen; AceCS2, acetyl-CoA-
synthetase 2; ANT, adenine nucleotide translocator, CPS1, carbamoyl phosphate synthetase 1; 
FOXO, forkhead box, subgroup O; GDH, glutamate dehydrogenase; IDE, insulin degrading 
enzyme; NF-B, nuclear factor kappa B; PGC-1, peroxisome proliferator-activated receptor 
gamma coactivator 1 alpha; Pol 1, DNA polymerase 1, rDNA, recombinant DNA. 
 
 
Caenorhabditis elegans Sirtuins 
In C. elegans, there are four C. elegans yeast Sir2 and human SIRT paralogs; sir-2.1, sir2-
2, sir-2.3, and sir-2.4, each encode proteins with regions of homology to the sirtuin core domain 
(Frye 2000, Greiss and Gartner 2009). Of the four C. elegans SIRT homologs, sir-2.1 is the most 
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comprehensively studied worm sirtuin homolog, in part due to its close similarity to both yeast 
Sir2p and mammalian SIRT 1 according to phylogenetic analysis. It is widely expressed in muscle 
cells, intestine, hypodermis, nerve cells in the head, in the tail, and the ventral nerve cord 
(Berdichevsky, Viswanathan et al. 2006, Wang and Tissenbaum 2006, Bamps, Wirtz et al. 2009).  
As mentioned earlier, sir-2.2 encodes one of the four C. elegans proteins with similarity to 
yeast Sir2p. It is thought to play a role in genomic stability by protecting the genome against 
mutations, as RNAi knockdown of SIR-2.2 function produces an elevated level of spontaneous 
mutagenesis in the animal (Tissenbaum and Guarente 2001). Additionally, sir-2.3 shares 
similarities to yeast Sir2p and SIRT1, but little else is known about this particular family member. 
Lastly, sir-2.4 is an ortholog of human SIRT6 and is thought to be involved in P granule assembly 
(perinuclear RNA granules specific to germline) and response to heat. SIR-2.4 is expressed in the 
head and tail neurons, along with the spermathecal-uterine valve cell. It is also thought to be 
localized in the P granule, cytoplasmic stress granule, and nuclear pore (Chiang, Tishkoff et al. 
2012, Jedrusik-Bode, Studencka et al. 2013). Earlier nematode sirtuin role in aging studies were 
mostly dedicated to phenotypic analysis of sirtuin gene dosage manipulation.  More recently, 
research focus pivoted to utilizing various interdisciplinary techniques to establish the role of 
sirtuins in longevity. 
Sirtuin Biochemical Activity 
Most sirtuin catalyze NAD+-dependent deacetylation (Imai, Armstrong et al. 2000, Landry, 
Slama et al. 2000, Tanner, Landry et al. 2000, North, Marshall et al. 2003). More specifically, 
regarding their biochemical properties (Fig. 1.3)1, SIRT1, SIRT2, SIRT3, and SIRT6 display 
                                                        
1 Figure 5, adapted from May, Olivia. “Sirtuins, to your health.” Cayman Chemicals Article 
Library. n. d., n. pag. Web. 14 July 2016. Reprinted with permission of Cayman Chemicals 
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NAD-dependent deacetylase activity, although their catalytic efficiency and substrate specificities 
vary (Vaziri, Dessain et al. 2001, North, Marshall et al. 2003). SIRT4 and SIRT6 are ADP-
ribosyltransferases, with SIRT6 known to perform both auto-ADP-ribosyltransferase and 
substrate-specific deacetylase activities (Michishita, McCord et al. 2008), whereas SIRT4 
possesses NAD+-dependent mono-ADP-ribosyltransferase activity (Liszt, Ford et al. 2005, Haigis, 
Mostoslavsky et al. 2006). Fascinatingly, SIRT5 was discovered to have desuccinylase and 
demalonylase activity that acted as more physiologically relevant than its modest deacetylase 
activity (Du, Zhou et al. 2011). SIRT7 was described as a tumor suppressor p53 deacetylase 
(Vakhrusheva, Smolka et al. 2008), but this finding contradicted an earlier study (Michishita, Park 
et al. 2005) thus, the catalytic activity of SIRT7 remains unknown pending fuller characterization. 
In summary, sirtuin activity may be determined by the quantity of sirtuin molecules, availability 
of its NAD+ co-substrate, and local concentration of its regulatory inhibitor, nicotinamide. 
Furthermore, sirtuin activity may be influenced by other intracellular proteins (Kim, Kho et al. 
2007, Zhao, Kruse et al. 2008). 
Regulation of Sirtuin Activity via NAD+ Salvage Pathway 
 NAD+ is a well-studied coenzyme mediating many redox reactions; it plays an important 
role in the regulation of NAD+ consuming enzymes, which not only include sirtuins, but poly-
ADP-ribose polymerases (PARPs) and CD38/157 ectoenzymes as well. The absolute requirement 
of the co-substrate NAD+ in sirtuin reactions places sirtuins at the nexus of cellular energy 
metabolic regulation and provides a probable linkage between cytosolic energy status and nuclear 
signaling. While the NAD+/NADH ratio always favors NAD+, in conditions with an abundance of 
energy, intracellular NADH levels will rise and NAD+ levels will drop concurrently (Nogueiras, 
Habegger et al. 2012). In low energy/fasting states or during certain cellular stressors, the 
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NAD+/NADH ratio increases, therefore decreasing nicotinamide levels, which then activates 
sirtuins (Lin, Kaeberlein et al. 2002, Anderson, Bitterman et al. 2003). The NAD+ concentration 
in cells is maintained in equilibrium between its synthesis and its consumption.  
In humans, NAMPT (nicotinamide phosphoribosyltransferase) converts nicotinamide to 
nicotinamide mononucleotide, which is the rate-limiting step of the NAD+ salvage pathway 
(Magni, Amici et al. 2004, Revollo, Grimm et al. 2004). NAMPT expression is upregulated during 
caloric restriction and cellular stress (Magni, Amici et al. 2004, Iqbal and Zaidi 2006, Yang, Lavu 
et al. 2006), and is especially elevated in ties of prolonged fasting (Yang, Yang et al. 2007). Several 
lines of evidence show caloric restriction implicated in decreasing intracellular NADH and 
Figure 1.3. Sirtuin biochemistry. Sirtuins catalyze either ADP-dependent deacetylation or ADP-
ribosylation reactions. Both mechanisms cleave NAD to release nicotinamide (NAM). 
Abbreviations: ADP, adenosine diphosphate; NAD+, nicotinamide adenine dinucleotide; NAM, 
nicotinamide; NAMPT, nicotinamide phosphoribosyltransferase; NMN, nicotinamide 
mononucleotide; NMNAT, nicotinamide mononucleotide adenylytransferase; O-AADPR, 2’-O-
acetyl-ADP-ribose. Reprinted with permission from Cayman Chemicals. 
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nicotinamide concentrations, as well as increasing Sir2 activity and lifespan (Lin, Defossez et al. 
2000, Lin, Kaeberlein et al. 2002, Anderson, Bitterman et al. 2003, Lin, Ford et al. 2004, Sauve, 
Moir et al. 2005). Lastly, biochemical studies confirmed that the NAD+ to nicotinamide ratio is 
the main regulatory mechanism of sirtuins (Schmidt, Smith et al. 2004). 
Sirtuins in Calorie Restriction and Aging 
 Notwithstanding the multitude of nutrient-sensing pathways implicated in longevity (e.g., 
insulin signaling (Kenyon 2010), targets-of-Rapamycin (TOR) (Johnson, Rabinovitch et al. 2013), 
AMP kinase (Kahn, Alquier et al. 2005), and sirtuins (Guarente 2000)) at present, the NAD+-
dependent sirtuin pathway is one of the mechanisms which characterize the effects of caloric 
restriction (CR) on aging. Eighty years ago, Clive McCay first demonstrated that a decrease in 
energy intake by 30-40% increased up to 50% longer median and maximum lifespans in white rats 
(McCay, Crowell et al. 1935). Caloric restriction, i.e. a reduction of calorie consumption to 60-
90% of a normal balanced diet without malnutrition, increases longevity in a wide variety of 
species, from unicellular yeast to multicellular fungus and metazoans including fruit flies, worms, 
fish, rodents, non-human primates, and presumably humans as well (Roth, Lane et al. 2002, Smith, 
McClure et al. 2007, Smith, Kaeberlein et al. 2008, Anderson, Shanmuganayagam et al. 2009, 
Finley and Haigis 2009, Wang, Neretti et al. 2009, van Diepeningen, Maas et al. 2010). However, 
caloric restriction did not mediate longevity effects in a few species, namely wild mice and 
houseflies (Cooper, Mockett et al. 2004, Harper, Leathers et al. 2006).  
In primates, there are conflicting results in the two large-scale primate studies reported thus 
far; CR did not increase the average lifespan of the rhesus monkey cohort at the NIH, while a 
cohort of similar monkeys housed in Wisconsin were reported to live longer on a CR diet (Colman, 
Anderson et al. 2009, Mattison, Roth et al. 2012). It is possible differences in food composition, 
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genetic background, and experimental design may account for these discrepancies. Even so, CR is 
the only non-genetic strategy known to extend not only mean and maximum lifespan but also 
healthspan by delaying the onset of age-related disorders such as cardiovascular disease, 
inflammation, arthritis, cancer, diabetes, diverticulosis, neurodegeneration, and cognitive and 
motor impairment (Weindruch, Walford et al. 1986, Nikolich-Zugich and Messaoudi 2005, 
Colman, Anderson et al. 2009, Mattison, Roth et al. 2012). 
 Amassed data points to the role of sirtuins in modulating longevity, chiefly in CR-mediated 
longevity across various organisms. In 2000, Leonard Guarente proposed the following hypothesis 
in a review in Genes & Development; sirtuins were activated upon calorie restriction to slow the 
rate of aging and decline in health in organisms (Guarente 2000). This theory was put forth in part 
because of the following key early evidence; the discovery that sirtuins require NAD+ for its 
biochemical activity (Imai, Armstrong et al. 2000) in conjunction with the revelation that extra 
gene copies of sirtuins results in increased longevity in yeast, nematodes, and flies (Kaeberlein, 
McVey et al. 1999, Tissenbaum and Guarente 2001, Wood, Rogina et al. 2004). In addition, 
another crucial evidence for a sirtuin role in CR-mediated lifespan extension rose from the 
correlation of replicative aging (the number of times a mother cell divides) in yeast to longevity, 
whereby lifespan extension by CR requires SIR2 (Kaeberlein, McVey et al. 1999). Studies of 
asymmetric division in yeast mutants lacking sir2 have shown fewer than normal division times 
(20-30 times), which resulted in a shortened lifespan. Mutant lacking sir2 also displayed premature 
aging, which can be evidenced by an increase in extrachromosomal rDNA. This was thought to be 
a sign of rDNA recombination dysregulation in the sir2 mutants (Gottlieb and Esposito 1989, 
Sinclair and Guarente 1997, Smith and Boeke 1997).  
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Other evidence was brought forth, connecting sirtuins to CR and aging. In these studies, 
investigators found that a simple glucose starvation regimen (0.5% glucose) in yeast resulted in 
effects similarly seen in models with increased sirtuin activity.  Glucose starvation promoted 
transcriptional changes in metabolism away from normal fermentation towards respiration, which 
resulted in Sir-2 dependent shift in mother cell longevity (Lin, Kaeberlein et al. 2002). This 
suggests that sirtuins were activated by NAD+/NADH ratios increasing. An alternative explanation 
for the observed shift hypothesizes that CR-induced stress concurrently activates both yeast 
pyrazinamidase/nicotinamidase 1 (PCN1), which is one of the early initiators in the NAD+ salvage 
pathway (catalyzes deamidation of nicotinamide), in conjunction with increased Sir2 activation in 
order to promote longevity. Despite the plausibility of either or both mechanisms in obliquely 
explaining sirtuin’s nutrient sensing regulation of CR, a direct molecular mechanism is still 
needed. 
However, there is some debate about the exact role of sirtuins in CR-mediated lifespan 
extension. Kaeberlein and colleagues demonstrated a more austere CR regimen (0.05% glucose) 
also prolongs yeast replicative lifespan, but surprisingly does not require either Sir2p activity or 
mitochondrial respiration (Kaeberlein, Kirkland et al. 2004, Kaeberlein, Hu et al. 2005). SIR2 was 
also found to have no effect on yeast survival and chronological lifespan under starvation 
conditions, along with appearing to reduce survival of certain exceptionally long-lived mutant 
strains (sch9) (Fabrizio, Gattazzo et al. 2005). Other challenges to the robustness of the sirtuin 
control on CR-induced lifespan extension have arisen in other model organisms; perhaps, the 
greatest contest to the sirtuin/CR-mediated longevity hypothesis was Burnett and colleagues’ study 
which illustrated the lack of lifespan extension in both worms and flies transgenic for the respective 
SIR2 orthologs following adjustment of genetic bias (Burnett, Valentini et al. 2011). While 
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Burnett’s main thesis hinged on the thought that controlling for genetic background explains for 
the differences in sirtuin mediated effects in CR and aging, a few of the earlier studies did due 
diligence in controlling for genetic background (e.g. Bauer, Morris et al. 2009). Taken all together, 
this set of conflicting results points to a critical re-assessment of the staying power of the 
sirtuin/CR-mediated longevity hypothesis.  
Burnett’s paper in 2011 challenged the dogma of the field and provoked a reexamination 
of earlier published findings. Subsequently, Stumpferl and other groups replicated the original 
findings after additional in-depth considerations in a myriad of studies performed in yeast and 
nematodes. Stumpferl and colleagues set out to integrate the paradoxical reports of sirtuin role in 
CR and lifespan in yeast, along with reaffirming the pivotal role of sirtuins in longevity (Stumpferl, 
Brand et al. 2012). Within this study, genome-wide quantitative trait locus (QTL) analysis was 
performed on contradictory yeast strains which originated from different sources (i.e. a laboratory 
strain and a clinical isolate). Crossing these divergent strains for QTL analysis pinpointed five 
codon differences in the SIR2 alleles in the different strains. The five codon differences were 
attributed to more than half of the reported inconsistences between the strains and sirtuin role in 
aging. In addition, studies from the Guarente group, Rizki et al., Ludewig et al., Mouchiroud et 
al., and Schmeisser et al. rebutted Burnett’s claim (Rizki, Iwata et al. 2011, Viswanathan and 
Guarente 2011, Ludewig, Izrayelit et al. 2013, Mouchiroud, Houtkooper et al. 2013, Schmeisser, 
Mansfeld et al. 2013). Under a number of conditions manipulation of the SIR-2.1 showed increase 
in lifespan while controlling for genetic background, granted, not to the similar level as previously 
published (Tissenbaum and Guarente 2001). In sum, the collected work presented above robustly 
reaffirms the paradigm that sirtuins are conserved mediators of longevity. 
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Small Molecule Modulators of Sirtuins 
 Shortly following the fundamental studies establishing the sirtuin/CR-mediated longevity 
field,  (Kaeberlein, McVey et al. 1999, Imai, Armstrong et al. 2000), medicinal chemistry efforts 
opened up the field of CR mimetic drugs by developing small molecule activators of mammalian 
SIRT1 (Howitz, Bitterman et al. 2003). During the past decade, over 3,500 sirtuin activating 
compounds (STACs), like the first widely studied small polyphenol resveratrol, have been 
synthesized and analyzed (Lavu, Boss et al. 2008). The discovery and development of STACs 
arose from the finding that sirtuin regulation occurs on both transcriptional and posttranslational 
level. All of this evidence assembled into a cogent theory formed a rational drug design paradigm 
where researchers aim to discover small molecules and protein interactors that can mimic the 
benefits of CR without undergoing a caloric restriction regimen.  
The detection of sirtuin activating compounds is an exciting frontier in drug discovery. 
Through the use of medicinal chemistry, STACs with improved specificity for sirtuin activation 
along with enhanced bioavailability have been developed. Considering SIRT1 and its orthologs 
are the most widely studied sirtuin family member, it is not surprising the number of small-
molecule modulators of SIRT1 currently being characterized. A few of these sirtuin modulating 
compounds targeting SIRT1 include the following inhibitors: splitomycin, sirtinol (Solomon, 
Pasupuleti et al. 2006), and EX-527 (Solomon, Pasupuleti et al. 2006), as well as sirtinol analogs 
which target yeast SIR2, SIRT1, and SIRT2 (Mai, Massa et al. 2005). Resveratrol, SRT1720, 
SRT2183, and analogs of nicotinamide (NAM) can activate SIRT1 activity (Howitz, Bitterman et 
al. 2003, Milne, Lambert et al. 2007, Smith, Kenney et al. 2009). NAM analogs interfere with 
NAM inhibition of sirtuins (Sauve, Moir et al. 2005), whereas SIRT1 activators achieve efficacy 
through two modes. First, via lowering the binding affinity for the substrate and for NAD+, and 
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second, in a more limited capacity through an increase in enzyme velocity  (Howitz, Bitterman et 
al. 2003, Milne, Lambert et al. 2007).  
A high-throughput screen using a fluorophore-linked peptide reporter identified resveratrol 
and other polyphenol small molecules as sirtuin activators. This particular assay used low 
concentrations of the fluorophore-linked substrate, NAD+, and SirT1 enzyme in order to maximize 
signal of compounds which activate SirT1. A set of well-known polyphenol compounds with high 
sirtuin activation was identified from this screen. These particular polyphenol compounds were 
identified in part due to their known biological and antioxidant activities. Furthermore, these 
compounds showed activation levels two- to eight-fold higher than the best activation level 
observed for resveratrol. From the group of activators identified from the assay, quercetin and 
other catechins were of particular interest due to their similarity to the most widely known sirtuin 
activator, resveratrol.  Resveratrol was found to produce many of the same beneficial outcomes 
consistent with CR-mediated SIRT1 activation– for example, it has been reported in suppressing 
tumor growth and inflammation, which in turn promotes cardiovascular health and protect against 
neurodegenerative diseases (Jang, Cai et al. 1997, Baur, Pearson et al. 2006, Baur and Sinclair 
2006, Richard, Pawlus et al. 2011). Most of all, resveratrol administration produces transcriptional 
profiles similar to those obtained with caloric restriction (Barger, Kayo et al. 2008, Pearson, Baur 
et al. 2008) and prevents early mortality in obese mice (Baur, Pearson et al. 2006).  
Nonetheless, the proposed mechanism of sirtuin activating compounds was challenged due 
to several studies indicating in vitro substrate-specific effects on SIRT1 activity (Kaeberlein, 
McDonagh et al. 2005, Dai, Kustigian et al. 2010, Huber, McBurney et al. 2010, Pacholec, 
Bleasdale et al. 2010). These studies dispute the claim that resveratrol and other STACs are direct 
modulators of sirtuin activity due to loss in reporter activity in the in vitro assay upon removal of 
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the fluorescent tag on the substrate peptide. (Kaeberlein, McDonagh et al. 2005). Likewise, the 
finding of Park et al. pointed to an indirect activation via cAMP signaling cascades (Park, Ahmad 
et al. 2012). In the wake of these challenges, Dai et al., Price et al., and Hubbard et al. each supplied 
clarification of resveratrol and other STACs functioning directly on SIRT1. Three following 
studies provide strong evidence that resveratrol and other STACs work by directly activating 
SIRT1. First, Dai et al. demonstrated activation can occur with peptides lacking moieties (Dai, 
Kustigian et al. 2010), and activation transpires with aromatic amino acids at residues proximal to 
the deacetylated lysine. This necessary configuration was conceivably overlooked in earlier studies 
focusing more attention to the apparent requirement for fluorescent tags. Second, a study 
conducted by Price and colleagues established a link between SIRT1 and resveratrol along with 
other STACs. This study outlined the requisite for SIRT1 in imparting the beneficial physiological 
effects of resveratrol and other STACs administration; researchers found that deletion of SIRT1 in 
adult mice abrogated drug effects (Price, Gomes et al. 2012). Third, site-directed mutagenesis 
pinpointed a single mutation in SIRT1 that abrogated resveratrol and SIRT1 interaction (Hubbard, 
Gomes et al. 2013). More specifically, this mutation described in the study lies nearby to the outer 
portions of the catalytic domain and delineates the allosteric site in the protein for activation by 
small molecules. En masse, all of these findings in a wide variety of models highly suggest 
resveratrol and other STACs directly activate sirtuins to achieve favorable lifespan and healthspan 
outcomes. 
Conclusions 
 Currently, there are no known pharmaceutical interventions that definitively retard aging 
in humans. Effort continues to provide further insight into the multi-faceted process of normal and 
diseased aging, which with every new discovery allows for different avenues of pharmacotherapies 
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to retard the development of aging. Hypothetically, isoketal scavengers could pose as a potential 
modulator of sirtuin activity – a proposed mechanism of action might entail activation of sirtuin 
activity via prevention of oxidative damage-mediated IsoK adduction to sirtuins. Working from 
this supposition, normal sirtuin function could be inhibited by IsoK adduction upon an outside 
stressor such as oxidative injury. By preventing IsoKs from adducting to the protein, sirtuins will 
be able to signal and regulate supposed pathways involved in the aging process. Therefore, IsoK 
scavengers could be a small molecule modulator of sirtuins, and potentially be a pharmacotherapy 
for averting age-related diseases, extending life, and improving the quality of life in individuals of 
advanced years. 
Overview of Specific Aims2 
 Highly reactive acyclic -ketoaldehydes termed isoketals (IsoKs), are formed via the 
isoprostane pathway of lipid peroxidation. IsoKs covalently adduct ε-amino groups in lysyl 
residues of proteins, forming stable adducts and intramolecular cross-links. IsoK-lysyl-lactam 
adducts are increased in atherosclerosis, end-stage renal disease, and Alzheimer’s disease. A 
selective IsoK scavenger, salicylamine (SA), was developed and tested in Caenorhabditis elegans 
to elucidate the molecular processes in isoketal-mediated oxidative injury, and in doing so to 
provide the basis for the development of novel rational pharmacological interventions to limit 
oxidative damage. The overarching hypothesis of this thesis is that the biochemical reactivity of 
the lipid peroxidation products of polyunsaturated fatty acids (PUFAs) (such as arachidonic acid 
                                                        
2 Portions of this section have been published in a research article in Aging written by 
Nguyen, T. T., S. W. Caito, W. E. Zackert, J. D. West, S. Zhu, M. Aschner, J. P. Fessel and L. J. 
Roberts, 2nd (2016). "Scavengers of reactive gamma-ketoaldehydes extend caenorhabditis 
elegans lifespan and healthspan through protein-level interactions with sir-2.1 and ets-7." 
Aging (Albany NY) 8(8): 1759-1780.  
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or the more abundant PUFA in C. elegans, eicosapentaenoic acid), the reactive IsoKs, adversely 
affect the function of key lifespan regulating proteins, ultimately resulting in normal and diseased 
aging. Administration of the selective IsoK scavenger, SA, is hypothesized to delay and reverse 
the signs of aging, in addition to illuminating the pathophysiological process of aging. 
Chapter II. The optimization and characterization of the chromosomally integrated, dual 
fluorescence-based reporter strain, Pgst-4::GFP (VP596 dvls19[pAF15(Pgst-
4::GFP::NLS)];vsIs33[Pdop-3::RFP]) will be discussed. This chapter establishes a use for the 
Pgst-4::GFP transgenic reporter strain in qualitative observations of in vivo oxidative stress in C. 
elegans, whereas measurements of F3-isoprostanes is more conducive to quantitative measures of 
oxidative stress. 
Chapter III. The development of a quantitative gas chromatography-negative ion chemical 
ionization-mass spectrometry (GC-NICI-MS) approach to measure in vivo oxidative stress in C. 
elegans will be discussed. The methods described in this chapter have been optimized and 
validated to provide the most sensitive and selective assay for quantification of lipid peroxidation 
from C. elegans lysates. 
Chapter IV. The role of IsoKs, SIR-2.1, and ETS-7 in salicylamine-mediated lifespan 
extension will be discussed. Notably, beneficial SA longevity effects appear to operate primarily 
at the protein level, placing SA broadly in the role of a proteostasis mediator. SA administration 
preserves SIR-2.1 and ETS-7 function to enhance normal antioxidant defenses, while effects on 
mitochondrial function and gene expression were found to be small to nonexistent. Markedly, 
salicylamine was shown to be a potent anti-aging intervention, with a high translational potential 
for affecting mammalian models of disease.
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CHAPTER II 
 
DEVELOPMENT AND CHARACTERIZATION OF a FLUORESCENT-BASED ASSAY 
FOR in vivo MEASUREMENT OF OXIDATIVE STRESS 
 
Introduction  
 The free radical theory of aging as proposed by Denham Harman theorizes that reactive 
oxygen species (ROS) accumulates over time, causing damage which leads to aging. Harman 
expanded the theory to propose that cells and tissues decline in activity due to the cumulative 
effects of macromolecular damage caused by byproducts of the normal oxidative metabolism, the 
oxygen radicals produced by respiration (Harman 1956). Oxidative stress was generally thought 
to occur due to an imbalance between ROS production and elimination. Later, Harman adapted his 
theory to incorporate the role of mitochondria [and specifically the electron transport chain (ETC) 
activity] in aging since ROS was considered to be largely produced by mitochondria (Harman 
1972).  
This model for aging is attractive, considering the mechanism of ROS production is 
universal among animals; but most of all, it is a mechanism that is universal throughout all 
organisms, seeing as this damage is a by-product of ordinary living (Stadtman and Levine 2000). 
There is abundant research that establish that ROS and oxidative damage increase with age 
(Stadtman 2006), increased production of ROS shortens lifespan (Kirkwood and Kowald 2012), 
and consequently, reducing oxidative damage extends the lifespan of various model organisms 
(yeast, nematodes, fruit flies, mice, etc.). The relationship of energy metabolism and ROS 
production can be observed at the mitochondrial level, in which accumulation of ROS is generated 
as an aftermath of normal and diseased ETC activity. Not only is the link between ROS and energy 
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metabolism seen at the mitochondrial level, studies have shown a connection at the nuclear level 
by means of the nuclear factor E2-related factor 2 (Nrf2)/antioxidant response element (ARE) 
pathway.  
 The Nrf/CNC (Cap’n’collar) family of transcription regulators are commonly known to 
initiate and mediate cellular defense against environmental stressors resulting in increased 
oxidative damage. The Nrf/CNC transcription factor is located in the cytoplasm until disturbances 
that increase oxidative stress cause this transcription factor to translocate to the nucleus. Nrf/CNC 
binds to the enhancer ARE sequence, which is present in genes that encode for proteins involved 
in antioxidative defenses such as glutathione synthesis (Kobayashi and Yamamoto 2006, Sykiotis 
and Bohmann 2010). Nrf/CNC nuclear translocation results in the expression of a host of phase II 
detoxification and antioxidants, including thioredoxins and glutathione-synthesizing enzymes to 
maintain the redox balance, enzymes to detoxify xenobiotics such as glutathione S-transferases, 
proteasomal subunits, and various other cytoprotective proteins (Lee, Calkins et al. 2003, Lee, 
Shih et al. 2003, Shih, Johnson et al. 2003, Oliveira, Porter Abate et al. 2009). Collectively, these 
enzymes work to mitigate the harmful effects of ROS. 
The inducible CNC transcription factors are conserved in worms, insects, fish, birds, and 
mammals, but absent in plants and fungi. In the nematode C. elegans, the Nrf/CNC functional 
ortholog is termed SKN-1 (Walker, See et al. 2000, An and Blackwell 2003). Similar to Nrf/CNC 
function in mammals, nematode SKN-1 plays a highly regulatory role in pathways which promote 
longevity. A condensed lifespan can be observed in loss-of-function skn-1 mutants (An and 
Blackwell 2003), and although overexpression of SKN-1 results in adverse effects in nematodes, 
modest SKN-1 overexpression has been shown to extend lifespan significantly (Tullet, Hertweck 
et al. 2008). 
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In light of the significant role free radical damage in aging, measures to assess in vivo 
oxidative stress may shed insight into disease etiology. There are several approaches to assess the 
role of oxidative damage in C. elegans – one could measure levels of ROS in either whole worm 
(living or lysates) or specifically in mitochondria, or quantify signs of oxidative damage (e.g. 
measuring levels of lipid and DNA oxidation products). Here, we describe usage of a GFP (green 
fluorescent protein) transgenic reporter strain, VP596, to relay activity of the nematode 
transcription factor SKN-1. The response to oxidative stress is regulated by the SKN-1 
transcription factor, which regulates cytoprotective genes that encode enzymes which initiate 
phase II detoxification and antioxidants (Lee and Johnson 2004, Mathers, Fraser et al. 2004). This 
assay utilizes a chromosomally integrated, dual fluorescence-based reporter for a core SKN-1 
activated gene, gst-4, which encodes for glutathione-S transferase (Choe, Przybysz et al. 2009, 
Leung, Deonarine et al. 2011). In the present study, we tested the fitness of the transcriptional 
reporter of gst-4 (Pgst-4::GFP) in monitoring in vivo oxidative damage in C. elegans by way of 
indirect SKN-1 signaling, through challenge with known pro-oxidant compounds (e.g. juglone, 
paraquat, etc.). We compared the results to other methods of oxidative damage measurement, such 
as isoprostane collection, and highlighted the strengths and weaknesses between these two 
approaches. 
 
Materials & Methods 
C. elegans Strains and Maintenance 
C. elegans strains were cultured at 20C on standard nematode growth media (NGM) agar plates 
seeded with Escherichia coli strain NA22. The following strains were used in this work: wild-type 
C. elegans Bristol strain N2, and VP596. N2 strains were provided by the Caenorhabditis Genetics 
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Center (University of Minnesota, St. Paul, MN) and VP596 strain was provided by Dr. Keith P. 
Choe (University of Florida). Synchronous L1 populations were obtained by isolating embryos 
from gravid worms by alkaline hypochlorite (0.5N NaOH, 1% hypochlorite; 8 min at 23C), and 
segregating eggs from worm and bacterial debris by floatation on a sucrose gradient. The recovered 
eggs were rinsed in M9 buffer and placed on fresh agar plates seeded with E. coli strain OP50 and 
maintained at 20C until late-L4/young adult stage.  
Reagents 
Unless otherwise stated all reagents were obtained from Sigma-Aldrich (St. Louis, MO). 
Pro-oxidant Exposure 
Synchronized (Lewis and Fleming 1995) late stage L4 larvae were exposed to varying 
concentrations of either 5-hydroxy-p-naphthoquinone (juglone), hydrogen peroxide (H2O2), tert-
Butyl-hydroperoxide (t-BOOH), or paraquat diluted in 85 mM NaCl supplemented with 0.1% 
Tween-20 medium (addition of 0.1% Tween-20 to liquid medium discourages mechanical 
shearing stress of animals) for 1 h, rotating at 23C. After 1 h treatment, animals were removed 
from the liquid, transferred to agar plates spread with E. coli bacterial strain OP50, and allowed to 
recover for 4 h before fluorescence was measured. 
Lethality 
Synchronized late-L4/young adult stage worms were acutely treated with juglone (0-200 µM) in 
glass tubes for 1 hr at 23C. Worms were then pelleted by centrifugation at 1200 rpm for 1 minute 
and washed twice with 85 mM NaCl + 0.1% Tween-20 buffer. 30-50 worms were counted and 
transferred to NGM agar plates seeded with E. coli bacterial strain OP50 in triplicate. Survival of 
 78 
worms was assessed by touch-provoked movement using a platinum wire (Gill, Olsen et al. 2003) 
48 h post-treatment. 
Oxidative Stress Reporter Assay and Microscopy 
Pgst-4::GFP fluorescence was quantified using a microplates reader (FLUOstar Optima 
microplate reader, BMG Labtechnologies). Synchronized (Lewis and Fleming 1995) late stage L4 
worms were exposed to pro-oxidants (juglone, t-BOOH, H2O2, and paraquat) for 1 h, removed 
from liquid, transferred to OP50-seeded bacterial plates, and allowed to recover for 4 h before 
fluorescence was measured. A sub-set of worms (~10-15 worms per condition) were mounted onto 
4% agar pads (in M9 medium) and anesthetized with 0.2% tricaine/0.02% tetramisole in M9 
buffer. Representative images of Pgst-4::GFP fluorescent intensity at varying concentrations of 
juglone was imaged using an epifluorescence microscope (Nikon Eclipse 80i) equipped with a 
Lambda LS Xenon lamp (Sutter Instrument Company) and Nikon Plan Fluor 20x dry and Nikon 
Plan Apo 60x 1.3 oil objectives. 
F3-Isoprostane Collection 
F3-Isoprostane levels were quantified from pro-oxidant treated worms using a gas-
chromatography-negative ion chemical ionization-mass spectrometry (GC-NICI-MS) approach 
(Milne, Sanchez et al. 2007), as previous described (Nguyen and Aschner 2014) in whole worm 
extracts from synchronized late L4 stage worms treated with various concentrations of either 
juglone, t-BOOH, H2O2, or paraquat. Protein concentration of nematode homogenates were 
determined using the bicinchoninic acid (BCA) protein assay as described by the manufacturer 
(Pierce Protein Biology, Waltham, MA). 
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Statistics 
All statistical analyses were performed using GraphPad Prism 6 (GraphPad Software, Inc.). Dose-
response lethality curves were generated using a sigmoidal dose-response model with a top 
constraint at 100% and determination of LD50 values (concentration at which drug induces 50% 
reduction in survival). 
Results & Discussion 
Establishing a SKN-1 response with xenobiotic juglone 
As oxidative stress and its resulting damage is involved in aging and age-related diseases, we 
examined whether the transgenic fluorescent reporter strain, VP596 would be a suitable measure 
of in vivo oxidative stress in C. elegans via indirect measurement of SKN-1 signaling. As described 
in depth in Leung et al. (2011), the transgenic strain VP596 (dvls19[pAF15(gst-
4::GFP::NLS)];vsls33[dop-3::RFP]) contains two fluorescent constructs to report SKN-1 activity 
[Pgst-4::GFP (Link and Johnson 2002)] and normalize worm number across all assay wells [Pdop-
3::RFP (Chase, Pepper et al. 2004)], which is then expressed as a ratio of GFP/RFP (Leung, 
Deonarine et al. 2011). To activate the SKN-1 response, a reactive oxygen-generating 
napthoquinone, juglone, was used. Juglone has previously been utilized in oxidative stress studies 
in C. elegans (Strayer, Wu et al. 2003, de Castro, Hegi de Castro et al. 2004, Przybysz, Choe et al. 
2009).  
 To assess the effect of juglone toxicity on nematode survival, juglone lethality curves were 
established for Bristol N2 WT and VP596 strains (Fig. 2.1A and 2.1B). Toxicity was assessed in 
order to conduct following fluorescent studies in a sub-lethal dose range. Dose-response survival 
curves following acute juglone exposure revealed N2 WT and VP596 had similar sensitivities to 
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juglone-induced lethality (LD50 = 48.6 µM and LD50 = 45.0 µM, respectively). All following 
experiments were conducted in the sub-lethal dose range of juglone (~30 – 50 µM). 
In order to establish the juglone concentration response curve, late-stage larval stage 4 
worms were exposed to juglone in liquid (85 mM NaCl + 0.01% Tween-20) for 1 h and then 
transferred to agar plates for recovery. GFP fluorescence intensity was then measured 4 h after 
plating worms at a concentration of 200 worms/well and 5 replicates per juglone concentration, 
using a FLUOStar Optima (BMG LabTech, Ortenberg, Germany). Maximal efficacy of a ~4.5-
fold increase in Pgst-4::GFP fluorescence intensity was found to be ~35 M juglone, and half-
maximal efficacy was 16.6 M (Fig. 2.1C). VP596 worms express GST-4::GFP in the intestinal 
lining of the worm, which can be seen visualized in worms treated with 0, 10, 30, and 50 µM 
juglone. Representative epifluorescence microscopic images depicting intestinal expression of 
GST-4::GFP (Fig. 2.1D) shows dose-dependent increase in fluorescent intensity, up to 30 µM 
juglone. Concentrations higher than 30 µM show a slight decrease in fluorescent intensity, possibly 
due to lethality issues at this particular dose, considering LD50 was found to be in the same 
concentration range. 
Methods to quantify oxidative stress in C. elegans 
 Juglone (5-hydroxy-1,4-naphthoquinone) is a potent redox active compound with the 
potential to generate superoxide anion radicals (Bolton, Trush et al. 2000). This naphthoquinone 
and has been used previously in C. elegans to isolate genetic programs to defend against 
deleterious effects of oxidative damage (Strayer, Wu et al. 2003), identify genes that promote 
resistance to oxidative stress (de Castro, Hegi de Castro et al. 2004), and to establish a hormetic 
response (Przybysz, Choe et al. 2009). In addition, juglone is also an electrophilic xenobiotic that 
can react with either superoxide (O2‾•), hydroxyl radical (•OH), and hydrogen peroxide (H2O2), of 
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which is a concern because hydroxyl radicals are powerful oxidizing agents that could potentially 
cause damage to essential macromolecules. For example, oxidation of solvent-accessible cysteine 
residues in proteins create disulfide bonds which can modify protein structure and impede function 
(Bolton, Trush et al. 2000).  
Figure 2.1. Establishing a juglone dosing regimen with the Pgst-4::GFP reporter 
strain. (A) Dose response lethality curves following acute juglone exposure. Late-L4 
stage Bristol N2 WT worms were treated for 1 hr with increasing concentrations of 5-
hydroxy-1,4-naphthoquinone (juglone). LD50 was found to be 48.6 µM (B) Lethality 
curve for Pgst-4::GFP (VP596) reporter strain. LD50 = 45.0 µM. (C) Concentration 
response curve for Pgst-4::GFP reporter strain treated with increasing concentrations 
of juglone for 1 hr. Fluorescent intensity of gst-4 expression was measured from 
VP596 after a 4 hr recovery time. EC50 = 16.6 µM and ECMAX ~35 µM. (D) 
Representative epifluorescence images from juglone-treated Pgst-4::GFP animals. 
Data are expressed as means  SEM from three independent experiments.  
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From these earlier studies, juglone has been found to form harmful adducts to alter proteins 
(O'Brien 1991, Bolton, Trush et al. 2000), lipid peroxidation (Fong, McCay et al. 1973), and DNA 
damage (Bjelland and Seeberg 2003). Furthermore, quinones such as juglone, also act as Michael 
acceptors; mechanistically, damage to macromolecules could occur through covalent binding of 
quinones with cellular nucleophiles. An example of this occurrence can be seen through quinone 
reaction with glutathione (GSH) or solvent-accessible cysteine residues of proteins; these reactions 
lead to a reduction of GSH levels (Bolton, Trush et al. 2000). The possibility of juglone reacting 
with cysteine residues is troubling, bearing in mind the Pgst-4::GFP relies on fluorescent intensity 
reporting the activity of glutathione-s transferase activity. 
With these considerations in mind, concerns about off-target effects of juglone in the Pgst-
4::GFP reporter assay were raised, due to the potential for juglone interference in SKN-1 
regulation. To address these concerns, the transgenic fluorescent strain (VP596, 
dvls19[pAF15(gst-4::GFP::NLS)];vsls33[dop-3::RFP]) was exposed to various pro-oxidants 
typically used in C. elegans oxidative stress studies (juglone, H2O2, paraquat, and t-BOOH). A 
concentration response curve (CRC) was observed for juglone, with maximal efficacy over a 4.5-
fold increase concentrations higher than 30 µM, tert-Butyl hydroperoxide, with a maximal efficacy 
~2.5-fold increase at 1 mM t-BOOH, and paraquat, with a maximal efficacy ~1.5-fold increase at 
85 mM paraquat – but a CRC could not be observed for hydrogen peroxide (Fig. 2.2A). Of the 
pro-oxidants tested, juglone induced the strongest fold-change in fluorescent intensity. 
 F3-isoprostanes (F3-IsoPs) were collected from pro-oxidant exposed transgenic GST-
4::GFP nematodes as a comparative method to test whether the Pgst-4::GFP assay is an adequate 
measure of oxidative damage. F3-IsoPs are the non-enzymatically rearranged lipid peroxidation 
products of eicosapentaenoic acid (EPA), and are known to be a highly sensitive and accurate 
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marker of oxidative damage in C. elegans (Gao, Yin et al. 2006, Labuschagne, Stigter et al. 2013, 
Nguyen and Aschner 2014). Late-stage L4 worms were treated in the same manner as described 
previous (pro-oxidants: 0 and 30 M juglone; 0 and 1 mM t-BOOH; 0 and 1 mM H2O2; 0 and 85 
mM paraquat). Samples were homogenized using the BioSpec Mini-Beadbeater-16 with 
zirconium oxide beads (1 mm) at 4°C. Homogenates were prepared for GC/MS using protocols 
established previously in the lab (Nguyen and Aschner 2014). F3-IsoP sample collection from 
VP596 worms exposed to the various pro-oxidants all show a significant increase in F3-IsoP levels 
when compared to vehicle control (Fig. 2.2B), with juglone showing a ~1.8-fold increase in 
oxidant injury, an observed ~11-fold increase in oxidant injury upon administration of t-BOOH, a 
~1.5-fold increase in oxidative damage with paraquat, and an expected increase in oxidant injury 
with H2O2 dosing (~2.1-fold increase). Therefore, this suggests that F3-IsoP collection is a more 
appropriate measure of oxidative damage than the transgenic Pgst-4::GFP reporter strain, VP596. 
Conclusion 
 The C. elegans GFP reporter strain, VP596 dvls19[pAF15(Pgst-
4::GFP::NLS)];vsIs33[Pdop-3::RFP], was utilized for the exploration of the role oxidative stress 
plays in aging. For the first time, the current study provides evidence that while the Pgst-4::GFP 
reporter strain may be used for qualitative evaluation of in vivo oxidative stress in C. elegans, 
quantification of F3-Isoprostanes (F3-IsoPs) should be preferred in quantitative studies. From the 
data provided in this study, a discrepancy in sensitivity to measuring oxidative damage can be seen 
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Figure 2.2. Pgst-4::GFP reporter strain is a qualitative measure of oxidative 
stress. (A) Relative fluorescent intensity of Pgst-4::GFP reporter treated with 
juglone, t-BOOH, H2O2, and paraquat for 1 hr. Maximum fluorescent intensity was 
observed: juglone, ~4.5-fold increase at 30 M; t-BOOH, ~2.5-fold increase at 1 mM; 
paraquat, ~1.5-fold increase at 85 mM; no change in fluorescent intensity observed 
with H2O2. (B) F3-IsoP measurement of Pgst-4::GFP reporter strains treated with 
juglone, t-BOOH, H2O2, and paraquat. An increased fold-change in F3-IsoP levels 
were detected for all pro-oxidants: juglone, ~1.8-fold increase at 30 µM, t-BOOH, 
~11-fold increase at 1 mM; H2O2, ~2.1-fold increase at 1 mM; paraquat, ~1.5-fold 
increase at 85 mM. Data are expressed as means  SEM from two independent 
experiments.  
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 between the two approaches used: 1.) Pgst-4::GFP reporter strain, and 2.) F3-IsoP measurements. 
Higher responses to pro-oxidant treatment can be seen in quantification of endogenous F3-IsoP 
levels when compared to the responses of the Pgst-4::GFP assay when treated with pro-oxidants. 
In addition, juglone is an arylating agent that reacts with thiols on cysteine residues of protein to 
form covalent bonds resulting in quinone-thiol Michael adducts (O'Brien 1991, Bolton, Trush et 
al. 2000), which may potentially interfere with Pgst-4::GFP fluorescent intensity signals. In 
conclusion, we recommend use of the Pgst-4::GFP reporter strain in qualitative studies of in vivo 
oxidative stress in C. elegans, and to discourage the usage of juglone as a pro-oxidant in 
conjunction with this reporter strain.  
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CHAPTER III 
 
F3-ISOPROSTANES AS a MEASURE OF in vivo OXIDATIVE DAMAGE IN 
Caenorhabditis elegans3 
 
Introduction 
 Numerous environmental toxins cause oxidative damage to lipids, proteins, and DNA. 
Lipid peroxidation is a hallmark of oxidative stress, in part due to its susceptibility to free radical 
attack (Gardner 1989, Niki 2009). Damage to tissue biomolecules, including lipids, proteins and 
DNA by reactive oxygen species (ROS) is thought to be a major contributor to pathophysiology 
of oxidative stress (Halliwell and Gutteridge 1990, Gutteridge 1995, Butterfield 1997). ROS are 
chemically reactive, oxygen-containing molecules typically generated during aerobic metabolism, 
with the mitochondria being a major source of endogenous ROS (Chen, Vazquez et al. 2003, 
Muller, Liu et al. 2004). Some of the most common ROS produced in living systems are superoxide 
anion (O2
•─), hydrogen peroxide (H2O2), and hydroxyl radicals (∙OH). Reactive nitrogen species 
(RNS) are related reactive species formed in cells, which include peroxynitrite (ONOO─), nitric 
oxide (∙NO) and other carbon-centered radicals. Excess ROS accumulation can cause injury to 
surrounding biomolecules; therefore the cell has developed a series of antioxidant defense 
mechanisms to mitigate the effects of free radical-induced oxidative damage and maintain redox 
homeostasis. The primary antioxidant defenses include antioxidant enzymes to degrade ROS, such 
as superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase, along with low 
                                                        
3 Published as Thuy Nguyen and Michael Aschner UNIT 11.17 “F3-Isoprostanes as a measure of 
in vivo oxidative damage in Caenorhabditis elegans” Current Protocols in Toxiology 62:11 
(Nov. 6, 2014) :  11.17.1-11.17.13. © 2014 John Wiley & Sons, Inc. Reprinted with permission 
of John Wiley & Sons, Inc. 
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molecular weight antioxidant molecules to serve as free radical scavengers and/or reducing agents. 
Oxidative stress occurs when there is an imbalance between production of free radicals and 
antioxidant defenses to favor an environment where excess ROS can cause oxidant damage to 
biomolecules. 
Measuring oxidative stress requires accurate quantification of either free radical production 
or damaged biomolecules, such as lipid peroxidation products. Several analytical approaches 
[electron paramagnetic resonance (EPR), chemiluminescence, fluorescence] have been used to 
detect levels of intraworm ROS and their oxidation products; however many of these techniques 
suffer from lack of sensitivity and specificity, as well as being methodologically difficult to 
execute. In a recent multi-investigator study sponsored by the National Institutes of Health (NIH), 
the Biomarkers of Oxidative Stress Study (BOSS) found that the most accurate method to assess 
oxidant stress in vivo is through quantification of plasma or urinary F2-Isoprostanes (F2-IsoPs) 
(Kadiiska, Basu et al. 2013). The predominant mammalian polyunsaturated fatty acid, arachidonic 
acid (AA), can give rise to non-enzymatic formation of F2-IsoPs through free radical-induced lipid 
peroxidation (Morrow, Hill et al. 1990). Because of their chemical stability and prevalence in all 
human tissues and biological fluids, IsoPs are regarded as the gold standard for quantification of 
oxidative damage in mammals. In C. elegans the major fatty acid eicosapantaenoic acid (EPA) 
forms F3-IsoPs, which were also recently identified as markers for oxidative damage (Gao, Yin et 
al. 2006, Chang, Patel et al. 2008, Song, Paschos et al. 2009).  
This unit will describe methods to measure F3-IsoPs in C. elegans using a gas 
chromatography-negative ion chemical ionization-mass spectrometry (GC-NICI-MS) approach 
employing a stable isotope dilution (see Fig. 3.1). This includes solid-phase extraction (SPE), thin-
layer chromatography (TLC) purification, chemical derivatization, and MS detection using 
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negative ion chemical ionization (NICI) coupled with GC. The advantages of GC/MS include the 
high resolution of GC separation on fused silica capillary columns and the specificity and 
sensitivity of MS, which allows the lower limit of detection of the F3-IsoPs to be in the low 
pictogram range. This assay is a robust and sensitive method that enables quantification of 
endogenous levels of oxidative damage in C. elegans. A goal of this unit is to introduce a sensitive 
and accurate measure of endogenous oxidative damage in C. elegans for oxidant stress studies. 
Several considerations of this protocol and alternative approaches are discussed in the 
Commentary section below. Methods are described for collection of whole worm lysates, lipid 
extraction for measurement of total F3-IsoPs, and sample preparation with chemical derivatization 
and extraction for GC-MS analysis. 
 
Figure 3.1. Derivatization of 15-series F3-Isoprostanes for GC/MS analysis.  
F3-IsoPs must undergo chemical transformation to the pentafluorobenzyl ester, 
trimethylsilyl ester derivatives prior to GC/MS analysis. After separation phase 
extraction/purification, F3-IsoPs are first derivatized by PFBB, which attacks the 
carboxyl group of the F3-IsoP. The pentafluorobenzyl ester moiety of the resulting 
product is an ideal leaving group for formation of the carboxylate anion detected by 
the mass spectrometer. Trimethylsilyl groups are added to the hydroxyl groups 
through derivatization by BSTFA, which functions to lower polarity of the molecule 
and significantly lowers the boiling point of the resultant derivatives, for ease of 
vaporization when injected into the gas chromatograph. During ionization process, the 
pentafluorobenzyl ester is cleaved and the carboxylate anion is the resulting species 
detected by the mass spectrometer. 
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Sample Collection and Preparation 
This protocol describes the method for nematode collection and homogenization for quantification 
of F3-IsoPs as a measure of lipid peroxidation. A critical consideration in the accurate measurement 
of oxidant damage is decreasing the ex vivo oxidation of eicosopentaenoic acid, which can generate 
F3-IsoPs outside of the desired experiment. This may be addressed by flash-freezing washed 
samples in liquid nitrogen directly following collection if not used for sample preparation and 
analysis immediately.  
 
Table 3.1: Materials for sample collection and preparation 
NaCl 
1X Tris-buffered saline, pH 7.4 (Fisher, acidify to pH 6.8 with HCl) 
1x Protease Inhibitor Cocktail (Sigma, cat. no. P8465) 
1% Triton X-100 (Sigma, cat. no. T8787) 
2-ml sterile polypropylene screw-cap tubes 
1.0 mm zirconia beads (BioSpec Products, cat. no. 11079110zx) 
High-energy cell disruptor, (BioSpec Products, cat. no. 607) 
 
Worm collection 
Harvest healthy synchronized nematodes by washing plates with room temperature 85 mM 
NaCl, using 10-12 mL per plate. Transfer resuspended nematodes to 15 mL conical tubes using 
sterile pipettes and centrifuge to pellet worms for 1 minute at 400 x g, 23°C. Repeat washes at 
least 3 times or until aqueous phase is clear. Centrifuge worms at 1600 x g, 23°C, for 5 minutes. 
Aspirate the supernatant down to 100 L and transfer worm solution into 2-mL polypropylene 
microvials. 
Preparation of homogenization solutions 
Prepare lysis buffer: (0.0497 g NaCl, 100 L of 1% Triton X-100, 100 l of 1M Tris 
buffered saline, pH 6.8, 100 l of 1X protease inhibitor cocktail, and 9.7 mL of sterile water). 
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Aliquot 2 mL into 15 mL conical tubes and store at -20 °C. Keep aliquot of freshly prepared lysis 
buffer in an ice bucket for immediate use. To prepare samples for homogenization, add 400 L 
cold lysis buffer to 2-mL polypropylene microvial containing nematodes. Eicosapentaenoic acid 
in tissue samples can oxidize ex vivo to generate F3-IsoPs. If worm samples are not to be used 
immediately after collection, flash freeze the sample in liquid nitrogen and store at -80 °C. To add 
zirconia beads to sample vials, cut the tip off the plastic twist-top for easier pouring. Add 300 L 
1.0 mm zirconia beads into samples for homogenization. Bring total lysate volume of each sample 
to ~700 L by adding 200 L cold 85 mM NaCl. Prepare stirring ice water on stir plate to cool 
samples in between homogenization.                    
Homogenization of nematodes 
To homogenize worms, all following steps should be performed in a 4 °C cold room. 
Homogenize worms with a beadbeater at full speed for 20 s. Remove samples from beadbeater 
and place in stirring ice water for 1 min. Repeat homogenization and cooling steps for a total of 7 
cycles. Centrifuge for 30 min at 3500 x g in a tabletop centrifuge at 4 °C to separate aqueous and 
organic layers. After centrifugation, carefully pipette off aqueous layer and transfer to a new 2-mL 
polypropylene microvial. Lysates can be stored at -80 °C until ready for sample purification.  
Cleaning of zirconium beads 
Transfer used zirconium beads from sample tubes into a clean, open stainless steel or glass 
tray. Soak beads in diluted bleach mixture (1:10 bleach:H2O) for 5 minutes. Rinse beads in distilled 
water until aqueous phase is clear. Dry beads in glass tray at 40 – 70C oven. Beads can be 
autoclaved for 30 minutes and stored in dispensing container before use. Zirconium beads can be 
reused for approximately 10 uses before beads wear down in size. 
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Lipid Extraction and Hydrolysis of F3-IsoP-containing Phospholipids in C. elegans Lysates  
F3-IsoPs are formed in situ esterified to phospholipids and are subsequently released by 
phospholipases. In tissue samples and worm lysates, this phenomenon creates two forms of F3-
IsoPs; one form that remains esterified in the membrane, and a second that is hydrolyzed and 
released in free form. Both free and esterified F3-IsoPs are quantified for total F2-IsoP formation 
in the worm lysates. In order to quantify total F3-IsoPs, it is necessary to extract the phospholipids 
from the tissue and release esterified F3-IsoPs from the phospholipids via base hydrolysis. A free 
radical scavenging agent, BHT, is added to the organic solvent during extraction of phospholipids 
in order to decrease the amount of ex vivo oxidation of EPA. 
 
Table 3.2: Materials for lipid extraction and hydrolysis of C. elegans lysates 
15% KOH, wt/v (see recipe) 
Methanol containing BHT (0.005% v/v) (see recipe) 
pH 3 water (see recipe) 
1 N HCl 
1.7-ml microcentrifuge tube 
15-mL plastic tube (Denville, cat. no. T8173) 
 
Lipid extraction and base hydrolysis of C. elegans lysates 
Let samples thaw on ice. Once thawed, aliquot 30 L of lysate into a new 1.7-mL 
microcentrifuge tube for protein content normalization. To each sample add 500 L of KOH (15%, 
wt/v). Mix gently by inversion, making sure to not vortex samples and incubate at 37 °C for 30 
min. To quantify total F3-IsoPs formation, both free and esterified F3-IsoPs are analyzed by 
releasing F3-IsoPs from the phospholipids via base hydrolysis. Add 500 L of methanol containing 
butylated hydroxytoluene (BHT) to each sample. Adding a free radical scavenging agent like 
butylated hydroxytoluene (BHT) to the lipid extracts is important to inhibit ex vivo formation of 
F2-IsoPs. Total lipids are dissolved in 500 L methanol containing BHT (0.005% v/v) to saponify 
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lipid extracts and release esterified isoprostanes. Mix gently by inversion and centrifuge for 2 min 
at maximum speed in a tabletop centrifuge at room temperature. Following centrifugation, a 
semisolid protein layer should have formed between the upper (aqueous) and the lower (organic) 
layers. Carefully pipette off semisolid protein layer and discard. Transfer aqueous layer to a 15-
mL plastic tube by pipet and place on ice. Acidify the mixture to pH 3 with 1 ml HCl (1N) and 
bring total volume to 10 mL with pH 3 water in preparation for purification of F2-IsoPs with solid-
phase extraction (SPE). It is important that samples are corrected to pH 3 or slightly lower (down 
to pH 2.5) in order for the carboxylate moiety to be protonated in order to chromatograph correctly 
on the Sep-Pak cartridges. Note, it is important to continue immediately with the purification steps 
below. The sample should not be stored in this form because of the potential for oxidation. 
Sample Purification for Mass Spectrometric Analysis  
This GC/MS method is based on those described by Morrow, Roberts, and colleagues (Morrow, 
Zackert et al. 1999, Gao, Yin et al. 2006, Milne, Sanchez et al. 2007) and involves derivatization 
of carboxyl moieties on the F3-IsoPs to the pentafluorobenzyl ester, trimethylsilyl ether 
derivatives. Separation of compounds is achieved by solid-phase extraction using both C18 and 
silica Sep-Pak to remove the contaminants. Pentafluorobenzyl (PFB) moiety is then reacted with 
the molecule to enhance detection using electron capture chemical ionization techniques15. Lastly, 
trimethylsilyl (TMS) is introduced to add to cap the hydroxyl groups to lower its boiling point for 
ease of vaporization in the gas chromatograph. Analysis of the derivatives of 15-F3t-IsoPs and the 
internal standard is carried out using the selective-ion monitoring (SIM) techniques, where the ions 
monitored are m/z 567 for F3-IsoPs and m/z 571 for the internal standard, respectively. 
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Table 3.3: Materials for sample purification for GC/MS analysis 
[2H4]-15-F2t-IsoP (8-iso-PGF2α) (Cayman Chemical, cat. no. 316351) 
Methanol (Fisher, cat. no. A4544) 
pH 3 Water (see recipe) 
1 N HCl 
Heptane (Fisher, cat. no. H3504) 
Ethyl acetate (Fisher, cat. no. E1964) 
Acetonitrile (Fisher, cat. no. A9984) 
10% Pentafluorobenzyl bromide (PFBB) (Sigma, cat. no. 10105-2, see recipe) 
10% N,N’-Diisopropylethylamine (DIPE) (Sigma, cat. no. D3887, see recipe) 
Calcium hydride (Sigma, cat. no. 208027) 
Chloroform (VWR, EM-CX1059-1) 
Ethanol, absolute, 200 proof (Fisher, AC61509040) 
10-ml Disposable plastic syringe (Laboratory Supply, cat. no. SMJ5512878) 
15-ml plastic tube (Denville, cat. no. T8173) 
5-ml plastic vial with cap (Denville, cat. no. T8200) 
C18 Plus solid-phase extraction (Sep-Pak) cartridge (Waters Associates, cat. no. WAT036575) 
Silica Plus solid-phase extraction (Sep-Pak) cartridge (Waters Associates, cat. no. 
WAT036580) 
Supelco Visiprep SPE vacuum manifold (Sigma, cat. no. 57265) 
Analytical evaporation unit with water bath at 37°C (Organomation, cat. no. 11634-P) 
TLC filter paper (VWR, cat. no. 28298-020) 
TLC silica plates (Analtech, cat. no. 43931-2) 
Glass TLC tank (VWR, cat. no. 21432-761) 
 
Sample purification using Separation-Phase Extraction (SPE) 
To sample accurately add 248 pg of the internal standard ([2H4]-15-F2t-IsoP) and vortex. 
For reverse phase, connect one C-18 Sep-Pak cartridge to a 10-ml disposable syringe per sample 
and place on vacuum manifold. Precondition each cartridge with 5 ml methanol and 5 ml pH 3 
water. Use a pressure < 5 mm Hg for column conditioning. Dispense acidified sample to the 
preconditioned Sep-Pak cartridge. During sample loading, the vacuum manifold should be set at 
< 5 mm Hg for a flow rate through the column at 1-2 ml per min, such that individual drops emerge 
from the Sep-Pak. This is to avoid loss of IsoPs when applying sample to the cartridge. Wash 
cartridge first with 5 mL pH 3 water followed by 5 mL heptane. Heptane removes nonpolar 
contaminates including un-oxidized EPA. Elute F3-IsoPs with 10 mL of ethyl acetate/heptane 
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(50:50 v/v) into a 15-mL plastic tube. Dry ethyl acetate/heptane eluate with anhydrous sodium 
sulfate. Add 1-5 g Na2SO4 to vial and swirl gently for 5 s. This step removes residual water from 
the eluent. Remove used C-18 Sep-Pak cartridges from syringes and discard. Connect one silica 
Sep-Pak cartridge to each syringe per sample and place on vacuum manifold. Precondition each 
silica cartridge with 5 mL ethyl acetate/heptane (50:50 v/v). Apply eluent from C-18 Sep-Pak 
cartridge to silica Sep-Pak cartridge. Care should be taken to decant eluent and not to transfer any 
sodium sulfate to the extraction cartridge. Wash cartridge with 5 mL ethyl acetate, then elute F3-
IsoPs from the silica Sep-Pak cartridge with 5 mL ethyl acetate/methanol (45:55 v/v) into a 5-mL 
collection vial. Evaporate eluent under nitrogen in the analytical evaporation unit in a fume hood. 
Conversion of F3-IsoPs to corresponding pentafluorobenzyl esters  
Add 40 L of 10% (v/v) PFBB in acetonitrile and 20 L of 10% (v/v) DIPE in acetonitrile 
to the sample vial, vortex briefly, and incubate for 20 min at 37 °C.  
Convert F3-IsoPs to the corresponding pentafluorobenzyl esters. This derivatization facilitates 
compound analysis by GC/MS. Do not work outside of a well-ventilated fume hood due to PFBB 
being a potent lachrymator. Dry sample thoroughly under nitrogen in an analytical evaporation 
unit and resuspend material in 50 L methanol/chloroform (3:2, v/v). Vortex briefly. 
Thin-Layer Chromatography (TLC) 
Prepare TLC tank by adding 92 mL chloroform, 8 mL ethanol, 1 mL acetic acid, and TLC filter 
paper to saturate the tank. Allow tank to equilibrate for 30 min. Mark solvent front line and label 
sample lanes (see Fig. 3.2). Silica plates contain a pre-adsorbent zone towards the bottom of the 
plate and four pre-scored lanes. Measure 13 cm from top of the pre-adsorbent zone (origin line) 
and mark. Lightly score solvent front across plate. Above marked solvent front, label individual 
samples per each four lane. Apply mixture from each sample to a silica TLC plate. Dry samples 
 98 
for 5-10 s with a hair dryer. Samples are applied to the upper half of pre-adsorbent zone in four 
pre-scored lanes, taking care to apply only one sample per lane. Avoid adding sample to the first 
1 cm of the plate. Using a separate TLC plate, apply approximately 2-5 g of the methyl ester of 
prostaglandin F2α (PGF2α) to one lane for use as a standard. After ensuring that the application 
solvent has dried, place TLC plates into the TLC tank. Solvent is allowed to migrate 13 cm, and 
plates are removed from tank for solvent to evaporate. Not all TLC plates may reach 13 cm at the 
same time. Visualize the TLC standard by spraying the standard plate with the phosphomolybdic 
acid solution and then heating on a hot plate. Do not spray sample plates. Scrape silica from the 
sample TLC plates in the region of the TLC standard (Rf  should be approximately 0.18), scraping 
from 0.5 cm above the middle of the visualized standard to 1 cm below the standard. Keep sample 
plates until GC/MS analysis is complete. Place scraped silica from each sample into separate 1.7-
mL microcentrifuge tubes and add 1 mL ethanol in ethyl acetate (15%, v/v). Vortex vigorously for 
10-30 s to extract analytes from the silica, then centrifuge in a table-top centrifuge at maximum 
speed (126,600 x g) for 2 minutes at room temperature. Carefully transfer ethanol in ethyl acetate 
and place in a new 1.7-mL microcentrifuge tube. Silica may affect instrument sensitivity; therefore 
Figure 3.2. TLC plate set-up. Solvent front should be marked lightly in pencil 13 cm 
from origin line (top of the pre-adsorbent zone) on a silica TLC plate. Sample is 
applied in separate lanes in the pre-adsorbent zone. 
 
 99 
take care not to disrupt the silica pellet in the bottom of the tube. Dry under nitrogen in the 
analytical evaporation unit in a fume hood.Formation of trimethyl silyl ether derivatives 
Once dried, dissolve samples in 20 L bis(trimethylsilyl)trifluoroacetamide (BSTFA) and 
6 L dry dimethylformamide (DMF). This reaction converts analytes to the trimethylsilyl ether 
derivatives. Vortex well and incubate sample at 37 °C for 5 min. Dry reagents under nitrogen in 
the analytical evaporation unit.  
Quantification of F3-IsoPs by GC-MS 
Resuspend sample in 20 L dry undecane and vortex briefly. Transfer sample to an 
autosampler vial for GC/MS analysis. GC-NICI-MS approach employing stable isotope dilution 
will be utilized for F3-IsoP quantification. The major ions generated in the NICI mass spectra of 
the pentafluorobenzyl ester, tristrimethylsilyl ether derivatives of F3-IsoP are m/z 567 and 
corresponding ion for the [2H4]15-F2t-IsoP internal standard, m/z 573. To quantify, the height of 
the peak containing the derivatized F3-IsoP is compared to the height of the deuterated internal 
standard peak. Levels of F3-IsoPs in nematodes are reported in nanograms per gram of total protein 
content. 
Commentary 
Background information 
Given the amount of evidence implicating oxidative stress in the etiology of cancer, 
neurodegenerative disease, and aging, studying the role of oxidative damage will broaden 
knowledge of disease. In order to collect a comprehensive examination of the role of oxidative 
stress in disease, methods to directly quantify the amount of oxidative damage and ROS generation 
are in demand.  
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Fluorescent or chemiluminescent dyes, such as dichlorodihydrofluorescein (DCFH-DA), 
dihydroethidium, and dihydrorhodamine are used frequently for measuring H2O2, O2
•─ and 
ONOO─ either in whole worm or isolated mitochondria (Vanfleteren 1993, Schulz, Zarse et al. 
2007, Dingley, Polyak et al. 2010). The most prevalently used fluorescent probe for detecting 
intracellular H2O2 and oxidative stress is DCFH-DA. DCFH-DA is cell-permeable and is 
hydrolyzed intracellularly to the DCFH carboxylate anion, which is retained in the cell. Two-
electron oxidation of DCFH forms the fluorescent product, dichlorofluorescein (DCF), which can 
be monitored by several fluorescence-based techniques, such as fluorescent microplate readers, 
confocal microscopy, and flow cytometry. Despite the user-friendly appeal of DCFH-DA dye, 
there are several limitations and artifacts associated with the DCF assay due to the complex 
intracellular redox chemistry of DCFH (Hempel, Buettner et al. 1999, Burkitt and Wardman 2001, 
Bonini, Rota et al. 2006). A serious caveat to consider is the indirect nature of DCF fluorescence; 
DCF is not formed through the direct reaction between DCFH and H2O2. Therefore, DCF 
fluorescence is not a direct measure of H2O2 levels in the worm. In addition, several oxidizing 
species will oxidize DCFH to DCF, making the dye nonspecific for a particular form of ROS. And 
lastly, the intermediate radical, DCF•─, rapidly reacts with O2 to form O2
•─. The dismutation of 
O2
•─ yields additional H2O2 (Folkes, Patel et al. 2009), which can establish a redox-cycling 
mechanism leading to artificial amplification of fluorescence signal intensity. Therefore, it is 
important to recognize the limitation of the dyes and avoid erroneous interpretations; DCFH-DA 
cannot reliably quantify intracellular H2O2 and ROS as a measure of oxidative stress. 
As previously discussed, real-time quantification of ROS in living organisms is limited 
with redox-sensitive probes due to the non-specific and disruptive nature of the fluorescent dyes. 
To overcome the limitation of the dyes, recent advances in constructing genetically encoded redox-
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sensitive sensors allows for new avenues for investigating redox signaling (Back, De Vos et al. 
2012, Knoefler, Thamsen et al. 2012).  Use of redox sensors via either a hydrogen peroxide sensor 
protein coupled with a glutathione redox potential sensor (HyPer and Grx1-roGFP2, respectively) 
(Back, De Vos et al. 2012) or quantitative redox proteomics (OxICAT) (Knoefler, Thamsen et al. 
2012) can overcome limitations of the fluorescent dye to provide quantification of ROS in an intact 
organism. HyPer and Grx1-roGFP2 are ratiometric biosensors that can be used to determine the 
oxidized-to-reduced ratios of H2O2 and GSSG/2GSH. OxICAT is a redox proteomic technique, 
which monitors the oxidation status of various redox-sensitive protein thiols with a thiol-reactive 
affinity tag (ICAT). The use of genetically encoded redox-sensitive sensors and redox proteomics 
provide efficient methods to study ROS generation.  
The discovery of isoprostanes as products of non-enzymatic lipid peroxidation has been a 
major breakthrough in the field of free radical chemistry. The quantification of F2-IsoPs and related 
analogues has extended our understanding the role of free radicals in the physiological processes 
and has established the occurrence of oxidative stress in a wide variety of disease states. As stated 
previously, lipids react readily with free radicals, resulting in production of stable peroxidation 
products. F2-IsoPs and related analogues form in situ in the phospholipid bilayer, which then gets 
released in free form upon hydrolysis by phospholipases, presumably by the action of 
phospholipase A2 (Morrow, Awad et al. 1992) and in part, by platelet-activation factor (PAF) 
acetylhydrolysases I and II (Stafforini, Sheller et al. 2006). F2-IsoPs are stable, robust molecules 
detectable tissues and biological fluids, including plasma, urine, cerebrospinal fluid, and bile 
(Morrow, Zackert et al. 1999). Studies have shown that quantification of isoprostanes in either 
plasma urine is representative of their endogenous production, therefore measuring lipid 
peroxidation via IsoP quantification is an accurate index of in vivo oxidative stress (Kadiiska, Basu 
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et al. 2013). As EPA is the most abundant PUFA in C. elegans, quantifying the resultant free-
radical catalyzed oxidation product of EPA, the F3-IsoPs, is a highly sensitive and accurate 
representation of endogenous oxidant damage in the worm. 
Numerous approaches have been developed to quantify IsoPs either through use of mass 
spectrometry (Morrow and Roberts 1999, Song, Paschos et al. 2009, Labuschagne, Stigter et al. 
2013) or immunological approaches (Sodergren, Vessby et al. 2000). The methodology described 
herein uses a gas chromatography – negative ion chemical ionization – mass spectrometry (GC-
NICI-MS) approach, where F3-IsoPs are quantified through measurement of the 15-F3t-IsoP. The 
advantages of this technique over other methods include its sensitivity, specificity, and 
reproducibility, with quantitative yields in the low picogram range. One drawback to this particular 
method is the labor-intensive nature and requirement for considerable equipment expenditures. 
Several alternative mass spectrometric assays have been developed to quantify F3-IsoPs; 
Labuschagne and colleagues developed a liquid chromatography – mass spectrometry assay to 
measure F3-IsoPs in C. elegans (Labuschagne, Stigter et al. 2013). An advantage to the LC-MS 
method is that the sample preparation for LC-MS analysis does not require derivatization of the 
molecule, and therefore is simpler than sample preparation for GC-MS. One drawback to the LC-
MS assay is the higher limits of detection in contrast to the more highly sensitive nature of GC-
MS. Other methods to quantify IsoPs involve immunological approaches, employing antibodies 
against 15-F2t-IsoP, with at least three immunoassay kits available commercially (Sodergren, 
Vessby et al. 2000). The disadvantage of this assay is that precision and accuracy are limited. The 
sensitivity and/or specificity of these kits might vary substantially between manufacturers. In 
addition, currently there is a lack of commercially available immunoassay kits for detecting F3-
IsoPs. 
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In conclusion, we present a robust GC/MS approach for accurate, sensitive and selective 
quantification of endogenous oxidative damage in C. elegans. The equipment used for purification, 
derivatization and GC/MS analysis is readily available in most pharmacology laboratories. Robust 
quantification of F3-IsoPs can be detected for a wide-range of pathologies affected by ROS, 
therefore our method should be applicable to studying oxidative damage in the development of 
pathologies and aging. 
Critical parameters  
As F3-IsoPs can be readily generated ex vivo in biological materials containing polyunsaturated 
fatty acids, it is imperative to take care when the samples are obtained and during processing to 
prevent ex vivo oxidation, which can generate IsoPs. For best results, samples should be flash 
frozen in liquid nitrogen immediately upon collection and not thawed until sample preparation and 
analysis. Samples should be stored at -70°C until analysis.  
Troubleshooting 
For troubleshooting, if the peak signal is extremely low or if no peaks are detected by the mass 
spectrometer, the sample should be removed from the autosampler vial, dried thoroughly under 
nitrogen, and steps for “formation of trimethylsilyl ether derivatives” should be repeated. If peaks 
are still not detected, another likely point of error would be problems with the thin-layer 
chromatography. Scrape all silica from the bottom half of sample lane, place in a microcentrifuge 
tube, and extract with ethyl acetate as described earlier. Continue by finishing the assay as 
described above. If no result is obtained, it will be necessary to repeat the entire analysis with a 
new sample. If the internal standard is detected with a strong signal at m/z 573 but there are very 
low or nonexistent peaks at m/z 567, then the level of F3-IsoPs is below the limit of detection. The 
limit of detection for this assay is 5 pg. 
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Anticipated results 
A representative chromatogram obtained from the analysis of F3-IsoPs in C. elegans is shown in 
Fig. 3.3. The peaks in upper panel of Fig. 3.3 represent endogenous F3-IsoPs in worm lysates. The 
Figure 3.3. Representative chromatogram showing the elution of endogenous F3-IsoPs in 
C. elegans lysates. A representative selective ion monitoring chromatogram obtained from the 
analysis of F3-IsoPs in C. elegans lysates is shown in the top panel. The chromatogram peak 
in the lower m/z 573 ion current chromatogram represents the internal standard d4-15-F2t-IsoP. 
The series of peaks in the upper m/z 567 ion current chromatogram represent putative F3-IsoPs 
eluting over approximately a 1-min interval. These compounds possess a molecular mass 
predicted for F3-IsoPs and elute at the predicted retention time. F3-IsoPs are predicted to elute 
at later retention times than the deuterated 15-F2t-IsoP internal standard due to F3-IsoPs 
containing one more double bond than F2-IsoPs. The concentration of F3-IsoPs is calculated 
using the ratio of the intensity of this peak to that of the internal standards. Levels of F3-IsoPs 
are reported in picograms per milligram of protein content. 
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single peak in the lower m/z 573 chromatogram represents the [2H4]-15-F2t-IsoP internal standard. 
For quantification purposes, the height of the peak containing the derivatized F3-IsoP (m/z 567) is 
compared to the height of the deuterated internal standard peak (m/z 573). Levels of F3-IsoPs in 
whole worm lysates are reported in picograms per milligram of total worm protein. 
Time considerations 
In general, 12-15 samples can be assayed in approximately 10 hrs by an experienced investigator. 
Homogenization, lipid extraction, and hydrolysis of this number of worm samples requires ~3 hrs; 
Sep-Pak purification takes ~2 hrs; drying, derivatization, and TLC purification requires ~3 hrs; 
and extraction, drying, and silyation requires ~2 hrs. Although this method is more time intensive 
when compared to other assays of oxidative stress, quantifying F3-IsoPs through GC/MS analysis 
results in an accurate, sensitive, and linear assessment of endogenous oxidative damage. 
Reagents and Solutions 
85 mM NaCl 
10 g NaCl 
2 liter H2O 
Autoclave 45 min 
Store up to 1 year at 4°C 
 
15% wt/v KOH 
15 g KOH 
100 ml H2O 
Store up to 1 year at 23°C 
 
Methanol containing BHT (0.005% v/v) 
5 mg BHT 
100 ml methanol 
Store up to 1 year at 23°C in an amber-
colored bottle 
 
pH 3 Water 
500 ml H2O 
500 L 1 N HCl 
Store up to 1 year at 23°C 
 
10% v/v PFBB 
1 ml PFBB 
9 ml Dry acetonitrile 
Store over calcium hydride to keep 
solution free of water. 
 
10% v/v DIPE 
1 ml DIPE 
9 ml Dry acetonitrile 
Store over calcium hydride to keep 
solution free of water. 
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CHAPTER IV 
 
SCAVENGERS OF REACTIVE -KETOALDEHYDES EXTEND Caenorhabditis elegans 
LIFESPAN AND HEALTHSPAN THROUGH PROTEIN-LEVEL INTERACTIONS 
WITH SIR-2.1 AND ETS-74 
 
Introduction 
Peroxidation of polyunsaturated fatty acids is a hallmark of oxidative stress, in part due to 
their susceptibility to free radical attack (Gardner 1989, Niki 2009).  Accumulation of lipid 
peroxidation products has been implicated in the pathogenesis of a number of human diseases, 
such as atherosclerosis, cancer, and neurodegenerative diseases (Halliwell and Gutteridge 1990, 
Gutteridge 1995, Butterfield 1997).  This phenomenon plays a critical role in the propagation of 
oxidative damage and in cell death cascades, in part through the formation of reactive aldehydes 
(Poon, Calabrese et al. 2004).  These secondary products of lipid peroxidation, which include 
malondialdehyde (MDA) and the reactive hydroxyl-alkenals, are known to contribute to and 
partially mediate the effects of lipid peroxidation (Comporti 1998, Poon, Calabrese et al. 2004).   
Recent work at Vanderbilt has identified highly reactive levuglandin-like -ketoaldehydes 
(-KA, or isoketals, IsoK) comprised of 64 regio- and stereo-isomers. Isoketals are formed as 
products of the isoprostane pathway via rearrangement of prostaglandin H2-like endoperoxide 
intermediates (H2-isoprostanes) (Morrow, Hill et al. 1990, Brame, Salomon et al. 1999). IsoKs 
covalently adduct ε-amino groups in lysyl residues of proteins to form stable adducts (structurally 
                                                        
4 Published as Thuy Nguyen, Samuel Caito, William Zackert, James West, Shijun Zhu, Michael 
Aschner, Joshua Fessel, and L. Jackson Roberts, II “Scavengers of reactive -ketoaldehydes 
extend Caenorhabditis elegans lifespan and healthspan through protein-level interactions with 
SIR-2.1 and ETS-7” Aging (2016) Aug;8(8): 1759-80. 
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characterized as lactam rings) and intramolecular cross-links (Iyer, Ghosh et al. 1989, Boutaud, 
Brame et al. 1999, Brame, Salomon et al. 1999). IsoK-lysyl-lactam adducts have been shown to 
be significantly increased in atherosclerosis, end-stage renal disease, Alzheimer’s disease, and as 
a significant contributing cause of hypertension (Salomon, Batyreva et al. 2000, Zagol-Ikapitte, 
Masterson et al. 2005, Kirabo, Fontana et al. 2014). While the potent cytotoxicity of IsoKs and 
their ability to induce protein aggregation and to disrupt enzymatic function indicate a strong 
pathologic potential (Murthi, Salomon et al. 1990, Schmidley, Dadson et al. 1992, Boutaud, Ou et 
al. 2002, Davies, Amarnath et al. 2002), meaningful investigation into the extent to which 
formation of IsoK adducts on proteins contributes to disease requires methods to selectively reduce 
the formation of IsoK adducts in vivo. 
To better define the biological role of isoketals in oxidative injury and potentially prevent 
their detrimental effects, studies were performed to identify selective scavengers of IsoKs. A lead 
compound, pyridoxamine (PM) was identified through initial screens (Amarnath, Amarnath et al. 
2004). Structure-activity relationship studies identified the critical moiety to be a phenolic amine 
with the hydroxyl group adjacent to the methyl amine. Therefore, other phenolic amines such as 
salicylamine (SA) are similarly potent and as selective as PM for scavenging isoketals, but are 
more lipophilic. SA protects cellular viability in intact cells exposed to hydrogen peroxide, with 
SA pre-treatment leading to 5% occurrence in cell death, compared to 95% cell death in vehicle 
control treated cells, which suggests that IsoKs are major effectors of oxidative mediated death 
(Davies, Brantley et al. 2006). SA is orally bioavailable (Zagol-Ikapitte, Matafonova et al. 2010), 
and administering SA in mice prevents the age-related loss of working memory and the 
development of angiotensin II-induce hypertension (Davies, Bodine et al. 2011, Kirabo, Fontana 
et al. 2014). Although preventing IsoKs from adducting to proteins has broad and remarkable 
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beneficial biological effects, the precise molecular processes that are being altered by the IsoK 
scavengers are not clearly defined. More precisely, the potential role that IsoKs may play in the 
aging process, and how IsoK scavengers may be able to influence normal aging, is an open 
question currently. 
Aging is characterized by progressively diminishing function at the molecular, cellular, 
tissue, and whole organism levels (Kirkwood 2005, Jin 2010, Rose, Flatt et al. 2012, Wilkinson, 
Taylor et al. 2012).  The overall results are a gradual decline in the capacity to respond to 
environmental challenges and an increasing vulnerability to disease and death (Haigis and Yankner 
2010, Flatt 2012, Murshid, Eguchi et al. 2013).  The mechanisms contributing to the multi-level, 
multisystem changes that we recognize as aging are a matter of fairly intense debate.  Broadly, 
mechanisms underlying aging can be divided into theories of programmed aging (Lockshin and 
Beaulaton 1974, Forciea 1989) and theories of cumulative damage (Gladyshev 2014) and failed 
homeostasis (Comfort 1968), though it must be recognized that the two may be related (Hartl 
2016).  At least for the cumulative damage/failed homeostasis hypotheses (e.g., “rate of 
living”/metabolic theory (Lints 1989, Brys, Vanfleteren et al. 2007), free radical theory (Harman 
1956), failed proteostasis (Labbadia and Morimoto 2015), cumulative DNA damage (Maynard, 
Fang et al. 2015), etc.), pathways controlling molecular metabolism and redox homeostasis 
repeatedly emerge as being central to the aging process (Hartl 2016).  One of the best studied 
pathways lying at the intersection of metabolic control, redox regulation, and aging is the sirtuin 
pathway. 
Sirtuins are a highly conserved family of proteins that play major roles in adapting 
physiology to dietary extremes, as well as being implicated in countering aging and diseases 
associated with aging (Lin, Defossez et al. 2000, Donmez and Guarente 2010, Bell and Guarente 
 112 
2011). Sirtuins are nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylases 
and/or ADP-ribosyltransferases. Due to the requirement of NAD for biochemical activity, sirtuins 
sense and respond to the metabolic status of the cell. Indeed, this is thought to be a key mechanism 
by which caloric restriction extends natural lifespan – namely, by increasing NAD+ availability, 
which increases sirtuin activity. Numerous studies in model organisms, including yeast, worms, 
and flies, suggest that manipulation of sirtuin Sir2 (silent information regulator 2) and its homologs 
can extend lifespan (Kaeberlein, McVey et al. 1999, Guarente 2000, Lin, Defossez et al. 2000, 
Tissenbaum and Guarente 2001, Rogina and Helfand 2004). Over-expression of the closest 
homolog to yeast Sir2 in C. elegans, sir-2.1, leads to extension of lifespan, and deletion or 
knockdown of the gene shortens lifespan (Tissenbaum and Guarente 2001, Lee, Wilson et al. 2006, 
Wang and Tissenbaum 2006, Hashimoto, Ookuma et al. 2009). Although it is a family of seven 
mammalian sirtuins (SIRT1-7) that play various roles in the regulation of stress resistance, 
metabolism, and cell survival, their roles in the regulation of mammalian lifespan are still 
unresolved. Despite the uncertainty, many studies suggest that sirtuins are a linchpin, regulating 
multiple homeostasis and stress response pathways – antioxidant defenses, energy metabolism, 
mitochondrial genomic maintenance, and others – that contribute to aging and age-related diseases.   
In the present study, we tested the hypothesis that age-related oxidant injury and 
accumulation of IsoKs leads to adduction and inactivation of key proteins that regulate lifespan 
and healthspan. Specifically, we hypothesized that SIR-2.1 and downstream targets are inactivated 
by IsoK adduction, and that treatment with a scavenger of IsoKs would preserve protein function, 
extend natural lifespan and diminish degenerative changes in physical health. We found that 
treating wild-type Bristol N2 with SA, a potent scavenger of IsoKs, significantly extended lifespan 
and healthspan. We showed that SA’s effects on longevity are dependent upon SIR-2.1, as 
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knocking out its protein biochemical function abolished drug effect. In subsequent experiments, 
we have defined a SIR-2.1/ets-7 axis that is preserved by SA to regulate lifespan and healthspan 
along with classical markers of aging and oxidant injury, largely through maintaining proteostasis. 
Materials & Methods 
C. elegans Strains and Maintenance 
C. elegans strains were cultured at 20C on standard nematode growth media (NGM) agar plates 
seeded with Escherichia coli strain NA22. The following strains were used in this work: wild-type 
C. elegans Bristol strain (N2), sir-2.1(ok434) IV, F19F10.5(ok888) V, and daf-16(mu86). Strains 
were obtained from the Caenorhabditis Genetics Center (University of Minnesota, St. Paul, MN). 
For generating cultures of 15-day-old (Day 15) adult worms, synchronized late-stage L4s/early 
young adult worms (Lewis and Fleming 1995) were transferred to peptone enriched 15 cm plates 
containing UV-irradiated OP50 E. coli and 0.12 mM 5-fluoro-2’-deoxyuridine (FUDR) to inhibit 
progeny production(Mitchell, Stiles et al. 1979) with or without drug until harvest. 
Salicylamine Exposure 
Nematodes grown on NGM-agar plates containing 0.5% peptone, were harvested, and eggs were 
isolated by alkaline hypochlorite with 0.5 N NaOH, 1% hypochlorite; 8 min at 23C. The 
recovered eggs were rinsed in M9 buffer and placed on fresh agar plates seeded with E. coli strain 
OP50 and maintained at 20C until late-L4/young adult stage. After the late L4/young adult molt, 
worms were transferred to peptone enriched 15 cm plates containing 0.12 mM FUDR, OP50 E. 
coli, and varying concentrations of SA. Salicylamine drug plates were made fresh before transfer 
by spreading SA on top of the agar and plates were allowed to dry. E. coli strain OP50 was exposed 
to UV radiation for 30 minutes to kill the bacteria before seeding onto the SA-FUDR NGM agar 
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plates. Worms were exposed to SA throughout its life until harvest by transferring worms to fresh 
SA-FUDR-OP50 NGM plates every other day. 
Longevity Assays 
Survival cultures were grown on 60-mm agar plates; after the late-stage L4/young adult molt, 
approximately 100 adults were transferred onto SA-OP50-seeded NGM plates. Salicylamine drug 
plates were made fresh before transfer by spreading SA on top of the agar. Plates were allowed to 
dry before seeding with UV-irradiated OP50 bacteria. Worms were maintained at 20C and live 
worms were counted during transfer to freshly made SA-OP50-NGM agar plates every 2-3 days. 
Survival was scored as movement upon slight touch with the platinum wire. Worms were 
maintained until death. 
Autofluorescence Measurement 
Synchronized late L4/early young adult worms were plated on FUDR containing SA-OP50-seeded 
NGM plates and worms were maintained at 20C. Every fifth day, 10-15 worms were mounted 
onto 2% agar pads and anesthetized with 3 mM levamisole in DMSO. Images were taken at 250-
ms exposure under a DAPI filter using an epifluorescence microscope (Nikon Eclipse 80i) 
equipped with a Lambda LS Xenon lamp (Sutter Instrument Company) and Nikon Plan Fluor 20x 
dry and Nikon Plan Apo 60x 1.3 oil objectives. The fluorescence was calculated using ImageJ 
software(Gavet and Pines 2010). 
Pharyngeal Pumping 
C. elegans pharyngeal pumping rate assays were performed on 60-mm agar plates with bacterial 
lawns at room temperature. Every fifth day, worms were transferred to fresh bacteria-seeded NGM 
plates, and incubated at 25C for 10 min in order to equilibrate feeding rates before measurement. 
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After 10 min incubation, worms were observed under the Zeiss TLB 3.1 microscope with focus 
on the pharynx. The number of contractions in the terminal bulb of the pharynx was counted for 
20 s and then plotted.  
Oxygen Consumption Analysis 
Oxygen consumption rate for whole C. elegans was measured using a Seahorse Bioscience XFe96 
Analyzer. Worms were harvested from Day 0, 2, and 15 colonies maintained on FUDR containing 
SA-OP50-seeded NGM plates by washing in M9 medium, followed by floatation on an ice-cold 
60% w/v sucrose gradient to segregate clean bacteria-free adult worms from bacterial debris. 
Worms were seeded at 1,000 worms/well in M9. After 20 min equilibration, a 2-min measurement 
was performed to obtain basal OCR for all experimental conditions and strains. 
Genome Copy Number Analysis 
Relative mitochondrial and nuclear copy number were measured by quantitative, real-time PCR 
(Bratic, Hench et al. 2009). Primers for NADH dehydrogenase unit 1 (nd1) and a 164bp region of 
the cox-4 gene were used in determination of mtDNA copy number. The nd1 forward primer 5’ – 
AGCGTCATTTATTGGGAAGAAGAC – 3’ and reverse primer 5’ 
AAGCTTGTGCTAATCCCATAAATGT – 3’. Cox-4 forward primer 5’ – GCC GAC TGG AAG 
AAC TTG TC – 3’ and reverse primer 5’ – GCGGAGATCACCTTCCAGTA – 3’. Real-time PCR 
conditions were 2 min at 50C, 10 min at 95C, followed by 40 cycles of 15 s at 95C, and 60 s at 
63C. Amplified products were detected with SYBR Green (iQ™ SYBR® Green Supermix, Bio-
Rad) and fluorescent signal intensities were determined by CFX96 Touch™ Real-Time PCR 
Detection System (Bio-Rad) by software CFX Manager™ (version 3.1). Crude worm lysate was 
harvested from Day 0, 2, and 15 stage nematodes grown on FUDR containing SA-OP50-seeded 
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NGM plates and used as template DNA for real-time PCR based determination of mtDNA and 
nucDNA copy numbers.  
NAD+-dependent Deacetylation in Bioluminescence Assay 
Relative activity of the NAD+-dependent histone deacetylase (HDAC) class III enzymes (sirtuins) 
was measured using the SIRT-Glo™ Assay and Screening System (Promega Corporation, 
Madison, WI) according to the manufacturer’s instructions with minor modifications. This assay 
uses an acetylated, luminogenic peptide substrate that can be deacetylated by SIRT activities. 
Deacetylation of the peptide substrate is measured using a coupled enzymatic system with a 
protease in the reagent provided and then cleaves the luminogenic peptide to liberate 
aminoluciferin. Free aminoluciferin can be quantified using the Ultra-Glo™ firefly luciferase 
reaction to produce a stable, persistent emission of light. Purified recombinant human SIRT1 
(R&D Systems, Biotechne) activity was assayed in HEPES-buffered saline (10 mM HEPES, 150 
nM NaCl, 2 mM MgCl2) in the presence and absence of 15-E2-IsoK. 15-E2-IsoK was synthesized 
by the method of Armanath et al (Amarnath, Amarnath et al. 2005). Luminescence was detected 
by a microplate reader (FLUOstar Optima microplate reader, BMG Labtechnologies). 
Sample preparation and detection of endogenous F3-IsoPs by GC/MS 
F3-Isoprostanes were quantified from SA-treated worms using a gas-chromatography-negative ion 
chemical ionization-mass spectrometry (GC-NICI-MS) approach (Milne, Sanchez et al. 2007). 
Worms maintained on FUDR containing SA-OP50-seeded NGM plates were harvested at Day 15 
by washing in M9 medium, followed by floatation on an ice-cold 60% w/v sucrose gradient to 
segregate clean bacteria-free adult worms from bacterial debris. Clean worms were transferred to 
Eppendorf tubes and homogenized using the Mini-Beadbeater-24® (BioSpec, Bartlesville, OK) 
with zirconium oxide beads (1.0 mm), at 4C. Homogenates were then hydrolyzed by 15% w/v 
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KOH, containing 57 µM BHT (5% w/v BHT:MeOH) for 30 min at 37C. Next, samples were 
centrifuged at max speed to pellet worm debris and supernatant was transferred to a 16-mL 
polypropylene tubes (Denville Scientific, Inc., Holliston, MA).  
Samples were spiked with 248 pg of deuterated internal standards, [2H4]-15-F2t-IsoP, 
quantified and calibrated by the method of Milne et al. (Milne, Sanchez et al. 2007) and acidified 
to pH < 3 with HCl in preparation for further Separation Phase Extraction (SPE). C18 Sep-Pak 
cartridges (Waters, Milford, MA) were preconditioned with 5 mL of MeOH, followed by 5 mL of 
pH 3 water and subjected to vacuum to obtain a flow rate of 1 mL/min. Samples were applied to 
the cartridges and allowed to flow through completely before adding equal volume of pH 3 water 
and heptane to wash columns before eluting with ethyl acetate: heptane (1:1 v:v). Anhydrous 
sodium sulfate was then added to each sample to absorb excess water from samples and then 
applied to silica Sep-Pak cartridges (Waters, Milford, MA) preconditioned with ethyl acetate. 
Samples were transferred to the silica Sep-Pak columns and allowed to pass through before 
washing with ethyl acetate, and eluted with ethyl acetate: MeOH (45:55 v:v).  
Eluates were dried under nitrogen and F3-IsoPs and resuspended in MeOH for separation 
by Thin Layer Chromatography (TLC). The free acid TLC standard, 8-iso-Prostaglandin F2 
methyl ester (8-iso-PGF2, Cayman Chemicals, Ann Arbor, MI) and samples were spotted on pre-
washed silica TLC plates, placed in a TLC tank containing chloroform: MeOH: Acetic acid 
(84.5:14.5:1 v:v:v), and allowed to run until reaching solvent front. The free acid TLC standard 
was visualized by spraying standard plate with phosphomolybdic acid solution, and samples were 
scraped from the TLC plate in the region of the TLC standard (Rf ~ 0.35). Samples were extracted 
from silica by resuspension in ethyl acetate: EtOH (1:1 v:v) and dried under nitrogen. All steps 
from this point followed the F3-IsoP measurement protocol as described by the method of Nguyen 
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et al. (Nguyen and Aschner 2014). Deuterated F2-IsoP standard was measured at m/z 573. F3-IsoP 
was measured at m/z 567. Endogenous F3-IsoP levels were quantified by comparing the height of 
the peak containing the derivatized F3-IsoP to the height of the deuterated internal standard peak. 
Protein concentration of nematode homogenates were determined using the bicinchoninic 
acid (BCA) protein assay as described by the manufacturer (Pierce Protein Biology, Waltham, 
MA). 
Quantification of isoketal protein adducts using LC/MS 
Worms grown on FUDR containing SA-OP50-seeded NGM plates were collected at Day 15 adult 
stage by washing in M9 medium, followed by an ice-cold 60% w/v sucrose gradient to segregate 
clean bacteria-free adult worms from bacterial debris. Clean worms were transferred to Eppendorf 
tubes and flash-frozen in liquid nitrogen and thawed at 37C 3x. Samples were homogenized using 
a handheld homogenizer (Polytron PT 1200E, KINEMATICA AG), in buffer containing 
antioxidants (100 µM indomethacin, 220 µM butylated hydroxytoluene, and 5 mM 
triphenylphosphine) and 100 µM pyridoxamine dihydrochloride to prevent artifactural generation 
of IsoK protein adducts during sample processing. Levels of IsoK-lysyl-lactam adduct was 
measured as previously described (Davies, Amarnath et al. 2007).  
In brief, IsoK protein adducts are measured after enzymatic proteolysis and separation as 
IsoK-lysyl-lactam adducts by liquid chromatography tandem mass spectrometry (LC/MS/MS) 
using a heavy isotope labeled internal standard for quantification. Samples were treated with 15% 
KOH to hydrolyze esterified isoketals and then subjected to complete proteolytic digestion using 
pronase protease (Streptomyces griseus, Calbiochem, San Diego, CA) and aminopeptidase M 
(Calbiochem, San Diego, CA), consecutively, to release the IsoK-lysyl-lactam adduct. After 
digestion, 500 pg of a (13C6)-IsoK-lysyl-lactam internal standard was added to each sample, 
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followed by partial purification of lysyl adducts by solid-phase extraction (SPE) and further 
purification by preparative HPLC (2690 Alliance HPLC system, Waters, Milford, MA). Isok-
lysyl-lactam adducts were then quantified by selective reaction monitoring LC electrospray 
tandem mass spectrometry for transition from m/z 477 → 84 and m/z 487 → 90 for internal 
standard (ThermoFinnigan Surveyer MS pump coupled to TSQ quantum triple-quadrupole mass 
spectrometer, Thermo Fischer Scientific, Waltham, MA). 
Protein concentration of nematode homogenates were determined using the Thermo 
Scientific Pierce BCA Protein Assay as described by the manufacturer (Pierce Protein Biology, 
Waltham, MA). 
Western Blot 
Day 15 adult worms grown on FUDR containing SA-OP50-seeded NGM plates were harvested in 
M9 medium, followed by floatation on an ice-cold 60% w/v sucrose gradient to segregate clean 
bacteria-free adult worms from bacterial debris. Clean worms were transferred to Eppendorf tubes 
containing radioimmunoprecipitation assay (RIPA) buffer with protease inhibitor, trichostatin A, 
nicotinamide, and phosphatase inhibitors and flash-frozen in liquid nitrogen and thawed at 37C 
3x. Twenty to thirty µg of protein were loaded onto a 10% SDS-PAGE acrylamide gel. Proteins 
were electroblotted onto nitrocellulose membranes, blocked with 0.1% Tween PBS with 5% nonfat 
milk and 0.05% sodium azide, and western blots were performed with the primary antibodies anti-
MnSOD (ab13533, AbCam, Cambridge, MA), anti-acetyl-lysine 122 MnSOD (a generous gift of 
D.R. Gius, Northwestern University at Chicago, IL, USA; Epitomics, Inc, Burlingame, CA), anti-
acetyl-lysine 68 MnSOD (a generous gift of D.R. Gius, Northwestern University at Chicago, IL, 
USA;Epitomics, Inc, Burlingame, CA), and anti-β-actin (A5316, Sigma, St. Louis, MO). Proteins 
were visualized by species-appropriate secondary antibodies labeled with horseradish peroxidase 
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(Santa Cruz Biotechnology, Dallas, TX) and chemiluminescent substrate (Amersham ECL Prime 
Western Blotting Detection Reagent, GE Healthcare, Pittsburgh, PA). Densitometry was obtained 
with ImageJ.  
Microarray Analyses 
Total RNA was isolated via the Trizol method. Worms maintained on FUDR containing SA-OP50-
seeded NGM plates were harvested at Day 15 by washing in M9 medium, followed by floatation 
on an ice-cold 60% w/v sucrose gradient to segregate clean bacteria-free adult worms from 
bacterial debris. Clean worms were transferred to Eppendorf tubes containing Trizol (Life 
Technologies) and then snap-frozen in liquid nitrogen and thawed at 37C 3x. Chloroform was 
added to each sample, followed by precipitation using isopropanol and washing with 75% ethanol. 
The supernatant was then transferred to an RNeasy MinElute (Qiagen Inc., Valencia, CA) spin 
column and all steps from this point followed the RNA purification protocols described in the 
manufacturer’s instructions. 
 This mixture was then vortexed and transferred to a Shredder Column (Qiagen Inc., 
Valencia, CA) and centrifuged. Eluate from the Shredder Column was transferred to a Preclear 
Column contained in the Versagene Kit and all steps following protocols described in the kit 
manual. After isolation, total RNA was reverse transcribed to double-stranded cDNA, amplified, 
labeled, and fragmented using the NuGEN Ovulation Biotin Kit (San Carlos, CA). Fragmentation 
was confirmed using an Agilent Bioanazlyer 2100 (Santa Clara, CA) and fragmented, labeled 
product was hybridized to an Affymetrix C. elegans Gene 1.0 ST GeneChip (Santa Clara, CA) 
according to the manufacturer’s protocols. 
 Microarray data analysis was performed on arrays normalized by Robust Multi-chip 
Analysis (RMA). The quality controls on samples and on probe sets were performed stepwise to 
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detect the outlying samples and poor probe sets. The Principal Components Analysis (PCA) score 
plot and hybridization controls plot were applied for sample detection, with at least one sample 
with log2(expression)>7. Filtering for high-quality data resulted in 109 genes with at least 25% 
change in expression, which were defined as salicylamine responsive genes. Independent 
validation of microarray results was performed by examining changes in mRNA expression using 
RT-PCR methods as described below. 
TaqMan Gene Expression Assay 
Total RNA was isolated via the Trizol method, as described previously. Following isolation, 2 µg 
total RNA was used for cDNA synthesis using the High Capacity cDNA Reverse Transcription 
Kit (Life Technologies), per manufacturer’s instructions. Quantitative real time PCR (Bio-Rad) 
was conducted using TaqMan Gene Expression Assay Probes (Life Technologies) for each gene. 
Amplified products was normalized to housekeeping gene, ama-1 (RNA polymerase II) after 
determining fold difference using the comparative 2-Ct method (Latif, Bauer-Sardina et al. 2001). 
The following probes were used: ama-1 (Assay ID: Ce2462269_m1), ets-7 (Ce02477624_g1), 
F13D12.6 (Ce02439540_m1), siah-1 (Assay ID: Ce02462269_m1), and sma-4 (Assay ID: 
Ce202447346_g1). 
Statistics 
All statistical analyses were performed using GraphPad Prism 6 (GraphPad Software, Inc.). 
Concentration response curves were generated using a sigmoidal dose-response model with a top 
constraint at 100%. Statistical significance of the lifespan experiments were assessed using 
Mantel-Cox log-rank test, a nonparametric measure that assesses differences in entire survival 
curves. Comparisons between two groups were performed using a two-tailed Student’s t-test 
assuming equal variances. Multiple group comparisons at different time points was done using 
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two-way ANOVA with repeated measures, followed by Bonferroni’s multiple comparison post-
hoc tests. Values of P < 0.05 were considered statistically significant. 
Results 
Salicylamine increases lifespan and healthspan of wild-type adult C. elegans 
The oxidative stress theory of aging postulates that ROS formed by normal metabolic processes 
play a role in the aging process (Harman 1956). The imbalance between pro-oxidants and 
antioxidants leads to an accumulation of oxidative damage in a variety of macromolecules with 
age, resulting in a progressive loss in functional cellular processes. Given our observation that the 
reactive -ketoaldehydes termed IsoKs play a critical role in oxidative injury by adducting to and 
inactivating multiple proteins, we postulated that SA administration would extend natural lifespan 
by scavenging IsoKs and preventing age-related inactivation of key protein targets. Starting at Day 
1 of adulthood, N2 WT C. elegans were continuously exposed to increasing concentrations of SA 
until natural death (Fig. 4.1A). SA produced a significant dose-dependent increase in median 
lifespan (Fig. 4.1B), with 50 µM increasing median lifespan by 18% from 16 days to 19 days, 100 
µM increasing lifespan by 32% from 16 days to 21 days (p < 0.05), and 500 µM increasing median 
lifespan by 56% from 16 days to 25 days (p < 0.01). These data show a significant lifespan 
extension effect of SA in adult WT C. elegans. 
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Figure 4.1. SA extends the lifespan of N2 C. elegans worms. (A) Kaplan-Meier 
survival curves for concentration dependency of SA-mediated N2 lifespan extension. 
Upon day 1 of adulthood, SA was administered every 2 days and survival was assessed 
every other day until all the worms died.  (B) Summary of SA treated N2 median 
lifespans. SA administration shows a dose-dependent increase in median lifespan. 
Data are expressed as means  SEM from four independent experiments. *P < 0.05 as 
compared with vehicle control, **P < 0.01 as compared to vehicle control. (C) Effects 
of SA-mediated decreases in lipofuscin autofluorescence accumulation with age. SA 
response profiles were generated from integrating the area-under-the-curve (AUC) of 
fluorescent intensity as a function of time. Compared with N2 vehicle control, 
treatment with SA shows a significant reduction in autofluorescence. Data are 
expressed as means  SEM from five independent experiments. *P < 0.01 as compared 
with vehicle control, **P < 0.005 as compared to vehicle control. (D) Changes in 
pharyngeal pumping rate of aging worms. Pumping rate declines with age, however 
SA administration retards decline in pumping rate. Data are expressed as means  
SEM from five independent experiments. *P < 0.05 as compared with vehicle control, 
**P < 0.01 as compared to vehicle control. 
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We next sought to demonstrate that SA administration would not only prolong natural 
lifespan in adult worms, but that the longer-lived worms would also exhibit prolonged healthspan 
– i.e., that they would be phenotypically more youthful (Bansal, Zhu et al. 2015).  To quantify this, 
we chose both a biochemical endpoint (lipofuscin autofluorescence) and a behavioral measure 
(pharyngeal pumping) that change predictably with aging and are associated with healthspan.  The 
accumulation in the nematode intestinal epithelium of autofluorescent lipofuscin granules, a 
heterogeneous mixture of oxidized and crosslinked lipids and proteins and advanced glycation end 
products, is a known conserved phenomenon observed to increase with age (Clokey and Jacobson 
1986, Yin 1996). Visualization of lipofuscin granules is often used as an age-related assessment 
of healthspan. We quantified lipofuscin autofluorescence over time (every 5 days) in N2 adult 
nematodes (10-20 per colony) in the presence of increasing doses of SA (representative confocal 
images depicting nematode autofluorescence over age shown in Supplemental Figure 1). SA 
response profiles were generated from integrating the area-under-the-curve (AUC) of fluorescent 
intensity as a function of time (Fig. 4.1C).  Treatment with either 100 µM or 500 µM SA showed 
a significant reduction in age-associated lipofuscin accumulation compared with vehicle control 
in WT animals (p < 0.01).  For a behavioral/functional measurement of health, we quantified 
pharyngeal pumping rates.  Worms ingest bacteria using the pharynx, requiring constant pumping 
by the pharyngeal bulb (Wolkow 2006).  The rate of pharyngeal pumping declines reliably with 
age and has been attributed to multiple age-related processes (Herndon, Schmeissner et al. 2002, 
Huang, Xiong et al. 2004).  We quantified pharyngeal pumping rates in WT N2 worms established 
on OP50-seeded NGM agar plates with increasing concentrations of SA. The frequency of 
pharyngeal pumping was measured and recorded every fifth day as the animals aged. Overall, WT 
N2 worms showed dose-dependent protection against age-associated decline in pharyngeal 
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pumping rate (Fig. 1D) (p < 0.05).  Taken together, these data demonstrate that SA not only dose-
dependently prolongs lifespan but also healthspan when administered to adult N2 C. elegans. 
SA administration deceases formation of IsoK-lysyl-lactam protein adducts 
The mechanism by which IsoKs inactivate protein targets involves covalent adduction of the -
amine group on the side chains of lysine residues within target proteins (Fig. 4.2A).  The initial 
product of this covalent adduction is a lactam ring structure composed of the lysyl side chain and 
the isoketal.  SA’s amine group is much more reactive toward IsoKs and preserves protein function 
by more rapidly forming an adduct with the IsoK, preventing the adduction of lysyl side chains.  
If this mechanism is operative in vivo when C. elegans are treated with SA, a dose-dependent 
reduction in IsoK-lysyl-lactam adducts should be observed.  To test this hypothesis directly, WT 
N2 worms were treated with vehicle or increasing concentrations of SA until day 15, then collected 
for IsoK-lysyl-lactam adduct quantification by liquid chromatography tandem mass spectrometry 
(LC/MS/MS) using a heavy isotope-labeled internal standard for quantification (Davies, Amarnath 
et al. 2007).  SA treatment resulted in a significant, dose-dependent reduction in IsoK-lysyl-lactam 
adduct levels compared with vehicle control in WT animals (p < 0.01) (Fig. 4.2B). 
SIR-2.1 is a critical protein whose function is preserved by salicylamine  
Though SA treatment should prevent IsoK adduct formation on many different protein targets, and 
many of these proteins could have some impact on lifespan and healthspan, we hypothesized that 
there would be specific proteins of particular importance in mediating SA’s beneficial effects.  
Specifically, we hypothesized that SIR-2.1 would be one of these “high value targets” for several 
reasons.  Increased activity of SIR-2.1 and its orthologs have been significantly associated with 
increased lifespan in multiple studies.  Sirtuins are lysine deacetylases that are normally found in 
membrane-bound and membrane-rich subcellular compartments (e.g., mitochondria), so they are 
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in very close proximity to the membrane lipids that give rise to IsoKs and to the lysyl residues that 
are their targets.  Finally, some sirtuin isoforms have been shown to have greatest deacylase 
activity toward longer acyl chain lysyl moieties, raising the possibility of an enhanced likelihood 
of SIR-2.1 being present in close proximity to IsoKs and protein lysyl side chains (Zhu, Zhou et 
al. 2012, Choudhary, Weinert et al. 2014).  First, we wanted to directly test the hypothesis that 
isoketals are chemically capable of inactivating sirtuin proteins, as this would lend plausibility to 
a direct interaction in vivo and would support the hypothesis that sufficient oxidative stress, rather 
than activating sirtuins (Bokov, Chaudhuri et al. 2004, Caito, Rajendrasozhan et al. 2010, Someya, 
Yu et al. 2010, Tao, Coleman et al. 2010, Bell and Guarente 2011), will actually lead to inhibition.  
Figure 4.2. SA administration decreases formation of IsoK-lysyl-lactam protein 
adducts. (A) Schematic illustrating lipid peroxidation and formation of IsoKs. Isoks 
react with -amino in lysyl residues of proteins to form stable lactam adducts. 
Addition of the IsoK scavenger, SA, prevents IsoK adduction. (B) IsoK-lysyl-lactam 
adduct quantification by LC/MS/MS. IsoK-lysyl-lactam adducts were decreased with 
SA treatment. Data are expressed as means  SEM from four independent 
experiments. *P < 0.01 as compared with vehicle control, **P < 0.005 as compared 
to vehicle control. 
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Recombinant human SIRT1 was incubated with increasing concentrations of synthetically pure 
IsoK, and enzymatic deacetylase activity was assessed using the luminescence based Sirt-Glo 
assay (Promega).  Purified isoketals dose-dependently inhibited recombinant human sirtuin 1 (Fig. 
4.3A), with an IC50 of 97.8 M.   
 We next tested the hypothesis that, in vivo, SIR-2.1 is a critical protein that is functionally 
preserved from time-dependent oxidative inactivation when C. elegans are treated with increasing 
doses of SA.  We treated a nematode strain carrying a non-functional SIR-2.1 mutation, VC199 
[sir-2.1(ok434)], with the same concentrations of SA as were used in lifespan experiments with 
WT nematodes.  Starting at day 1 of adulthood, SIR-2.1 mutants were grown on SA-coated OP50-
seeded NGM plates. SIR-2.1 mutant worms were transferred to freshly made SA-OP50-NGM agar 
plates every 2 days and survival was assessed using a platinum wire until all worms died; survival 
was scored as movement upon slight touch with the platinum wire (Fig. 4.3B). When SA was 
administered to the VC199 strain, the effect of extending median lifespan that had been observed 
in the N2 strain was entirely abolished (Fig.3C; VC199 median lifespan: 16 days, 0 M SA; 15 
days, 50 M SA; 15 days, 100 M SA; 15 days, 500 M SA; p = 0.70). This suggests that SA-
mediated lifespan extension acts in part through preservation of sirtuin activity. In addition, we 
observed SA-mediated lifespan extension operates outside canonical C. elegans longevity 
pathways, such as the insulin/IGF-1-like signaling pathway (Supplemental Figure 2). 
 We next wanted to test the hypothesis that SIR-2.1 is required for the healthspan extending 
effects of SA in addition to the longevity effects.  As with the N2 strain, we treated VC199 
nematodes with increasing concentrations of SA and assessed the age-dependent accumulation of 
autofluorescent lipofuscin granules and decrease in pharyngeal pumping rate.  In worms lacking 
SIR-2.1, none of the doses of SA used were able to decrease the accumulation of lipofuscin (Fig. 
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3D) (p = 0.50) or to preserve pharyngeal pumping rates (Fig. 4.3E) (p = 0.50) at day 15.  Taken 
together, these data strongly suggest that SIR-2.1 is a critical target for SA’s effects on healthspan 
as well as lifespan in adult C. elegans. 
SIR-2.1 preservation enhances resistance to oxidant stress but does not affect 
mitochondrial function 
Sirtuins represent a regulatory hub for a variety of cellular processes that lie at the heart of 
molecular aging, including energy metabolism, mitochondrial structural and genomic integrity 
maintenance, and redox balance.  Indeed, one of the major stimuli for activation of sirtuins is 
oxidative stress.  Multiple sirtuin isoforms in multiple different species have been shown to play 
an important role in cellular defenses against oxidant injury (Caito, Rajendrasozhan et al. 2010, 
Someya, Yu et al. 2010, Bell and Guarente 2011).  The mitochondrial antioxidant manganese 
superoxide dismutase (MnSOD) has been identified as one of the major protein targets that is 
deacetylated by sirtuin isoforms, with deacetylation enhancing the enzymatic activity of MnSOD 
(Tao, Coleman et al. 2010).  If SA indeed preserves SIR-2.1 enzymatic function in vivo, we 
hypothesized that SA treatment would dose-dependently decrease biomarkers of oxidant injury in 
a SIR-2.1-dependent manner.   
To quantify oxidant injury, we measured F3-isoprostanes (F3-IsoPs).  F3-IsoPs are the 
products of free radical-mediated peroxidation of eicosapentaenoic acid (EPA), and are known to 
be a highly sensitive and accurate marker of oxidative damage in Caenorhabditis elegans (Gao, 
Yin et al. 2006, Labuschagne, Stigter et al. 2013, Nguyen and Aschner 2014).  F3-IsoPs were 
collected from WT N2 and from VC199 (SIR-2.1 deficient strain) nematodes grown on OP50-
NGM agar plates containing increasing concentrations of SA from Day 1 of adulthood until 
collection at Day 15. Quantification of F3-IsoPs from WT N2 worms (Fig. 4.4A) exhibited a dose- 
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Figure 4.3. SIR-2.1 is required for SA-mediated lifespan extension. (A) Synthetically 
purified IsoKs decrease biochemical activity of rhSIRT1. Recombinant human SIRT1 was 
incubated with increasing concentrations of IsoK and enzymatic activity was assessed using a 
luminescence based assay. Concentration-response curves were generated and IC50 values 
were calculated from three independent experiments. (B) Kaplan-Meier survival curves 
depicting effects of SA administration on lifespan of non-functional SIR-2.1 mutant. (C) 
Summary of SA-treated SIR-2.1 mutant median lifespan. SA administration does not affect 
median lifespan of SIR-2.1 mutants. Data are expressed as means  SEM from four 
independent experiments. P = 0.70. (D) Changes in lipofuscin autofluorescence accumulation 
with age. Compared to vehicle control in WT animals, SA response profiles indicate neither 
dose of SA were able to decrease the accumulation of lipofuscin. Data are expressed as means 
 SEM from four independent experiments. P = 0.5. (E) Changes in pharyngeal pumping rate 
in SA-treated SIR-2.1 mutants. Administration of SA failed to preserve pharyngeal pumping 
rate. Data are expressed as means  SEM from four independent experiments. P = 0.5. 
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dependent decrease in F3-IsoP levels, with 100 µM SA decreasing F3-IsoP production by 29% (p 
< 0.01) and 500 µM displaying a 44% decrease in F3-IsoP levels (p < 0.005).  In sharp contrast, 
SIR-2.1 deficient nematodes showed a slightly higher baseline level of F3-IsoPs that did not 
significantly decrease at any dose of SA tested (Fig. 4.4B), confirming that SA itself does not act 
as a direct antioxidant and supporting the hypothesis that SIR-2.1 enzymatic activity is preserved 
by SA treatment with the predicted positive effect on cellular defense against oxidant injury.  To 
further characterize SA’s ability to preserve SIR-2.1 function, we assessed acetylation of MnSOD 
at Lys 122.  At the highest dose of SA (500 µM) on day 15 of adult life, WT N2 nematodes show 
a trend toward lower acetyl-Lys 122 in MnSOD compared to the VC199 strain treated with the 
same SA dose (Fig. 4.4C and 4.4D), supporting at least a modest positive effect of SA treatment 
on MnSOD acetylation state and function, mediated by SIR-2.1. 
Mitochondria lie at the center of aging biology, playing crucial roles in energy production, 
carbon substrate metabolism, apoptosis regulation, and redox balance and signaling (Finkel and 
Holbrook 2000, Wallace 2005, Ryan and Hoogenraad 2007). Since sirtuins play a major role in 
regulating mitochondrial function, we next wanted to investigate whether SA was exerting any of 
its effects via protection of mitochondrial processes. To investigate SA’s effects on mitochondrial 
respiration, we administered SA to WT N2 (Fig. 4.5A) and non-functional SIR-2.1 mutant worms 
(Fig. 5B) and measured oxygen consumption rate (OCR) in whole worms over several days. OCR 
decreased with age in both N2 and VC199 strains, and SA showed no effect on mitochondrial OCR 
in either strain (p > 0.05).  We also examined the effect of SA treatment on mitochondrial DNA 
(mtDNA) integrity. Using a quantitative polymerase chain reaction (qPCR) assay to measure 
mtDNA content relative to nuclear DNA, WT N2 (Fig. 4.5C) and VC199 SIR-2.1 mutants (Fig. 
4.5D) showed no significant difference in mtDNA copy number with age or with SA treatment.   
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Figure 4.4. SA treatment dose-dependently decreases biomarkers of oxidant injury in a 
SIR-2.1-dependent manner. (A, B) Quantification of oxidant damage via F3-IsoP 
measurement. N2 WT and SIR-2.1 mutant animals were given SA from day 1 of adulthood 
until collection. Lysates were collected at day 15 of adulthood and F3-IsoPs were measured by 
GC/MS. Data are expressed as means  SEM from four independent experiments. * P < 0.01 
as compared with vehicle control, **P < 0.005 as compared to vehicle control. (C) Levels of 
acetyl-Lys 122 MnSOD was measured from N2 WT and SIR-2.1 mutant protein extracts and 
analyzed by Western blot. (D) Quantification of acetyl-Lys 122 MnSOD. Treatment with SA 
in WT N2 nematodes show a trend toward lower acetyl-Lys 122 MnSOD compared to SIR-2.1 
mutant animals. Data are expressed as means  SEM from four independent experiments. P > 
0.05. 
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Taken together, these data suggest that the SIR-2.1 dependent effects of SA treatment are 
not mediated through significant changes in mitochondrial function. 
Gene expression analysis reveals ets-7 as an important effector of salicylamine  
Programmed aging is one of the major theories of aging, wherein this theory implies there is a 
built-in program in the genome that activates senescence, which leads to death (Gershon and 
Gershon 2000). In addition to the functions discussed above, sirtuins can have powerful regulatory 
effects on gene expression programs by virtue of their proposed histone deacetylase activity. With 
supporting evidence that SA’s effects are at least in part SIR-2.1 mediated, we sought to better 
define the role of changes in global gene expression following SA treatment in WT N2 worms. 
We hypothesized that there would be fairly broad changes in gene expression that would converge 
on one or more specific pathways. To assess whether SA alters an aging gene transcriptional 
program, we carried out microarray analysis on adult WT N2 worms exposed to SA (0, 100, 500 
µM SA) for 15 days. Gene expression arrays showed that, surprisingly, SA treatment exerted a 
relatively minor effect on gene expression, with the major variable impacting on gene expression 
being aging itself. From the microarray, we identified 26 genes upregulated by both 100 and 500 
µM SA (Group I), 38 genes more strongly downregulated by 500 µM SA than 100 µM SA (Group 
II), 15 genes with variable downregulation (Group III), and 30 genes downregulated by both doses 
of SA (Group IV) (Fig. 4.6A). Of the 8,902 probe sets with unigene identifiers, only 109 probe 
sets showed at least a 25% change in expression with SA administration at Day 15. Thus, the major 
effect of SA treatment appears to be at the post-translational level, as would be predicted by SA’s 
proposed mechanism of action. 
Nonetheless, there were some significantly changed genes downstream from SA treatment.  
First, to validate the microarray results, we performed real-time RT-PCR on four genes, siah-1, 
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sma-4, F13D12.6, and ets-7 (Fig. 6B). The genes siah-1 and sma-4 showed downregulation by SA 
in Day 15 WT N2 worms, and F13D12.6 and ets-7 showed upregulation by SA. Messenger RNA 
levels for siah-1 and sma-4 were decreased by nearly 25%, and F13D12.6 and ets-7 message levels 
were increased by nearly 25% by SA administration (p < 0.05).  We did not observe SA effects on 
sir-2.1 mRNA levels from the gene expression arrays. Real-time RT-PCR confirmed 
administration of SA did not appreciably increase or decrease sir-2.1 transcript levels in aged 
Figure 4.5. SIR-2.1 preservation does not affect mitochondrial function. (A, B) SA 
administration does not alter oxygen consumption rate (OCR). OCR of N2 WT and SIR-2.1 
mutation in the presence and absence of SA was measured over time via XF Seahorse 
Biosciences Analyzer™. Data are expressed as means  SEM from four independent 
experiments. P = 0.1 and P = 0.3, respectively. (C, D) SA treatment does not alter mtDNA 
integrity. Analysis of mtDNA content collected over time from lysates of SA-treated N2 WT 
and SIR-2.1 mutant animals. Data are expressed as means  SEM from four independent 
experiments. P = 0.1 and P = 0.6, respectively. 
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animals (Supplemental Figure 3), supporting the hypothesis that SA-mediated lifespan extension 
is acting primarily via preservation of protein biochemistry. 
Pathway Analysis using Gene Ontology (GO) with WEB-based Gene SeT AnaLysis 
Toolkit (WEBGESTALT < http://bioinfo.vanderbilt.edu/webgestalt/>) highlighted the metabolic 
process, lipid metabolic process, proteolysis pathways among many others as being altered 
favorably by the administration of SA (Supplemental Figure 4).  From the array data confirmed by 
RT-PCR, we identified the ETS class transcription factor ETS-7 as a protein of interest. ETS 
factors are known to be involved in regulating lipid metabolism and regulate lifespan in both 
Drosophila melanogaster and C. elegans (Thyagarajan, Blaszczak et al. 2010, Alic, Giannakou et 
al. 2014).  
To investigate the role of ETS-7 in regulating lifespan downstream from salicylamine, SA 
was administered to the ets-7 gene knock-out strain, RB981 [F19F10.5(ok888) V]). Similar to the 
SIR-2.1 deficient VC199 strain, loss of ets-7 showed no SA-mediated effect on lifespan extension 
(RB981 median lifespan: 16 days, 0 M SA; 15 days, 500 M SA, p > 0.05) (Fig. 4.6C and 4.6D). 
We originally hypothesized that upregulation of ets-7 depends on SIR-2.1, which could result in 
enhanced longevity. In order to test this, we carried out real-time RT-PCR quantification of ets-7 
in non-functional SIR-2.1 mutant nematodes treated with increasing doses of SA (Fig. 4.6E). 
Messenger RNA levels for ets-7 were increased by 32% in Day 15 WT N2 worms by 500 µM SA 
administration (p < 0.05), and similarly, a dose-dependent increase in ets-7 transcriptional level 
can be observed in Day 15 non-functional SIR-2.1 mutants, VC199, with the highest dose of SA 
showing a significant 442% increase in mRNA expression (p < 0.01).  Taken together, these 
findings suggest that ets-7 upregulation in non-functional SIR-2.1 mutant may be an attempt at 
compensation for loss of SIR-2.1, which is further enhanced by SA-administration, but is 
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ultimately insufficient in extending lifespan in the absence of SIR-2.1.  Our data suggest that ets-
7 is necessary for SA-dependent increase in lifespan, but is insufficient without the presence of 
functional SIR-2.1. 
 
 136 
 
Discussion 
In the present study, we have shown that treatment with salicylamine, a scavenger of some 
of the most damaging products of oxidant injury – namely, -ketoaldehydes generally, and 
isoketals specifically – can prolong natural lifespan and healthspan in C. elegans, and that these 
effects are dependent upon SIR-2.1 and ETS-7.  We have shown that the effects of SA operate 
primarily at the protein level, in keeping with what is known about the biochemical mechanism of 
action and placing SA broadly in the role of a proteostasis mediator.  We further show that, 
although SIR-2.1 and ETS-7 are important targets preserved by SA treatment, the major 
biochemical effect of preserving the activities of these two targets is to enhance normal antioxidant 
defenses, with effects on mitochondrial function, mtDNA integrity, and gene expression being 
small to nonexistent. 
Figure 4.6. Gene expression analysis reveals ets-7 as an important effector of SA. (A) Heat 
map of genes differentially regulated by treatment in 15 day CE. 109 probe sets had at least a 
25% change in expression concordant in both samples. These include 26 genes upregulated by 
both doses of SA (group I), 38 genes more strongly downregulated by 500 µM SA than 100 
µM SA (Group II), 15 genes with variable downregulation (Group III), and 30 genes 
downregulated regardless of dose of SA (Group IV). (B) Real-time RT-PCR validation of 
microarray results on selected genes. The genes, siah-1 and sma-4 showed downregulation by 
SA in day 15 WT N2 worms, and F13D12.6 and ets-7 showed upregulation by SA. Data are 
expressed as means  SEM from five independent experiments. *P < 0.05 as compared to 
vehicle control, **P < 0.01 as compared to vehicle control. (C) Kaplan-Meier survival curves 
for concentration dependency of SA-mediated ets-7 knock-out mutant lifespan extension. (D) 
Summary of SA-treated ets-7 knock-out mutant median lifespan. SA administration does not 
affect median lifespan of ets-7 knock-out mutants. Data are expressed as means  SEM from 
five independent experiments. P = 0.40. (E) Real-time RT-PCR quantification of ets-7 in non-
functional SIR-2.1 mutant nematodes treated with increasing doses of SA. Transcriptional 
levels for ets-7 were increased by 25% in day 15 N2 WT worms by SA administration, and a 
dose-dependent increase in ets-7 mRNA levels can be observed in day 15 SIR-2.1 mutants. 
Data are expressed as means  SEM from four independent experiments. *P < 0.05 as compared 
to vehicle control, and **P < 0.01 as compared to vehicle control. 
 
 137 
Several aspects of this study are worth particular attention.  First, SA treatment was begun 
and exhibited its effects in adult worms.  This is distinct from some other longevity-extending 
interventions which rely on genetic manipulation or application of a particular treatment or stressor 
during a critical developmental period (Chin, Fu et al. 2014, Edwards, Canfield et al. 2015, 
McCormack, Polyak et al. 2015, Rauthan, Ranji et al. 2015).  Such interventions are certainly 
informative but are likely to be of limited direct translation potential.  Second, though SA exhibited 
predictable effects on oxidative stress by way of SIR-2.1 mediated activation of antioxidant 
enzymes (e.g., MnSOD), the lack of effect on gene expression and on mitochondrial function was 
striking and informative.  This suggests that SA is not working through maintenance or 
modification of large gene expression programs, nor probably through maintenance of overall 
nuclear and/or mitochondrial genomic integrity, nor through large effects on mitochondrial 
function.  The lack of any apparent effect on mitochondrial oxygen consumption is perhaps a bit 
surprising, given the central role of SIR-2.1 in mediating the effects of SA treatment.  However, 
as previously mentioned, SIR-2.1 is known to exert a wide range of pleiotropic effects beyond 
metabolic regulation (Tissenbaum and Guarente 2001, Wang and Tissenbaum 2006, Guo and 
Garcia 2014, Pant, Saikia et al. 2014, Furuhashi, Matsunaga et al. 2016).  Our data could be 
consistent with preservation of any number of these other functions ascribed to SIR-2.1, though in 
these investigations, the major effector mechanism identified downstream from SIR-2.1 was 
antioxidant defense.  Finally, SA treatment does not appear to induce any of the stress/hormesis 
loops (Calabrese, Dhawan et al. 2015, Edwards, Canfield et al. 2015, Monaghan and Haussmann 
2015, Hartl 2016)  that have been shown to impact upon longevity when activated or inhibited. 
The identification of ETS-7 by gene expression array and the subsequent finding that ETS-
7 is necessary but not sufficient for SA to exert its effects deserves specific mention.  We focused 
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on ETS-7 particularly because there is precedent in the literature for ETS family transcription 
factors regulating longevity through effects on lipid metabolism (Thyagarajan, Blaszczak et al. 
2010, Alic, Giannakou et al. 2014, Sun, Sun et al. 2015).  Given that other lipid metabolic genes 
were shown to be significantly regulated by SA treatment (Supplemental Tables 1 and 2), we 
reasoned that ETS-7 may be an important regulatory gene, with the other lipid metabolism genes 
identified being downstream from ETS-7.  Future investigations will focus on the specific gene 
targets regulated by ETS-7.  The finding that ETS-7 is required for SA’s effects, but DAF-16 is 
not (Supplemental Figure 2), also suggests that there are indeed specific protein targets modulated 
by SA.  Furthermore, the observed interactions between SA, SIR-2.1, and ETS-7 strongly suggest 
that extension of natural lifespan by SA treatment occurs through preservation of the biochemical 
activities of multiple regulatory proteins, with SIR-2.1 serving as a primary node in the signaling 
pathway and ETS-7 playing a secondary role.  We have certainly not exhaustively investigated all 
of the possibilities, with other targets (e.g., PCH-2 (Qian, Xu et al. 2015)) existing in the published 
literature that may be of particular interest.  Further delineation of all of the important signaling 
nodes impacted by SA treatment and elucidation of the signaling hierarchy will be major areas of 
focus for future investigations. 
Our study does have some important limitations.  Our data were generated exclusively in 
C. elegans.  While a powerful model system for aging research, and though SA treatment has been 
shown to have substantial beneficial effects in a variety of mammalian models of disease, the 
findings in the present study will need to be verified in more complex model organisms.  A precise 
dose-effect relationship with SA treatment cannot be accurately determined from the studies we 
report here.  The dose-dependent reduction in IsoK-lactam adducts quantified by mass 
spectrometry (Figure 4.2B) confirms that we are in the pharmacologic range, but the precise 
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location on the dose-response curve is not clear.  As mentioned above, we also know that there are 
other protein targets that are likely being preserved with SA treatment, but a full characterization 
of the proteome-level effects of SA is beyond the scope of the present study. 
The translation potential for SA as a clinically useful anti-aging therapy is fairly high.  
Salicylamine is orally bioavailable in mammals (Zagol-Ikapitte, Matafonova et al. 2010).  Long-
term administration (approximately one year) in mice via drinking water has shown no evidence 
of intolerance and no evidence of excess adverse events (Davies, Bodine et al. 2011).  This is 
particularly important when considering an anti-aging intervention, as we would anticipate that 
SA would need to be administered on an ongoing basis over a long period of time given its 
mechanism of action.  No excess tumor formation was observed in mice with long-term SA 
treatment (McMaster, Kirabo et al. 2015, Egnatchik 2016, Wu, Saleh et al. 2016), an important 
negative given recent reports regarding negative effects of nonspecific antioxidant therapies with 
regard to tumor metastasis (Prasad, Gupta et al. 2016, Wang, Liu et al. 2016).  Finally, the 
translation of SA into human studies should be able to proceed fairly rapidly, as it is a naturally 
occurring small molecule found in buckwheat seeds and is currently awaiting Generally 
Recognized as Safe (GRAS) designation for use as a natural supplement. 
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Supplemental Information 
 
 
Figure S1. Change in lipofuscin autofluorescence with age. (A) Representative confocal 
images are shown from four experiments. Synchronized late L4/early young adult worms were 
plated on FUDR containing SA-OP50-seeded NGM plates and worms were maintained at 
20C. Every fifth day, 10-15 worms were mounted onto 2% agar pads and anesthetized with 3 
mM levamisole in DMSO. Representative confocal images of each treatment condition were 
captured through Plan-Aprochromat 20x objective on an LSM510 confocal microscope (Carl 
Zeiss MicroImaging, Inc) scanning every 200 nm for XZ sections. Images were processed with 
the Zeiss LSM Image Browser. Figure S1 relates to manuscript figure 1C and 3D. 
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Figure S2. SA extends the lifespan of daf-16 gene knockout mutant strain. (A) Kaplan-
Meier survival curves depicting effects of SA administration on daf-16 gene knockout mutant 
strain. Starting at day 1 of adulthood, animals were transferred to OP50-seeded NGM-SA plates 
every 2 days. Survival was assessed every 2 days until all the worms died. (B) Summary of SA 
treated daf-16 knockout mutant median lifespans. SA increased maximum and median lifespan 
in daf-16 knockout worms. Data are expressed as means  SEM from four independent 
experiments. *P < 0.01 as compared to vehicle control. Figure S2 relates to manuscript figure 
3B. 
 
Figure S3. SA does not attenuate sir-2.1 mRNA levels. Real-time RT-PCR quantification of 
sir-2.1 in wild-type N2 nematodes treated with increasing doses of SA. Data are expressed as 
means  SEM from five independent experiments. P = 0.08 and P = 0.2, respectively. 
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Figure S4. Gene Ontology enrichment via WEBGESTALT. Pathway analysis of SA-
mediated genomic changes in day 15 N2 WT worms. To further explore the genomic effects 
of SA administration on N2 WT worms, Gene Ontology (GO) enrichment was performed 
using WebGestalt, an approach which incorporates information from different public 
resources and provides graphical depiction of large gene sets from functional genomic, 
proteomic, and large-scale genetic studies. Biological relationships among Directed acyclic 
graphs (DAG) were generated using GOView, a web-based application to allow users to 
visualize and compare multiple provided GO term lists to identify common and specific 
biological themes.  (A) DAG of Group I genes upregulated by SA administration. Chart 
highlights the metabolic process, lipid metabolic process, and proteolysis pathways among 
many others as being altered favorably by SA administration. 
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Supplemental Table 1: Lipid metabolism genes identified by Gene Ontology/WebGestalt 
analysis. List of lipid metabolism genes identified by Gene Ontology/WebGestalt analysis that 
are significantly upregulated by salicylamine treatment. This is the subset of genes most likely to 
represent downstream targets of ets-7. 
 
Supplemental Table 1: Lipid Metabolism Genes Identified by GO/WebGestalt 
Lipid Metabolic 
Process 
  ID: GO: 0006629 
Gene Symbol Gene Name EntrezGene Ensembl 
Y65B4BR.1 Protein 
Y65B4BR.1 
190488 CELE_Y65B4BR.1 
W02B12.1 Protein 
W02B12.1 
174746 CELE_ W02B12.1 
F28H7.3 Protein 
F28H7.3 
179490 CELE_ F28H7.3 
Y54G2A.45 Protein 
Y54G2A.45 
3896802 CELE_ Y54G2A.45 
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Supplemental Table 2: Metabolic process genes identified by Gene Ontology/WebGestalt 
analysis. The larger list of genes exhibiting significant changes with salicylamine treatment, and 
reorganized as representing metabolic processes more broadly by GO/WebGestalt. Notably, this 
list includes all of the genes in Supplemental T1 and captures ets-7 itself. 
 
Supplemental Table 2: Metabolic Process Genes Identified by GO/WebGestalt 
Metabolic Process   ID: GO: 0008152 
Gene Symbol Gene Name EntrezGene Ensembl 
Y65B4BR.1 Protein 
Y65B4BR.1 
190488 CELE_Y65B4BR.1 
pcp-2 Protein PCP-2 177741 CELE_F23B2.12 
W02B12.1 Protein 
W02B12.1 
174746 CELE_ W02B12.1 
ets-7 Protein ETS-7 184687 CELE_F19F10.5 
Y54G2A.45 Protein 
Y54G2A.45 
3896802 CELE_ Y54G2A.45 
smd-1 Protein SMD-1 173269 CELE_F47G4.7 
F13D12.6 Protein F13D12.6 174802 CELE_F13D12.6 
F28H7.3 Protein 
F28H7.3 
179490 CELE_ F28H7.3 
K10C2.3 Protein K10C2.3 180917 CELE_K10C2.3 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Introduction 
 The focus of this dissertation project was to elucidate the molecular processes involved in 
reactive -ketoaldehyde/isoketal-mediated oxidative injury, and in doing so to provide the basis 
for the development of new rational therapeutic interventions to limit oxidative damage in aging. 
This is a reasonable avenue to pursue in view of the multitude of studies suggesting that reactive 
oxygen species (ROS) play a role in normal aging by causing random deleterious oxidative damage 
to tissue biomolecules (e.g. lipids, proteins, and DNA) (Halliwell and Gutteridge 1990, Gutteridge 
1995, Butterfield 1997, Muller, Lustgarten et al. 2007). Previous studies have shown that lipid 
peroxidation leads to the formation of reactive aldehydes, amongst which the -ketoaldehydes 
formed via the isoprostane pathway of lipid peroxidation are the most reactive and injurious. 
Reactive -ketoaldehydes adduct to proteins, and increased IsoK-protein adducts have been 
reported in a number of disease conditions, including atherosclerosis, myocardial infarction, end-
stage renal disease, hypoxia, among other disease conditions (Brame, Boutaud et al. 2004, Fukuda, 
Davies et al. 2005, Davies, Brantley et al. 2006, Guo, Chen et al. 2011). The development and 
characterization of selective scavengers of IsoKs have proven to be a remarkable protective 
intervention against oxidative damage in a variety of animal models of oxidative stress (Davies, 
Brantley et al. 2006, Davies, Bodine et al. 2011).  
Throughout the work presented in this dissertation, we have dedicated efforts in 
investigating the role of IsoK-mediated oxidant injury and its effects on aging in the model 
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organism, Caenorhabditis elegans. We first set out to establish an in vivo measure of oxidative 
damage using the chromosomally integrated, dual fluorescence-based reporter strain, Pgst-4::GFP 
(VP596 dvls19[pAF15(Pgst-4::GFP::NLS)];vsIs33[Pdop-3::RFP]). After results indicated Pgst-
4::GFP reporter strain was best used for qualitative measurements, we refocused efforts into 
optimizing a quantitative measure of oxidative damage in C. elegans.  During the course of this 
thesis work, a highly sensitive and specific gas chromatography-mass spectrometry (GC/MS) 
technique was developed to measure endogenous lipid peroxidation in C. elegans via measurement 
of the lipid peroxidation product F3-isoprostanes (F3-IsoPs) by GC/MS approaches; specifically in 
the context of this thesis work, for the purpose in investigating the role of oxidative stress in aging. 
The core of this dissertation revolved around the discovery of two major nodes through which 
IsoK-mediated oxidative damage contributes to the aging process. We discovered that SIR-2.1 and 
ETS-7 play important roles in the progressive molecular development of aging, and that selective 
scavengers of IsoKs (i.e. salicylamine, SA) preserves the biochemical activity of these proteins to 
enhance normal antioxidant defenses against aging. Taken together, this body of work supports 
the potential for IsoK scavengers, such as SA, as a clinically useful anti-aging therapeutic 
intervention 
Summary of Findings 
Development of a fluorescent-based assay for in vivo measurement of oxidative stress 
 The development of tools for sensitive, specific, and accurate measures of oxidative 
damage is an important area of current research. In Chapter II, we reported the adaptation of the 
Pgst-4::GFP transgenic reporter strain for studying the role of oxidative stress in aging. Initial 
efforts in establishing an oxidative stress paradigm utilized the potent redox-generating agent, 5-
hydroxy-1,4-naphthoquinone (juglone) to generate a stress environment to activate antioxidant 
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response elements with the hopes in capturing a protective effect against oxidative stress when 
pre-treated with the selective IsoK scavenger, salicylamine. In fact, after establishing a juglone 
dosing paradigm and a concentration range within maximum efficacy (ECmax), preliminary studies 
showed the effect of salicylamine pre-treatment on attenuating the SKN-1 response in C. elegans 
(Fig. 5.1). 
 Although this data seemed promising, the oxidative stress model used in the Pgst-4::GFP 
reporter strain was troubling, as juglone is an arylating agent known to react readily with sulfur 
nucleophiles. Concern was raised for the veracity of this reporter strain in indirectly measuring 
Figure 5.1. SA protects against juglone-mediated oxidative stress. Salicylamine (0, 50, 100 
µM) was plated onto nematode growth media (NGM) agar plates and allowed to dry before 
plating with UV-killed E. coli OP50. Worms were grown on foil-covered SA-NGM-OP50-
seeded agar plates at 20C for 2 days in the dark, as salicylamine is light-sensitive (Zagol-
Ikapitte, Matafonova et al. 2010). A maximal dose (ECmax = 40 µM) of juglone and vehicle 
control was administered for 1 hr in liquid and then transferred to OP50-seeded NGM agar 
plates for 4 hr recovery. Juglone-exposed worms were transferred to 96-well plates at a 
concentration of 200 worms/well with 5 replicate wells per treatment condition, and GFP/RFP 
fluorescence intensity was measured with a FLUOStar Optima (BMG LabTech, Ortenberg, 
Germany). Data are expressed as means  SEM from 5 technical replicate wells per treatment 
condition from one independent experiment. 
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SKN-1 activation, due to the potential for juglone reaction with cysteine residues on the proteins 
that regulate SKN-1 activation, which may produce a false positive fluorescent signal. Bearing 
these concerns in mind, other pro-oxidants typically used in C. elegans were tested on the 
transgenic fluorescent reporter strain in order to establish a juglone-free oxidative stress paradigm. 
Comparison of fluorescent intensity results to GC/MS analysis of F3-IsoPs collected from the Pgst-
4::GFP animals treated with various pro-oxidants (juglone, hydrogen peroxide, tert-Butyl-
hydroperoxide, and paraquat) lead to the discovery Pgst-4::GFP reporter strain was a less sensitive 
measure of oxidative stress. In the Pgst-4::GFP reporter strain, the pro-oxidant juglone produced 
the greatest effects in fluorescent intensity; possibly due to its ability to create additive 
fluorescence when reacting with regulators of SKN-1. In the GC/MS approach, F3-IsoP collection 
resulted in the predicted increased oxidative damage responses in the presence of all pro-oxidants 
tested. Not surprisingly, tert-Butyl hydroperoxide (t-BOOH) generated the greatest response in 
increasing lipid peroxidation products. This is possibly due to the fact t-BOOH is a more 
hydrophobic agent and could more readily undergo lipid peroxidation in the hydrophobic 
environment in which F3-Isoprostanes are generated within. 
 In sum, Pgst-4::GFP is best used in qualitative studies of in vivo oxidative stress, and the 
use of juglone as a pro-oxidant in conjunction with this reporter strain is highly discouraged. 
Studies needing quantitative measures of oxidative damage are best serviced by measurement of 
F3-Isoprostanes in the animals. 
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F3-Isoprostanes as a measure of in vivo oxidative damage in C. elegans5 
 Oxidative stress has been associated with development of a wide variety of disease 
processes, including cardiovascular disease and neurodegenerative diseases, as well as progressive 
and normal aging processes.  Isoprostanes (IsoPs) are prostaglandin-like compounds that are 
generated in vivo from lipid peroxidation of arachidonic acid (AA, C20:4, -6) and other 
polyunsaturated fatty acids (PUFA). Since the discovery of IsoPs by Morrow and Roberts in 1990, 
quantification of IsoPs has been shown to be excellent biomarkers of in vivo oxidative damage. 
Eicosapentaenoic acid (EPA, C20:5, -3) is the most abundant PUFA in C. elegans and gives rise 
to F3-IsoPs upon nonenzymatic free radical-catalyzed lipid peroxidation. In Chapter III, the 
protocol presented is the current methodology that our laboratory uses to quantify F3-IsoPs in C. 
elegans using gas chromatography/mass spectrometry (GC/MS). The methods described herein 
has been optimized and validated to provide the best sensitivity and selectivity for quantification 
of F3-IsoPs from C. elegans lysates. 
 One major addendum to the assay that was not originally included in the time of its printing 
is the inclusion of an additional thin-layer chromatography (TLC) separation modification to 
strengthen signal strength of the individual samples collected. This particular modification was 
historically used as an additional extraction step to purify urine or plasma samples from human 
patients that received the anesthetic, Propofol. Although an additional separation step decreases 
the overall yield of the sample, this extraction services as a method of tweaking the signal-to-noise 
ratio. Utilizing this second TLC separation step has led to sharper m/z 567 peaks in the GC/MS 
                                                        
5 Excepts taken from Thuy Nguyen and Michael Aschner “F3-Isoprostanes as a measure of in 
vivo oxidative damage in Caenorhabditis elegans” Current Protocols in Toxicology 62:11 
(2014) : 11.17.1-11.17.13. © 2014 John Wiley & Sons, Inc. Reprinted with permission of John 
Wiley & Sons, Inc. 
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chromatogram with an increased signal-to-noise ratio. Considering the loss in yield of sample due 
to the presence of a second TLC extraction/separation step, it is recommended to having a starting 
material of 2-3 mg total protein concentration (~30,000 – 40,000 worms) per sample condition. In 
summary, it is highly recommended to utilize this modification when measuring F3-isoprostanes 
in C. elegans (Appendix A). 
Scavengers of -KAs extend C. elegans lifespan through interactions with SIR-2.1 & ETS-76 
 As stated earlier, IsoKs are highly reactive -ketoaldehyde products of lipid peroxidation 
that covalently adduct lysine side chains in proteins, impairing their function.  In Chapter IV, we 
tested the hypothesis that IsoKs contribute to molecular aging through adduction and inactivation 
of specific protein targets, and that this process can be abolished using the selective IsoK 
scavenger, SA. Administration of SA extends adult nematode longevity by nearly 56% and 
prevents multiple deleterious age-related biochemical and functional changes. Testing of a variety 
of molecular targets for SA’s action revealed the sirtuin SIR-2.1 as the leading candidate. When 
SA was administered to a SIR-2.1 knockout strain, the effects on lifespan and healthspan extension 
were abolished.  Further investigations into the mechanisms of SIR-2.1-dependent SA-mediated 
lifespan extension indicated these beneficial effects were not mediated by large changes in gene 
expression programs or by significant changes in mitochondrial function.  However, expression 
array analysis did show SA-dependent regulation of the transcription factor ets-7 and associated 
genes.  In ets-7 knockout worms, SA’s longevity effects were abolished, similar to sir-2.1 
knockouts. However, SA dose-dependently increases ets-7 mRNA levels in non-functional SIR-
                                                        
6 Excerpts taken from Thuy Nguyen, Samuel Caito, William Zackert, James West, Shijun Zhu, 
Michael Aschner, Joshua Fessel, and L. Jackson Roberts, II “Scavengers of reactive -
ketoaldehydes extend Caenorhabditis elegans lifespan and healthspan through protein-level 
interactions with SIR-2.1 and ETS-7” Aging  (2016) In press. 
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2.1 mutant, suggesting that both are necessary for SA’s complete lifespan and healthspan 
extension. 
 In this study, we identified the ETS transcription factor, ETS-7, as a longevity determinant 
in C. elegans. ETS factors are members of one of the largest families of evolutionarily conserved 
transcriptional regulators, which play fundamentally important roles in differentiation, 
development, transformation, and cellular proliferation (Findlay, LaRue et al. 2013). The 
oncogenic v-ets was the first member of its family to be studied; discovered in 1983, this family 
member was found to be a part of the transforming fusion protein (p135, gag-myb-ets) expressed 
by the avian retrovirus E26 (Leprince, Gegonne et al. 1983, Klempnauer and Bishop 1984). This 
particular family member, the v-ets oncogene, is known to cause mixed erythroid and myeloid 
leukemias (Blair and Athanasiou 2000). It is from this founding member that the name ets is 
derived from; ETS stands for the E26 transforming sequence or E-twenty-six specific sequence. 
 All ETS family members are characterized by a conserved sequence that encodes the DNA-
binding (ETS) domain. The ETS family of transcription factors is one of the largest families, 
consisting of 28 ETS genes in humans, 27 in mice, 11 in sea urchin, 10 in Caenorhabditis elegans, 
and 9  in Drosophila [see reviews, (Seth and Watson 2005, Gutierrez-Hartmann, Duval et al. 2007, 
Hollenhorst, McIntosh et al. 2011)]. The ETS family of transcription factors was of particular 
interest in this work due to a number of recently published manuscripts implicating ETS family 
members in regulation of longevity through effects on lipid metabolism (Thyagarajan, Blaszczak 
et al. 2010, Alic, Giannakou et al. 2014, Sun, Sun et al. 2015).  
 In 2014, Thyagarajan and colleagues identified ETS-4 as a longevity determinant in C. 
elegans through gene knock-out studies, wherein worms that lack ETS-4 lived significantly longer; 
this group demonstrated that ets-4 is required in the post-developmental stage to regulate adult 
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lifespan (Thyagarajan, Blaszczak et al. 2010). Using bioinformatics, this group identified seventy 
ETS-4-regulated genes that were enriched for known longevity effectors in the function of lipid 
transport and metabolism, as well as immunity. The C. elegans ets-4 is the ortholog of the 
vertebrate SPEDEF/SAM pointed domain containing ETS transcription factor. Studies in human 
cell lines have implicated SPDEF function in tumorigenesis, where SPEDEF was found to have 
alterations in mRNA levels in breast and prostate tumors (Feldman, Sementchenko et al. 2003, Gu, 
Zerbini et al. 2007), as well as alterations in cell migration and invasion pathways of tumor cell 
lines (Oettgen, Finger et al. 2000, Chen, Nandi et al. 2002, Gunawardane, Sgroi et al. 2005, Gu, 
Zerbini et al. 2007, Turner, Moussa et al. 2007). Thus, the findings in this study provided a link 
between ETS factor, physiological aging and tumor susceptibility. 
 In Drosophila, two studies from the Partridge group found a role for the ETS transcriptional 
repressor, Anterior open (Aop) in extending adult lifespan (Alic, Giannakou et al. 2014, Slack, 
Alic et al. 2015). Aop is the functional ortholog of human Etv6 gene, and in Drosophila, it is found 
in the adult gut and is regulated by the dFOXO, along with being known to counteract the activity 
of the ETS activator, Pointed (Pnt). In 2014, Alic, Partridge, and colleagues showed that dFOXO 
activates Aop in adult fly gut to antagonize the ETS activator, Pnt, by AOP directly displacing 
PNT from a dFOXO gene promoter/enhancer bound region to extend lifespan. In addition, using 
Gene Ontology (GO) analysis, this group found that the most represented GO category was “lipid 
particle” which encapsulates both lipid droplets and sites of cellular lipid storage. From this, the 
group proved through genetic, biochemical, and functional studies that PNT/AOP and dFOXO 
together regulate lipid metabolism. Taken together, this indicates that Aop/Pnt coupling have 
metabolic and longevity functions in the fly. Most importantly, in 2015, the same group identified 
a potent small-molecular inhibitor of the Ras-Erk-ETS signaling as an anti-aging intervention, 
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which solidifies the “druggability” of pathways involving ETS signaling as a pro-longevity 
mechanism. 
 In summary, we found that SIR-2.1 and ETS-7 are major nodes that play important roles 
in selective scavengers of IsoK-mediated lifespan extension in Caenorhabditis elegans. Most 
importantly, this work indicates the translation potential for the selective scavenger of isoketals, 
salicylamine, is a clinically useful anti-aging therapy. The translation of SA into studies of human 
longevity can proceed relatively fast, as it is a naturally occurring compound found in buckwheat 
seeds and is currently awaiting approval for use as a natural supplement by Generally Regarded as 
Safe (GRAS). 
Future Directions 
 While the data presented in this dissertation clearly suggests a role for lipid peroxidation-
mediated oxidative stress in aging, and consequently salicylamine-mediated protective effects 
against aging via an undefined pathway involving SIR-2.1 and ETS-7 in Caenorhabditis elegans, 
the exact mechanism which SA administration affects longevity regulation remains to be 
determined. Considering the mechanism of action for SA scavenging of IsoKs, we are well aware 
that SA functions to protect against deleterious effects of isoketal adduction on the protein level, 
therefore it is within reason to assume there are other protein targets likely to be preserved with 
SA treatment which may also function in the regulation of longevity. A full characterization of the 
proteome-level effects of SA was beyond the scope of this present dissertation, but a next logical 
step in order to flesh out the findings from this dissertation. 
 The dosing regimen from the study presented is also of slight concern. The precise drug 
exposure response with SA administration cannot be obtained from the studies reported in this 
dissertation. Animals were exposed continually with SA throughout its lifetime, but biochemical 
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measures were taken at a snapshot of its life time. To develop a more accurate SA exposure 
response profile in future directions, we would recommend measuring drug exposure over time for 
every experimental approach, similar to the drug exposure over time profiles generated in the 
progressive autofluorescent lipofuscin experiments (Fig. 4.1C and 4.3D). By measuring drug 
exposure over time and generating area-under-the-curve (AUC) analysis we were able to develop 
a more comprehensive profile for drug administration for that particular assay. Developing drug 
exposure profiles with AUC analysis for our biochemical measures (such as F3-IsoP collection, 
western blot analysis, etc.) would have given us more powerful tools to analyze the pharmacologic 
range of SA in C. elegans and determine a dose-effect relationship with SA administration. 
 Lastly, all studies conducted in this dissertation was generated exclusively in C. elegans. 
While the genetic tractability and short lifespans makes C. elegans a powerful model for aging 
research, the anti-aging effects of SA administration will need to be verified in a more complex 
model organism. Considering the beneficial effects of SA treatment in a variety of mammalian 
models of disease (reviewed more in-depth in Chapter I), the translation into other mammalian 
models of aging is feasible and the next logical progression of this research. 
Conclusions 
 The overall goal of this thesis research was to examine the molecular and biophysical 
processes of IsoK-mediated oxidative damage that contribute to aging, and to consequently 
provide the basis for the development of new rational therapeutic interventions, such as 
salicylamine, to limit oxidative damage. Through these studies, we have developed an analytical 
approach to assess endogenous levels of oxidative stress in C. elegans, and identified a major pro-
longevity pathway in which pharmacological manipulation could extend organismal lifespan.  
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APPENDIX A 
 
F2-Isoprostane Assay – Additional Steps Required for Samples from Patients Receiving 
Propofol Anesthetic 
 
Introduction 
 The following scheme is to be performed after samples are extracted using the silica Sep-
Pak cartridge, and dried under nitrogen at 37C. After TLC chromatography is performed, proceed 
with the existing protocol by reacting samples with PFBB. This modification is in courtesy of 
William E. Zackert from the Clinical Pharmacology Department in Vanderbilt University Medical 
Center. 
Thin-Layer Chromatography Protocol 
Dry samples eluted from silica Sep-Pak in normal assay, under N2 at 37C. Re-suspend in 
50ul methanol. Spot on a pre-washed silica TLC plate and place in tank containing 100mls of 
solvent consisting of: 
Supplementary Table 3: TLC chromatography tank composition 
Chloroform 85 % 
Methanol 15 % 
Acetic Acid 1 % 
Water 0.8 % 
 
Spot a standard plate with 5ug PGF2a, free acid TLC standard, place plates in tank and 
run to 13cm above the origin. Spray standard plate with phosphomolybdic acid and place on hot 
plate until standard band appears. Scrape 2cm of silica off each sample plate from 0.5cm above 
the top of the F2a band, to 1.5cm below the top of the band. Extract the silica with 1ml, 1:1 ethyl 
acetate: ethanol. Centrifuge, transfer supernatant to another microcentrifuge tube and dry under 
N2. Perform PFBB and 2
nd TLC (93:7) steps as normal.  
